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Chronic irritant contact dermatitis (ICD) is a common clinical problem, arising from 
contact with a diverse range of irritants, affecting people both in the workplace and the 
home. Previous studies have concentrated on the late acute irritant response (24 hours 
onwards) in normal volunteers. To date there is limited knowledge of acute irritant 
reactions in patients with established ICD. For this reason we have compared the effect 
of three chemically diverse common irritants on 100 patients with a history of chronic 
ICD for more than 6 weeks, and 31 normal volunteers. The irritants were titrated on 
normal skin to induce similar grades of erythema by 48 hours. The final concentrations, 
80% nonanoic acid (NA), 5% sodium Iaury! sulphate (SLS) and 0.01% dithranol (DL) 
were applied to the volar aspect of the forearm for various timepoints up to 48 hours. 
Samples were obtained from punch biopsies and suction blisters enabling us to study the 
cellular and molecular mechanisms associated with the onset of irritant reactions. In 
addition this has allowed comparisons to be made between acute reactions in ICD 
patients with previous data from normal volunteers. 
Immunohistochemical methods were used to investigate a number of parameters, the 
findings of which were entered onto a database and statistically analysed. DL irritation 
evoked minimal histopathological changes. Epidermal damage however, was observed 
after both NA and SLS application. NA irritation profoundly affected the epidermal LC 
population, inducing redistribution, apoptosis and a dramatic decrease in LC numbers by 
24 hours. Keratinocyte (KC) apoptosis and mild spongiosis was also evident. In 
contrast SLS irritation had a marked affect upon the epidermal KC population, inducing 
proliferation, parakeratosis, severe oedema and focal KC activation by 24 and 48 hours. 
KC activation, defined by .tvrn:C IT and CD54 expression accompanied an extensive 
leucocyte exocytosis. SLS irritation also reduced epidermal LC numbers by 48 hours, 
but not as a result of apoptosis. These findings suggest that for the two irritants different 
mechanisms are involved in LC reduction and therefore have important implications for 
antigen presentation and immune responses. KC activation and the resultant leucocyte 
influx were probably triggered through cytokine production. We suggest that the potent 
T cell and neutrophil chemoattractant IL-8, present after SLS application, was 
responsible for the heavy dermal and subsequent epidermal leucocyte influx observed by 
24 and 48 hours. In the case of NA irritation leucocyte infiltration was less significant, 
neutrophils were present in the papillary dermis infiltrate at 6 hours, although this influx 
was not sustained. In contrast, SLS irritation caused dermal accumulation of larger 
numbers of neutrophils at 24 and 48 hours. Western blotting studies revealed no 
evidence for the involvement of autoimmune mechanisms in the pathogenesis of either 
irritant reaction. 
Our results clearly indicate that the pathological processes induced by NA or SLS are 
distinct despite comparable clinical reactions. Both irritants provoked epidermal 
damage, differentially affecting the epidermal architecture and cellular components, with 
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1.0. INTRODUCTION 
Dermatitis is a widespread, social and economic problem. Its prognosis is often poor 
and to date there is little knowledge concerning cellular and molecular mechanisms 
underlying the disease process. This study investigated early irritant reactions in both 
patients and normal healthy volunteers to determine the mechanisms involved m 
initiation of chronic inflammation. 
This introduction initially gives a brief description of the cutaneous environment. 
The cutaneous immune system is the main emphasis of the thesis; therefore two 
sections describe the · cellular immunology in some detail. Then sections move onto 
chronic lCD itself and outline the irritants chosen for the study. Finally, a section on 
autoimmunity is also included as I propose that the chronicity of lCD may in some 
cases be the result of an autoimmune response. 
1.1. THE CUTANEOUS ENVIRONMENT 
The skin is the largest organ in the body and functions as a protective barrier from the 
external environment. This physical barrier provides protection from sunlight, 
microorganisms, mechanical and chemical insults. 
The skin comprises two distinct layers, the epidermis and dermis (Figure 1.1). These 
are separated by a semi-permeable basement membrane (dermal-epidermal junction) 
which permits the bi-directional movement of molecules across it. The epidermis is 
between 75-150J.tm thick over the whole body, except on the palms and soles where 
it is considerably thicker ( 400-600J.tm). It is composed predominantly of 
keratinocytes (KC) (90-95%), with smaller numbers of Langerhans cells (LC) (2-
8%), melanocytes and Merkel cells. The underlying dermis is of varying thickness 
FIGURE 1: Schematic representation of the skin 
(adapted from diagram by G.Priestley in The Molecular Aspects of Dermatology John 
Wiley and sons, Ltd. , 1993) 
KEY : 
sc Stratum corneum KG Keratohyalin granules 
SG Stratum granulosum LC Langerhans cell 
ss Stratum spinosum M Melanocyte 
SB Stratum basale FB Fibroblast 
BM Basement membrane CB Collagen bundles 
SF Subdermal fat MC Mast cell 
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depending on the body region. This layer consists of a dense fibrous network of 
proteoglycans, fibronectin and other proteins, providing strength and elasticity to the 
skin as well as housing resident cells such as tissue macrophages and mast cells. The 
dermis also provides support to the vascular and nerve networks, and contains 
excretory and secretory glands, and keratinised appendageal structures such as hair. 
Based on evidence that both epidermal and dermal cells show immune function it has 
now become clear that the skin is an immunologically active organ capable of 
eliciting a local immune response (reviewed by Bos and Kapsenberg, 1986). 
1.2. THE CUTANEOUS IMMUNE SYSTEM 
Observations made by Silberberg and her colleagues in 1973, demonstrating the 
spatial apposition of epidermal dendritic cells and infiltrating T lymphocytes in 
allergic contact dermatitis, gave the first indication that the epidermis contained 
res ident immunocompetent cells (Silberberg, 1973). These findings suggested that 
the epidermis is actively involved in immunological responses, providing more than 
just innate immunity. Early in this century, Alexander Besredka was one of the first 
people to suggest the existence of organ specific immunity (reviewed by Bos and 
Kapsenberg, 1993). Since then it has been hypothesised that the skin may function as 
a primary or secondary lymphoid organ although there has been no definitive 
evidence for these theories. The concept of the skin as an immune organ is supported 
by evidence of a cutaneous microenvironment capable of processing and presenting 
antigen (Ag), strategically located peripheral lymph nodes and subsets of 'skin 
homing' T lymphocytes. The phrase 'Skin Associated Lymphoid Tissue' (SALT) 
was coined in 1978 by Streilein to describe this cutaneous microenvironment. SALT 
is comprised of four functional ly distinct cell types and a set of draining peripheral 
lymph nodes (reviewed by Streilein, 1983, Krueger and Sting!, 1989). The 
lymphatics start in the papillary dermis and drain the adjacent tissue in a one-way 
flow toward the regional lymph nodes, providing a regulatory mechanism for cell 
hydration, osmosis and immunological responses (Brand el al, 1992). 
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The cellular components of SALT include : 
1. Langerhans Cells and dermal dendritic cells, the antigen presenting cells (APC) 
of the skin. 
2. Keratinocytes, the largest cellular component creating a microenvironment 
suitable for Ag uptake. 
3. Lymphocytes. B cells are seldom found in normal skin; the lymphocyte 
population is composed entirely of a distinct cutaneous subpopulation of T 
lymphocytes (Bos eta!, 1987, reviewed by Krueger and Sting!, 1989). 
4. Endothelial Cells (EC). Through receptor-ligand interaction the EC of dermal 
vessels promote the influx of lymphocytes into the dermis and eventually 
epidermis. 
In 1986 Bos and Kapsenberg proposed the term 'Skin Immune System' (SIS) to 
further describe the complexity of cutaneous immune function. SIS describes the 
overall interactions of the cellular components of SALT with humoral factors and 
other cell types present in normal human skin. These include mast cells, 
macrophages and granulocytes (reviewed by Bos and Kapsenberg, 1986, 1993) 
• LANGERHANS CELLS (LC) 
In 1868, whilst working as student in Berlin, Paul Langerhans first described a 
population of epidermal dendritic cells in skin impregnated with gold chloride. 
Langerhans published elaborate drawings clearly showing the regularly spaced 
suprabasal dendritic cells within the epidermis, with branched and tapering processes 
extending far into the surrounding epithelium (reviewed by Hunter, 1983, Schuler, 
1991 ). He suggested these cells were of neural origin, a concept unchallenged until 
the advent of the electron microscope and Birbeck's historic paper in 1961. 
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MORPHOLOGY AND DISTRIBUTION 
Birbeck and colleagues first described LC ultrastructure using electron micrographs 
(Birbeck eta/, 1961 , reviewed by Choi and Sauder, 1986). 
The main electron microscopic features include: 
• an irregular surface membrane, lacking desmosomes. 
• a lack of cytoplasmic tonofilaments and premelanosomes giving a 'clear' 
cytoplasm. 
• a convoluted nucleus. 
• a well developed Golgi zone with numerous mitochondria. 
• the presence of unique rod-like trilaminar cytoplasmic organelles now known as 
Birbeck granules, found in association with small vesicles, fonning a 
characteristic tennis racket-like structure, with the handle portion having a linear, 
striated lamella between its two membranes. The origin and function of these 
structures remain unclear. 
LCs can also be characterised at the light microscope level by utilising 
immunological plasma membrane markers such as CDla, MHC II and Fe receptors 
(Hanau et a/, 1988). 
There is a relatively even distribution of LCs throughout the skin. However, the 
cornea of normal eyes is devoid of LCs, except at its limbic attachment (Streilein, 
1983). It was originally believed that LCs were confined to the epidennis but they 
have now been described in the dennis, lymph nodes and lymphatics draining the 
skin. Nevertheless, the largest number of LCs are found within the epidennis, 
comprising between 2-8% of epidennal cells (reviewed by Wolff and Stingl, 1983, 
Choi and Sauder, 1986) 
ORIGIN AND FUNCTION 
By the late 1970s two functional roles had been put forward for the LC. Firstly, 
involvement in regulation of KC proliferation and differentiation and secondly, 
performing macrophage-like functions in immune reactions. Little evidence exists to 
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prove that LCs play a role in KC regulation, although LCs constitutively produce IL-
l , important for KC growth (reviewed by Sauder, 1984). Elaborate chimera 
experiments on mice, carried out by Katz and colleagues, provided indisputable 
evidence of the bone marrow (i.e. leucocyte) origin of the LC (reviewed by Katz et 
al, 1979), suggesting that LCs may perform macrophage-like functions. The origin 
of these cells was further corroborated by the recent finding that LCs uniformly 
express CD45, an Ag shared by allleucocytes (Schuler, 1991). 
In the late seventies two independent groups showed LC expression of surface 
receptors already known to be present on the surface of cells involved in immune 
functions. LCs constitutively express Fe receptors (FcRs) and C3 receptors and are 
MHC II positive (Rowden et a/, 1977, Klareskog et al 1977, Sting! et al, 1977). 
More recently it has been demonstrated that the FcRs expressed by normal epidermal 
LC are of the type FcyRJIICD32 (De la Salle et al, 1992). These receptors are 
believed to be important in endocytosis, phagocytosis and antibody {Ab) dependent 
cell mediated cytotoxicity. Since LCs have been shown to have a relatively poor 
phagocytic ability, expression of these receptors may be important in uptake of Ag, 
and may, for instance, play a role in allergic dermatitis (Schuler, 1991). 
Shelley and Juhlin proposed that LCs form a reticuloepithelia1 trap for external Ag 
and then transport the Ag to the draining lymph node via the afferent lymphatics 
(Shelley and Juhlin, 1976). This was corroborated by Rowden and colleagues who 
demonstrated that LCs may bind to various allergens and then migrate to the draining 
lymph node (Rowden et al, 1977). Studies utilising skin-sensitising tluorochromes, 
for example, fluorescein-isothiocyanate (FITC) have demonstrated that a significant 
proportion of the DCs arriving in the draining lymph node (LN) after sensitisation 
bear the fluorochrome Ag (Macatonia et al, 1987). These data provide definitive 
evidence that the DCs found in the LN originate from the epidermis where they 
acquired the Ag. 
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Mixed lymphocyte reactions (MLR) have shown that LC enriched epidermal cell 
cultures can induce an Ag-specific T cell proliferative response comparable to that 
seen with macrophage cultures (Sting! et a!, 1978). Antigen-presentation and MLR-
stimulation ofT cells by LCs is abrogated by the introduction of anti-Ia antibodies 
and complement, showing that LC-T cell interactions are MHC IT restricted as would 
be expected from a professional APC (Sting! et a!, 1978). Collectively these findings 
support the concept that LCs function as professional APCs forming a major part of 
the epidermal immune system. 
Various groups have shown that freshly isolated epidermal LCs are very effective Ag 
processors but are relatively poor at Ag presentation. Cultured or dermal LCs on the 
other hand are inefficient Ag processors but are very good at Ag presentation 
(reviewed by Bos and Kapsenberg, 1993) The reports that LCs can perform a variety 
of functions depending on their cutaneous location indicate that LCs undergo some 
form of phenotypic and functional maturation during the migration from the 
epidermis allowing effective Ag presentation in the draining lymph nodes. The 
increase in LC APC function seen after cell culture is therefore thought to mimic the 
in vivo differentiation process occurring in LC migration to the draining lymph nodes 
(Symington eta/, 1993, Shibaki eta!, 1995). 
LC MATURATION AND ACTIVATION (Table 1.1, page 9) 
LC migration and ensuing maturational changes are mediated by cytokines. IL-l 
(Heufler et a/, 1988) and GM-CSF (Heufler et a/, 1988, Kolenik, et a!, 1990) have 
been implicated in maturational changes, while TNFa. (Kimber and Cumberbatch, 
1992) and GM-CSF (Rupee et a/, 1996) are thought to be important signals for 
migration. IL-l alone does not maintain LC viability but acts in synergy with GM-
CSF in the enhancement of APC function (Heufler el al, 1988). GM-CSF is the 
major cytokine involved in the LC maturational process acting through decreased 
CD 1 a expression and an increase in the cell's ability to stimulate T cell proliferation 
(Kolenik er a!, 1990). Further maturational changes occur during migration, 
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including an increase in MHC II expression (Cumberbatch et a/, 1992), alteration in 
the patterns of adhesion molecules expressed and induction of B7 expression 
(Symington et a/, 1993). TNFa is important for migration; various groups have 
shown that cutaneou~Jy injected recombinant TNF induces a time and dose 
dependent LC response (Kimber and Cumberbatch, 1992: Groves et a/, 1995). GM-
CSF and TNFa are also thought to be important in the generation of LCs from 
CD34+ haematopoietic progenitors (Caux et a/, I992). 
Epidermal LCs express CD1a, CDlc and MHC II, once in the dermis they show a 10 
fold lower expression of CD I a (Meunier et a! , 1993), with CD I expression now 
predominantly CD I c (Elder et a/, 1993). Four CD I proteins have been described 
(CD I a, b, c, and d). The CD I isoforms are expressed on the cell surface in 
association with beta-2-microglobulin resulting in the formation of a novel, 
nonpolymorphic, Ag-presentation mechanism independent of MHC II (reviewed by 
Porcelli and Modlin, I995). Preliminary data suggests that CD I molecules may have 
evolved to present non-peptide lipid Ags to T cells in the skin (reviewed by Porcelli 
and Modlin, I995). 
Maturation not only involves downregulation of CD 1 a; LCs begin to express 
accessory molecules such as CD54 (ICAM-1) and CD58 (LFA-3) (Table 1.1). 
Mixed lymphocyte and time-course studies have revealed that interactions with 
CD 54, and also CD 58 are of prime importance during initiation ofT cell activation 
(Marcel et al, 1994). LCs have also been shown to constitutively express CD50 
(ICAM-3) which, as described for CD54, plays an important role in the initiation 
phase ofT cell activation. Expression of these two LFA-1 ligands is differentially 
regulated (Teurussen et al, 1995). The cytoplasmic domains of the two molecules 
share little homology, resulting in the promotion of different signals upon LFA-1 
(CD 11 a/ CD 18) ligation (Manara et al, 1996). It has been suggested that the initial T 
cell adhesion via CD50 (ICAM-3) may lead to an increase in CD54 (ICAM-1) 
expression (Manara et al, I996). Members of the B7 family, expressed upon 
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TABLE 1.1: Adhesion molecules expressed on LC. 
CD OTHER NAMES CELLULAR DISTRIBUTION CUTANEOUS FUNCTIONS 
NUMBER 
•' .:. . _.., . · ~· .. 
COla immature LC antigen presentation 
COle mature LC antigen presentation 
COl le a. chain, 132 integrins mature LC, Jeucocytes adhesion and T cell activation 
COlla/CD18 LFA-1 (132 integrins) mature LC and other leucocytes adhesion and T cell activation 
C049a/CD29 VLA-1 LC, acti vated T cells, monocytes 
\0 
C049b/C0 29 VLA-2 LC, KC, 8 cells, monocytes LC migration 
C049c/C029 VLA-3 LC, KC, 8 cells LC migration 
C049d/C029 VLA-4 LC, 8 cells 
CD49e/C029 VLA-5 LC, memory T cells, monocytes 
C049f/CD29 VLA-6 LC, memory T cells, monocytes 
coso ICAM-3 mature LC, leucocytes adhesion and T cell activation 
CD 54 ICAM- 1 mature LC, endothelium, activated cells adhesion and T cell activation 
C062E E-Selectin endothelium binds sialyllewis-X on LC, aids migration 
C080 87-1 mature LC, 8 cells accessory molecule 
C086 87-2 mature LC, 8 cells accessory molecule 
~ . 
maturation, are also T cell costimulators, and may synergise with the effects of CD 54 
to initiate T cell activation (Symington eta/ , 1993). 
Mature LCs have been shown to express both B7-l (CD80) and B7-2 (CD86) which 
have recently been shown to be involved in the selective activation of THl and TH2 
cell clones respectively (Nickoloff et al, 1995, Ozawa eta!, 1996, table 1). In mice 
anti-B7-l antibodies induce T cell production of IL-4 (TH2) whereas anti-B7-2 
antibodies result in IFNy production (THl). Expression of adhesion molecules is 
known to be modulated by cytokines. In the case of B7- l, GM-CSF and IL- l up-
regulate LC expression whereas, IFNy and IL-l 0 have been shown to suppress 
induction in cultured LC (Chang et a!, 1995, Furue, 1996)). GM-CSF, can partially 
restore IFNy induced suppression of B 7-1 but the mechanism for IL-l 0 suppression is 
as yet unclear (Ozawa eta!, 1996). The modulatory effects of these cytokines are seen 
only in early LC maturational stages, during initiation of B7 expression. This suggests 
that cytokines affect synthesis not degradation of already existing B7 molecules 
(Kawamura and Furue, 1995). IL-l 0 may therefore exert immunosuppressive effects 
by inhibiting B7 expression on LCs. IL-10 has also been shown to inhibit CD54 
expression (Kawamura and Furue, 1995). KCs produce a wide spectrum of cytokines 
and it is possible that B7 expression may be reciprocally regulated in the epidermal 
microenviroment. 
LCs weakly express the Very Late Antigen (VLA) adhesion molecules. These are 
made up of a common P chain (CD29) and variable a chains (the CD49 Ags). LCs 
express VLA-l/CD49a and VLA-3/CD49c and moderately express VLA-2/CD49b & 
VLA-5/CD49e (Table 1.1). The predominant VLA molecules expressed are 4 
(CD49d) & 6 (CD49f), the function of which are still unclear. It has been suggested 
that the proportion of these VLA molecules expressed on the LC surface may vary 
during the maturation process. For example, CD49b and CD49c are also present on 
KCs, and may allow the formation of weak, transient bonds between the two cell 
types, allowing LC to either remain in the suprabasal area while their neighbouring 
KCs move upwards, or to migrate from the epidermis. LC motility is further aided 
because of the lack of firm cell-cell associations due to the absence of LC 
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desmosomes. On migration into the dermis CD49b and CD49c loose their importance 
and other VLA molecules take over (Le Varlet eta/, 1991) 
Ross and colleagues (1994) have shown expression of sialyl Lewis-x on epidermal 
LCs, which is enhanced upon activation. The ligand for sialyl Lewis-x, CD62E (E-
selectin), is expressed on the dermal endothelium. Interaction between these 
molecules is therefore of significant importance in LC migration both into and out of 
the skin. LC expression of sialyl Lewis-x in normal skin is consistent with frequent 
turnover of the epidermal LC population, such that residual levels of adhesion 
molecules required for migration are present on resting cells. The increase in sialyl 
Lewis-x upon activation r:nay therefore facilitate LC migration to the draining lymph 
nodes (Ross eta!, 1994). 
Recent data reveal that different phenotypic and functional stages of the LC may be 
present not only in the dermis and epidermis but within the epidermis itself. Flow 
cytometric analysis has revealed two populations ofLCs within the epidermis. Firstly, 
a HLA-DRhi, CD1lchi population. This may represent a recently activated group, 
having undergone maturational changes but without yet having migrated or a group of 
cells which has recently arrived in the epidermis. CD 11 c is the alpha chain of P2 
integrins. P2 integrins are adhesion molecules responsible for cytoskeleton 
connection. Variation in expression may therefore regulate LC morphology, function 
or intraepidermal position. The second group of LC is the more traditional HLA-
DRlo, CDllclo population of resident cells (Shibach eta/, 1995). 
LC-T LYMPHOCYTE INTERACTIONS 
Activation ofT cells requires two signals. The first must be a specific signal through 
MHC-Ag binding T cell receptor (TCR) and the second a costimulatory signal 
package via adhesion molecule binding and/or soluble cytokine/receptor ligation. LCs 
can interact with two distinct populations ofT cells. They process and present Ag, not 
previously encountered by the immune system, to naive T cells in the draining lymph 
nodes. They may also function as professional APCs for the memory T cells present 
in the epidermis. Memory/effector T cells have less stringent requirements for 
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activation and may be stimulated by APCs resident in the epidermis. Adhesion 
molecule and cytokine expression are quantitatively and qualitatively more important 
in activation of naive T cells, initiated by mature LCs in the draining lymph nodes. 
These findings are supported from work carried out by Hauser and colleagues who 
have demonstrated that cultured LCs, pulsed with Ag, were able to activate unprimed 
T cells in vitro (reviewed by Streilein et a!, 1990). This topic is covered in more 
detail in further sections. 
• KERATINOCYTES (KC) 
KC derive their name from the keratins that comprise between 30 and 50% of their 
total cellular protein. The keratin family encompasses more than 30 proteins forming 
8nm intermediate cytoplasmic filaments, consisting of 2-5 polypeptides. Keratins are 
encoded by two separate gene families: one responsible for basic (type I) and the other 
for acidic (Type II) keratins. Individual keratins exist in pairs always consisting of 
one type I and one type II keratin. Keratin classes have been used in the literature to 
determine different stages in the terminal differentiation pathway (Woodcock-Mitchell 
et al, 1982). The main keratins in the basal cell and prickle cell layers are K5 (type II, 
58kDa) and K 14 (type I, 50kDa) (Fuchs and Green, 1980). As KC differentiation 
occurs these are replaced by K1 and K1 0 (reviewed by Fuchs, 1993 and Hunter et a!, 
1996). 
TERMINAL DIFFERENTIATION (Fig 1.2) 
The epidermis is a stratified squamous epithelium which undergoes a genetically 
programmed pathway of terminal differentiation or keratinisation (programmed cell 
death). Cells originate in the lower epidermal layers and undergo maturation, 
involving a series of morphological and biochemical changes, as they move up 
through the epidermal layers (reviewed by Montagna eta!, 1992). 
KCs arise in the basal layer, and move to the surface through the prickle layer which 
consists of several layers of polyhedral cells. This layer is so named because 
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histologically the cells appear to be joined by 'spikes', bundles of keratin filaments 
which insert into the desmosomal plaques of opposing cells. Two or three layers of 
flattened KCs superficial to the prickle zone comprise the granular layer, 
characteristically defined by the presence of keratohyalin granules and physiological 
disintegration of cytoplasmic organelles, including the nucleus (Karasek et al, 1972). 
Keratohyalin and lamellar granules represent newly synthesised organelles containing 
a variety of lipids, complex carbohydrates and hydrolytic enzymes which contribute to 
the barrier function of the horny layer. An extension to the granular layer a compact 
transitional layer, may be observed in thickened skin . 
The cells eventually reach the outermost or horny layer, which comprises several 
layers of flat anucleate cells which are ultimately sloughed from the skin. The 
characteristic feature of this layer is the formation of an insoluble cross-linked protein 
envelope, closely apposed to the cytoplasmic surface of the plasma membrane 
(reviewed by Watt, 1983). A complex mixture of polar and nonpolar lipids exists in 
the intercellular spaces of the SC which act together with keratohyalin granules to 
serve as a barrier against transcutaneous water loss (reviewed in Schurer, 1991 ). 
Based on cellular kinetics the epidermis can be divided into a proliferative and a 
differentiating compartment (reviewed by Hamilton, 1972, Lavker and Sun, 1983) 
which are part of the terminal differentiation pathway. The proliferative compartment 
is comprised of basal and suprabasal cells which are responsible for steady cellular 
turnover within the skin. This is considered to be a mixed cell population containing 
both slow cycling stern cells and transient amplifying cells capable of undergoing a 
finite number of divisions. Differentiation occurs in the upper prickle and granular 
layers, where maturation, involving increased cell size (Sun and Green, 1976), altered 
keratin expression (Fuchs and Green, 1980, Woodcock-Mitchell et a/, 1982) and 
adhesion molecule expression (reviewed by Haynes, 1987, Adams and Watt, 1990, 
Watt 1993) take place without cellular generation (reviewed by Lavker and Sun, 
1983). 
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FIGURE 1.2: Terminal differentiation in the KC. 
(adapted from diagram by Gawkrodger. In: An illustrated colur text. 
Dermatology. Longman group UK, Ltd., 1992). 
Stratum corneum r 
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Programmed cell death (PCD) results in controlled cell deletion, avoiding induction of 
inflammation. PCD plays a complementary but opposite role to mitosis and is 
therefore of major importance in tissue homeostasis. The epidermis is an organ that 
undergoes terminal differentiation with the eventual death of KCs; this process has 
therefore been suggested to be a specialised form of programmed cell death (reviewed 
by Haake and Polakowska, 1993). The importance of the balance between cell death 
and proliferation is highlighted by the epidermal hyperplasia observed in many skin 
diseases, for example psoriasis. This hyperplasia may result not only from increased 
proliferation but may also be due to disruption of terminal differentiation. 
IM:MUNE FUNCTION 
KCs are not solely programmed to synthesise keratin and undergo terminal 
differentiation, they are also capable of an immune/inflammatory function through the 
constitutive and inductive expression of surface molecules and cytokines (see section 
1.2.6). In 1981 the potential role of the KC in immune functions was first proposed 
after two independent observations, the production of IL-l by KCs (Luger et a/, 1981) 
and KC expression ofMHC II (Lampert eta/, 1981). 
MHC II expression is not constitutive but KC synthesis and expression of HLA-DR 
molecules has been described in diseased skin (Volc-Platzer et a!, 1984; Lampert et 
a!, 1981) or in culture after exposure to IFNy (reviewed by Nickoloff et a!, 1986). 
Expression of MHC II enables KCs to produce co-stimulatory signals for skin 
infiltrating T cells (reviewed by Nickoloff and Naidu, 1994 ). KCs are capable of 
phagocytosis (Mottaz and Zelikson, 1970) a function relevant to the concept of the KC 
acting as an APC through expression of HLA-DR, uptake of particulate Ag and 
presentation to LC. As LCs phagocytose poorly this may be an important early step in 
the initiation of an immune response against particulate Ag (reviewed by Streilein, 
1990). 
Constitutive production of KC cytokines is very low and, like many other cell types, 
KCs require an exogenous signal to initiate cytokine synthesis and/or secretion. KCs 
may become directly activated by environmental stimuli, such as mechanical irritation, 
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UVB irradiation or bacterial products (Nickoloff and Turka, 1994), responding 
through production of cytokines which influence both surrounding epidermal as well 
as dermal cells. Cytokine production results in KC activation and up-regulation of 
various surface accessory molecules including CD54 (Griffiths et a/, 1989) and CD86 
(Nickoloff eta/, 1995). CD54/LF A-1 ligation is thought to be important in KC-T cell 
interactions as the presence of intraepidermal lymphocytes correlates well with KC 
CD54 expression in many skin diseases including psoriasis, atopic dermatitis and 
lichen planus. Cytokines also play a role in T lymphocyte migration into the 
epidermis. IL- l and IL-8 are involved in T lymphocyte chemotaxis (Yoshimura, 
1987; Dowd, 1988, reviewed by Barker et al, 1991) and are both produced by KCs 
(Luger et al, 1981; Larsen et al, 1989). 
• APOPTOSIS 
Apoptosis is a form of physiological PCD but may also occur as a co-ordinated 
cellular response to external stimuli which cause irreversible cell damage. The 
cellular triggers of apoptosis include DNA damage, intracellular receptor ligation (e.g. 
by steroid exposure) and ligand binding to specific cell surface receptors (for example 
CD95, TNFR). Further regulatory molecules may be required in addition to these 
triggers, for example various members of the bcl-2 family. This family will be 
discussed further as it is thought to be of particular importance in the skin. The 
apoptotic process itself depends on the activation of a group of cysteine proteases 
which appear to be directly responsible for the structural changes of apoptosis. 
Examples include Ced-3 in C.elegans (Ellis and Horntzl, 1986) and the lL-1 p 
converting enzyme (ICE- like proteases) in man (Thornberry et al, 1992, Dost.B and 
Wyllie.A, 1996). 
Apoptosis is characterised morphologically by two distinct stages (Figure 1.3). 
Firstly, nuclear and cytoplasmic condensation, cell shrinkage with compaction of the 
cytoplasmic organelles, rounding up of the cell and loss of cell-cell contact. This 
leads to the production of membrane bound apoptotic bodies of varying size. The 
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second stage is the rapid phagocytosis and degradation of these apoptotic bodies by 
macrophages or neighbouring cells (Kerr et a!, 1972). Many factors, including 
cytokines, growth factors, non-physiological stimuli (such as UVB) and cell surface 
molecules (such as CD95/fas-Ligand) can initiate or suppress apoptosis. 
The AP0-1/fas antigen (CD95) is a member of the TNF receptor family, and can 
initiate apoptosis in many cell types through binding of fas ligand (fas-L) (Suda eta!, 
1993). It is thought that CD95 is involved in immune-related apoptosis, for instance 
in the development of T lymphocytes in the thymus and cytotoxic T lymphocyte 
mediated killing (Matsue et al, 1995). 
Apoptosis occurs when an internally encoded suicide program, regulated by, among 
other molecules, members of the bcl-2 gene family. Bcl-2 functions as a repressor of 
PCD induced by a variety of stimuli, and therefore acts at a step common to many 
death pathways (reviewed by Cory, 1995). Bcl-2 has been shown to associate with 
another family member bax. Bax shows extensive homology with bcl-2 and forms 
homodimers and heterodimers with Bcl-2. Oltvai and co-workers have outlined a 
model to explain the interactions between these two closely related proteins (Figure 
1.4). They have suggested that the ratio of bcl-2 to bax determines the susceptibility 
of a cell to death following an appropriate signal. When bcl-2 is in excess the cell is 
protected from death. In contrast, excess bax infers susceptibility to apoptosis 
following a death signal , i.e. bax itself will not trigger apoptosis (Oltiva et al, 1993). 
Bcl-x is yet another member of the bcl-2 family. It exists as two splice variants, the 
larger of which, bcl-xL, enhances cell survival. The smaller variant, bcl-xs, 
antagonises the survival function of bcl-2 (Boise et a!, 1993). Bcl-x may also play a 
central role in regulation of PCD, and may be important for regulation of apoptosis 
occurring through mechanisms that bypass or are independent of bcl-2 (Boise et al, 
1993). 
APOPTOSIS IN THE SKIN 
Increased levels of apoptosis have been described in a variety of skin diseases. For 
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FIGURE 1.3: 
The morphology of an apoptotic thymocyte. (Howie eta!, 1994) 
A). explosion to membrane-bound fragments B). nuclear, chromatin condensation. 
C). phagocytosis D). the pock-marked surface resulting from fusion of dilated 
endoplasmic reticulum with the cell membrane. 
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instance, high numbers of apoptotic bodies has been described in the epidermis of 
lichenoid diseases, graft versus host disease, fixed drug eruptions, regression of warts, 
UVB irradiation (sunburn cells) (reviewed by Haake and Polakowska, 1993) and more 
recently in psoriasis (Bianchi et a/, 1994). This increased apoptosis suggests that the 
pathogenesis of many cutaneous diseases may involve an imbalance in the homeostatic 
mechanisms which determine whether KC death occurs through TD or apoptosis. 
UVB induction of KC TNFa production is thought to be involved in the induction of 
apoptosis, as anti-TNF antibodies can reduce DNA fragmentation (Schwarz et a/, 
1995). In psoriatic plaques downregulation of bcl-2 expression in the basal layer is 
proposed to be central to disease pathogenesis (Bianchi et al, 1994). 
FIGURE 1.4: 
Model of the interrelationships ofbcl-2 and bax in the regulation ofPCD. 
(adapted from Oltiva et a/, 1993) 




Minimal bel-2 expression has been demonstrated in normal KCs and in inflammatory 
skin diseases such as contact dermatitis. In contrast strong expression of bcl-2 has 
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been found in tumours such as basal cell carcinoma (Nakagawa et a/, 1994). These 
findings suggest that cutaneously expressed bcl-2 may play a role in the increased 
proliferation found in malignant tumours but not in proliferation induced by 
inflammatory stimuli. 
Sayama and co-workers have shown that normal KCs express CD95 (Sayama et a/, 
1994), and that this expression is constitutive (Matsue eta/, 1995). CD95 expression 
is minimal in normal skin when compared with levels of expression observed in the 
lesional epidermis of a variety of inflammatory diseases, for example contact 
dermatitis (Sayama eta!, 1994). CD95 mediated apoptosis in KCs has been shown to 
require KC activation, through IFNy or IL-2 signalling (Matsue et a/, 1995). In fact 
IFNy exposure has been shown to result in a 4 fold increase in the number of cultured 
KCs expressing CD95 (Sayama et a/, 1994). These findings suggest that CD95 may 
not be involved in promoting terminal differentiation but rather in induction of 
apoptosis in inflammatory skin diseases. 
Dendritic cells undergo apoptosis unless they are appropriately stimulated either via 
cell-cell contact or through cytokines. Mature LCs have been shown to be rescued 
from apoptosis by TN Fa. or CD40-CD40L interaction. Conversely, IL-l 0 has been 
shown to reduce LC viability (Ludewig et a/, 1995). Apoptosis of LCs, and other 
effector cells, may play an important role in the control or resolution of skin 
inflammation. 
• SKIN LYMPHOCYTES 
Lymphocytes are mobile cells which normally circulate in the peripheral blood. 
However at specific sites these cells migrate into organs including spleen, lung, lymph 
nodes and skin. This is not a random migration and is dependent upon a variety of 
factors including whether the cell is a T or B lymphocyte, if the cell is resting or 
activated and where the Ag specificity of the lymphocyte was acquired. Under these 
specific conditions lymphocytes adhere to and migrate through the vessel wall into the 
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tissue. These migratory processes are directed by highly specific receptor/ligand 
interactions (reviewed by Nickoloff, 1990). 
The existence of organ-specific migration pathways has been demonstrated by various 
groups by showing, for example, that some T lymphocytes generated within the 
peripheral lymph nodes will preferentially infiltrate the skin. Further examples 
include mesenteric T lymphocytes which when injected back into the host will home 
to the gut (reviewed by Streilein, 1983). The migratory properties of these cells are 
independent of Ag-specificity . 
Specific migration is thought, in some cases, to be determined by selective recognition 
of organ-specific determinants on the endothelial cells of the specialised high 
endothelial venules (HEY) (Stevens et a!, 1992). In the case of skin, memory T 
lymphocytes expressing the cutaneous lymphocyte antigen (CLA) specifically migrate 
into the skin through CLA - E-selectin (CD62E) interaction (reviewed by Bos and 
Kapsenberg, 1993). 
Small numbers of lymphocytes are present in normal skin, suggesting that lymphocyte 
trafficking occurs as part of the normal homeostatic mechanism. Ninety percent of 
cutaneous T lymphocytes are seen to be clustered around postcapillary venules, with 
an even distribution of CD4 and CD8 positive cells, the majority of which are 
activated. Less than 10% of the lymphocytes are observed subepidermally or as single 
cells, this small population is mainly CD8 positive suppresser/cytotoxic cells. The 
presence of intraepidermal lymphocytes was probably first described by Kondon in 
1922. Since that time it has been established that less than 2% of the total lymphocyte 
population in normal skin is intraepidermal (reviewed by Bos et a!, 1987) and of the 
CD2/CD3/CD8 phenotype (reviewed by Krueger and Sting!, 1989). 
The skin homing T lymphocyte plays an important role in disease and is prominent in 
many dermatological disorders ranging from the cutaneous lymphomas to common 
inflammatory skin diseases such as psoriasis. 
21 
LYMPHOCYTE MIGRATION 
Adhesion of lymphocytes to the vascular endothelium is the first step in the migration 
(diapedesis) of cells from blood into tissue. Adhesion molecules have been described 
as playing an important role in this process, for example CD54 (ICAM-1), CDI06 
(VCAM-1) and CD62E (E-Selectin) (reviewed by Barker, 1992). Many of the EC 
adhesion molecules important in diapedesis are not expressed or expressed only in 
low levels in normal skin. CD54, for example, is expressed only in low levels on the 
vascular endothelium of normal skin (Griffiths et a/, 1989). This low level expression 
of adhesion molecules is probably important for T lymphocyte migration involved in 
normal homeostatic control. Work carried out by Haskard et a! suggested that the 
mechanisms involved in the initial binding of the lymphocyte to the endothelium may 
differ depending on the activation state of the endothelium. LFA-1 appears to be 
important for binding to unstimulated rather than stimulated endothelium where CD54 
is important (Haskard et a!, 1986). The intensity of EC CD 54 expression correlates 
with the degree of dermal infiltration and is pivotal in the migration process (Griffiths 
et a!, 1989). 
The early immune events following any type of skin injury, be it antigen driven, 
chemical, or simply mechanical, are very similar. Firstly, the dermal endothelium 
becomes activated by primary cytokines, particularly IL-l and TNFa. Primary 
cytokines are those cytokines released immediately upon skin injury. Stored IL-l 
released from the stratum corneum and in concert with IL-l and TNFa production 
from subsequently activated KC results in EC activation and expression of CD62E, 
VCAM-1 and CD54 (Butcher et al, 1979). IFNy and lipopolysaccharide have also 
been shown to increase the avidity and density of adhesion molecules expressed on the 
EC membrane (Haskard et al, 1987). IFNy in combination with TNFa induced 
expression of mRNA for IL-8 and CD 54 in epidermal KC (Barker et al, 1990). The 
importance of IL-l and TNFa in inflammation have been highlighted in experiments 
where recombinant cytokine was injected into the dermis. IL-l resulted in the 
generation of a local inflammatory infiltrate (Butcher et a/, 1979, Dowd et a!, 1988). 
Injection of recombinant TNFa resulted in induction of EC CD62E, CD54 and 
VCAM-1 expression; KC CD54 expression was also evident (Groves eta/, 1995). 
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Upon EC activation circulating lymphocytes bind to adhesion molecules and migrate 
through the endothelium into the injured site. The infiltrating cells then migrate 
through the dermis and into the epidermis along a gradient of increasing concentration 
of chemotactic factors. IL-l , released by epidermal KC, has been shown to be a 
potent T cell chemoattractant (Sauder et al, 1988) which in concert with many other 
factors plays a key role in cutaneous inflammation. Once in the epidermis T 
lymphocytes interact with the epidermal KC resulting in further KC activation (see 
KC section). 
• GRANULOCYTES 
Polymorphonuclear leucocytes contain a multilobed nucleus and many granules and 
are classified as neutrophils, eosinophils or basophils. These cells play an important 
role in acute inflammation through phagocytosis of microorganisms (Fehr and 
Dahinden, 1979). 
Neutrophils contain two major types of granules; primary or azophilic granules which 
are lysosomes containing acid hydrolases, myeloperoxidase and lysozyme. Secondary 
granules which contain lactofein in addition to lysozyme. Neutrophils are phagocytes 
which engulf and destroy harmful organisms entering the body. Extracellular release 
of granules and cytotoxic substances may also occur, usually through ligation of FcyR 
on the neutrophil cell surface. Neutrophils are thus an important element of the 
natural immune system defences. 
Neutrophils are particularly important in skin defence due to their rapid migratory 
ability. Neutrophils have been shown to bind E-selectin on endothelial cells (Rohde et 
a!, 1992) and migrate into the skin. Recently a novel transcellular mode of neutrophil 
diapedesis has been put forward. The endothelial cell is observed to engulf the 
neutrophil and subsequently release it at the abluminal side (Shubert et al, 1989). 
Once in the dermis the cells respond to chemoattractants, released upon acute injury 
(Rees er a!, 1994), in particular IL-8 (Swensson et a!, 1991 ). Exposure of 
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granulocytes to chemoattractants increases adhesion molecule expression and induces 
metabolic stimulation of these cells (reviewed by Csato et al, 1985). 
• MASTCELLS 
Mast cells are large, mononuclear cells filled with membrane-bound secretory 
granules. Mature mast cells are not usually found in the peripheral blood stream but 
are located in extravascular areas, adjacent to blood vessels, nerves or beneath 
epithelial surfaces. Mast cells undergo a characteristic pattern of biochemical and 
morphological changes during degranulation. A multitude of biologically active 
mediators, including histamine, proteases and acid hydrolases are released from 
preformed secretory granules resulting in acute inflammation (reviewed in Galli, 
1993, Dvorak, 1995). 
The tissue distribution of these cells enables them to provide a degree of natural 
immunity, giving some protection against parasites, microbes and environmental Ags. 
The precise nature of the mast cell and the mediators which they produce vary with 
anatomical location (reviewed in Galli, 1993, Dvorak, 1995). 
• CYTOKINES IN THE SKIN 
Cytokines are several different family types of glycoproteins with immunoregulatory 
capabilities. These molecules bind specific receptors through which they regulate 
activation, proliferation, differentiation, migration and immune function of many 
cells. Most cytokines have pleiotropic effects and may act both locally and 
systemically. They may act synergistically or as antagonists, and can reciprocally up 
or downregulate their own production and activity in an autocrine fashion. Cytokines 
have been separated into several groups including :-
CHEMOKINES e.g. IL-8 
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GROWTH FACTORS e.g. GM-CSF 
INTERFERONS (a,p,y) 
TUMOUR NECROSIS FACTOR (a and p) 
SUPPRESSIVE FACTORS e.g. IL-l 0 
A number of cells within the skin, including dermal leucocytes, KCs, LCs and 
melanocytes are capable of cytokine synthesis. KCs produce significant amounts of a 
wide variety of cytokines (Table 1.2, page 29) capable of interaction with high 
affinity receptors on their own and other cell membranes. Production of cytokines is 
modulated by a plethora of factors including cell cycle, cell-differentiation and 
biological or physiochemical agents such as UV irradiation, bacterial cell products, 
toxins and cytokines themselves. This chapter will summarise the cytokines pertinent 
to this thesis. 
INTERLEUKIN 1 (IL-l) 
Most cells in the body are capable of responding as a target for IL-l , including 
LCswhich constitutively produce IL-l (Choi and Sauder, 1986) and KCs which can 
also synthesise and secrete IL-l (Luger eta/, 1981; Gahring et al, 1985; Didierjean et 
a/, 1989). In contrast to macrophages , IL-l a is the predominant active form of IL-l 
released from KCs; IL-l p forms are inactive. This can be explained by the 
observation that pro-IL-l P can only be cleaved by a specific protease present in 
macrophages but not KCs (reviewed by Luger, 1989). This may be biologically 
irrelevant as both IL-l peptides bind the same receptors with comparable although not 
identical affinities (Kupper et al, 1988). There are two distinct forms of IL-l receptor 
(type l - IL-l Rti [80kD]and type 2 - IL-l Rtll [ 68kD]), type 1 being expressed on T 
cells, fibroblasts, KCs and endothelial cells and type 2 on B cells, neutrophils and 
bone marrow cells. The two forms of IL-l bind distinct sites on the receptors; in 
general IL-l a binds more effectively to type 1 and IL-l P to type 2. KCs are able to 
regulate the number of IL-l R expressed on the cell surface and can therefore regulate 
their own sensitivity to exogenous IL-l. For instance, activated KCs show 
heightened receptor expression and IL-l production and can therefore respond to IL-l 
in an autocrine or paracrine fashion. The absence of inflammation in normal skin 
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suggests that the interaction of IL- I with its receptor on KCs is somehow blocked 
and/or that KCs may decrease the numbers of receptors expressed on the cell surface. 
An IL-l receptor antagonist (IL- Ira) has recently been described as a competitive 
inh~bitor of IL-l, without resulting in cell activation (reviewed by Kupper, 1990). The 
fact that KCs express IL-l R suggests an autocrine function for IL-l within the skin. 
IL-l, may activate KCs to express new surface molecules including ICAM-1 (CD54) 
or to initiate synthesis or secretion of various cytokines including IL-l, IL-6, IL-8, 
GM-CSF and TNFa (reviewed by Luger, I 989, Kupper, 1990, Larsen et al, I 993). 
IL-l has been shown to induce KC proliferation (Sauder et al, 1988) and may be of 
importance together with many other KC cytokines in maintenance of cell turnover in 
normal skin or in induction of increased proliferation in the case of some skin 
diseases. 
Several groups have reported that large quantities of IL-l can be found in the SC 
(Gahring et al, 1985) and outer layers of the epidermis (Didierjean et a!, 1989). IL-l 
is synthesised in the basal layer forming large stores of cytoplasmic IL-l in cells of the 
upper epidermal layers which are not capable of IL- I production (reviewed by Ansel, 
I 990). This may make pathological sense as basal proliferating KC are involved in 
wound healing and inflammation where KC cytokines most probably play a vital role 
(reviewed by Ansel, 1990). Epidermal KC also secrete IL-1ra (Hammerberg et al, 
1992). This finding highlights the complexity of cytokine networks, suggesting that 
the balance between IL-ra and IL-l may be critical in KC growth as well as 
inflammatory processes. 
TUMOUR NECROSIS FACTORa (TNFa) 
This cytokine mediates a variety of cellular functions including induction of KC CD 54 
expression, IL-8 secretion (reviewed by Nickoloff et a!, 1991; Barker et a!, 1991) and 
increased production of IL-6 and IL-l (Kirstensen et a!, 1993 ). Various exogenous 
agents, including endotoxin, UV radiation and urushiol have been shown to induce 





Epidermal cytokines described in this section. 
Cytokine, Synthesised by: M.Wt. 
KG LC 
IL-l a Yes Yes 17 kD (biologically active form) 
IL-l p Yes Yes 17 kD (biologically active form) 
TNFa. Yes No 51 kD homotrimer 
IL-8 Yes No 8.4 kD 
GM-CSF Yes No 22 kD dimer 
IL-10 Yes No 30-40 kD 





pro-inflammatory, KC proliferation Luger, 1981 
pro-inflammatory, KC proliferation Luger, 1981 
pro-inflammatory, LC viability Ansel, 1990 
Neutrophil and T cell recruitment Larsen, 1989 
KC growth factor, LC maturation Kupper, 1988 
inhibition of cytokine synthesis Enk, 1995 
Although the role of TNFa in the epidermis is still unclear, there is evidence that 
along with other epidermal cytokines such as IL-l and GM-CSF, TNFa controls LC 
viability. TNFa has also been shown to influence LC migration during cutaneous 
immune responses (Cumberbatch et a!, 1992). TNFa induces KC CD54 expression 
and endothelial expression of E-selectin, VCAM-1 and CD54 leading to the 
recruitment ofleucocytes into the site of injection (Groves et al, 1995). 
INTERLEUKIN 8 
IL-8 is a member of the supergene family of pro-inflammatory and chemotactic 
cytokines known as the chemokines. Twelve recently cloned cytokines have been 
assigned to this group, on the basis of containing a conserved motif of four cysteine 
residues (reviewed by Taub et a!, 1993). Intradermally injected IL-8 results in 
neutrophil and monocyte recruitment (Leonard et al, 1991, Swensson et al, 1991 ). 
IL-8 itself is not a monocyte chemoattractant, therefore induction of other 
chemokines must occur after IL-8 receptor ligation. 
IL-8 is not found in normal skin (Paludan and Thestrup-Pedersen, 1992) but KC 
production is upregulated upon barrier perturbation (Gamer et al, 1994) or in various 
diseases, particularly psoriasis. IL-8 along with monocyte chemoattractant and 
activating factor (MCAF) can be upregulated by various cytokines, including IL-l , 
TNFa and IFNy (Larsen eta!, 1989). 
GRANULOCYTE MACROPHAGE COLONY STIMULATING 
FACTOR (GM-CSF) 
Results from Braunstein's group corroborated previous in vitro studies (Kupper et al, 
1988, Kaplan et a/, 1992) by showing that intradermal injection of GM-CSF induces 
KC proliferation as well as regenerative differentiation of the epidermis (Braunstein 
et a!, 1994). Production of GM-CSF by epidermal KC may therefore provide a 
potential autocrine or paracrine regulator of epidermal growth. 
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Other studies indicate that GM-CSF may also activate mature granulocytes, 
eosinophils, T cells (Griffin eta!, 1990, Burgess et al, 1987) and KC (Kupper et al, 
1988) and play a role in LC maturation (Heuffler et al, 1988; Kimber et al, 1992). 
GM-CSF synthesis is upregulated by IL-l (Kupper et a!, 1998) and both cytokines 
act synergistically in the activation of granulocytes and macrophages and in 
enhancement of LC function, thereby transiently enhancing local antimicrobial 
defences at the site of tissue injury. 
INTERLEUKIN-1 0 
IL-l 0 inhibits the production of IL-l, IL-6, IL-8, TNFa and GM-CSF at the 
transcriptional level · in monocytes, and has also been shown to inhibit its own 
synthesis (De W aal-Malefyt et a!, 1991 ). Some of the effects of IL-l 0 in the skin 
have been described in the previous sections, including downregulation of both 
ICAM-1 and B7 molecule expression (Kawamura eta!, 1995). IL-10 has also been 
shown to play a role in induction of apoptosis or decreased viability in cultured LC 
(Ludewig et a!, 1995). All the functions of IL-l 0 in the skin appear anti-
inflammatory. 
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1.3. IRRITANT CONTACT DERMATITIS 
Skin diseases are the commonest occupational illness, of which dermatitis is the most 
prevalent. Contact dermatitis may be allergic (ACD) or irritant (lCD), with irritant 
considered to be the commoner of the two. ACD is associated with immunological 
memory, resulting from sensitization to a specific antigen. In contrast, lCD is 
defmed as a localised non-immunological inflammation due to the direct influence of 
single or repeated exposure to one or more external factors (Mal ten, 1981 ). Irritant 
dermatitis is characterised clinically by erythema, oedema and dryness at the affected 
site and, too often, has a poor prognosis. 
Contact allergens initiate inflammation by immunological reactions, whereas, 
irritants induce damage through direct cytotoxic action, without prior sensitisation 
(Kligman and Wooding, 1967). Both irritant and allergic dermatitis, although 
induced by different initiating pathways, result in very similar end stage 
inflammatory responses, making the diagnosis problematic (Brasch et a/, 1992). 
They are usually distinguished by examination and patch testing. Diagnostic 
confusion means that knowledge of disease prevalence is inadequate and more 
accurate diagnostic aids are urgently required. 
Differentiation between many allergic and irritant reactions can be made with 
epicutaneous patch tests (Kligman and Epstein, 1975). This method is used routinely 
for diagnosis of ACD in the clinic and for research purposes. The chemical is usually 
applied to the skin for 24 - 48 hours and the resulting reaction assessed: 
1. ALLERGIC REACTION 
This evolves slowly, peaking 2-3 days after exposure. The reaction radiates out from 
the patch site and takes between 7 and 10 days to resolve. 
2. IRRITANT REACTION 
This often starts with burning and discomfort, seen a few hours after exposure. The 
reaction often peaks after only 24 hours, staying sharply confined to the patch area, 
and generally heals within a few days. 
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Two major types of lCD have been defined, acute and chronic (reviewed by Maltem, 
1981 , Berardesca and Distante, 1994 ): 
1. ACUTE 
Caused by a single exposure to an irritant. This results in inflammation which may 
be clinically and histologically indistinguishable from allergic contact dermatitis. 
The reaction is restricted to the site of exposure, is dose dependent and may result in 
a wide spectrum of clinical responses. Acute lCD may be the result of an 
occupational accident, for example chemical bums. 
2. CHRONIC 
This is more complex than acute lCD and may involve exposure to multiple 
causative factors over a considerable period of time. These factors on their own 
would not be sufficient to induce lCD but the cumulative effect results in disease. 
The chronicity of lCD has therefore been largely attributed to cumulative 'irritant 
effect', usually associated with impaired stratum corneum function. The SC forms 
the outermost protective epidermal layer, damage of which enhances irritant 
penetration into the skin. The condition will not always resolve with avoidance of all 
irritant exposure and the molecular and cellular basis of its persistence have yet to be 
determined. 
A wide variety of structurally unrelated chemical irritants may be encountered in 
daily life affecting people in a great many occupations, including builders, caterers, 
cleaners and hairdressers. These irritants have been separated into 4 major classes 
(shown in Table 1.3) and affect the skin through many different mechanisms. SC 
damage is a mechanism common to many irritants and is an important feature of 
irritant reactions. 
Organic solvents and detergents are the most important groups. Organic solvents are 
believed to be responsible for between 6 and 20% of lCD cases, with detergents 
accounting for almost as many cases (Bruze and Emmett, 1990). 
The response to contact with any given irritant is unpredictable and dependent on 
many factors, some of which are outlined in Table 1.4. Susceptibility varies among 
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Table 1.3: Major categories of irritation inducing substances. (Adapted from tables 
by Bruze and Emmett. In: Irritant contact dermatitis. Marcel Dekker, Inc. 1990) 
IRRITANT CLASSES EXAMPLES MODE of ACTION 
DESICCANTS acrylic dust increase SC brittleness, 
resulting in increased 
permeability 
ABRASIVES fibre-glass mechanical irritation 
ACIDS/ ALKALIS H2SOJNaOH increase TEWL, protein 
denaturation 
ORGANIC SOL VENTS & SLS decrease barrier function, 
*DETERGENTS benzalkonium denature keratins and alter 
chloride skin lipids 
*group of most importance in induction ofiCD. 
TABLE 1.4: Factors which influence irritant reactions. (Adapted from tables by 
Bruze and Emmett. In: Irritant contact dermatitis. Marcel Dekker, Inc. 1990) 
IRRITANT physical nature 
chemical properties 













populations (Kligman and Wooding, 1967), with some individuals even showing 
reactions to water if exposed frequently enough. Water can cause dry skin through 
solubilisation and removal of hygroscopic substances from the epidermis. In 
contrast, frequent contact may also result in increased hydration of the skin, 
facilitating penetration of water soluble irritants (Kligman and Wooding, 1967, 
reviewed in Bruze and Emmet, 1990) Dry skin, a result of increased transepidermal 
water loss (TEWL) (reviewed by Berardesca and Distante, 1994) is more susceptible 
to irritation. Therefore irritation is more common in the winter months when outdoor 
temperatures are low with low relative humidity, resulting in skin dryness (Tupker et 
a/, 1990). Patients with atopic dermatitis also show an increased risk of developing 
lCD, possibly because of dry skin, and therefore lower barrier function (Tupker et al, 
1990; Lee eta!, 1995). 
Young children have been shown to be susceptible to irritants; this is believed to be 
due to their high TEWL. TEWL decreases with age and maybe associated with 
increased barrier function. Therefore elderly people have a decreased susceptibility 
to irritation (reviewed by Berardesca and Distante, 1994). Race and gender may also 
be contributory factors but, so far, studies have been contradictory. 
EXPERIMENTALLY INDUCED IRRITANT REACTIONS 
As already stated the mechanisms involved in induction of lCD and the resultant 
immunological consequences are poorly understood. In order to shed some light on 
the process several groups have investigated experimentally induced irritant and 
allergic reactions in healthy volunteers. It is from these experimental studies that the 
majority of information concerning cellular infiltration and activation in lCD has 
been obtained. Table 1.5 outlines experimental methodologies previously employed 
in studies of experimental lCD. 
Some experimentally induced allergic and irritant reactions produced 48 hours after 
patch testing show similar inflammatory response in biopsies taken at 72 hours. This 






Summary of experimental designs used in the investigation of experimentally induce irritant reactions. 
EXPERIMENTAL DETAILS 
REFERENCE Subjects Irritants (vehicle) Skin site Application 
Fisher and normal 0.5%, 1% or 2% SLS (DW) upper back 24, 48, 96 hrs 
Maibach, 1975 volunteers (replaced every 
24 hrs) 
Kanerva et al, normal 0.2%DL back 30 mins 
1984 volunteers (petrolatum) 3 hrs 
Ferguson et al, ACD patients, 2%, 5% or 10% SLS upper back 48 hrs 
1985 uninvolved skin (yellow soft paraffin) 
Lindberg and normal 0.5% SLS (DW) outer thigh 6 or 24 hrs 
Emtestam, 1986 volunteers 
Willis et al, 1986 normal 0.5% BC volar forearm 3, 6, 12, 24 or 
volunteers 48 hrs 
A vnstorp et a!, normal 5% SLS (DW) lower back 4, 8, 24, 48 hrs 




B- 48 hrs 
B- 24 hrs 
B- 72 hrs 
B- 6, 24,48 & 
96 hrs 
B - 3, 6, 12, 
24, 48, 98, 196 
hrs 
B- 72 hrs 
w 
VI 
TABLE 1.5 (contd.): 
EXPERIMENTAL DETAILS 
REFERENCE Subjects Irritants (vehicle) 
Lindberg et al, normal 2% or 4% SLS (DW) 
1990 volunteers 20% or 80% NA (propan-ol) 
Willis et al, normal 5% SLS(DW), 0.5% BC(DW), 
1989, 1992 and volunteers 0.8% CO(yellow soft paraffin), 
1993 0.02% DL(yellow soft paraffin) 
80% NA (propan-ol), 100% PG 
Kanerva, 1990 normal 0.1% DL (petrolatum) 
volunteers 
Brasch et a!, ACD patients 1%, 2% or 5% SLS (DW) 
1992 
Mikulowska and normal 1% SLS (DW) 
Falck, 1994 volunteers 
Gerberick et a/, normal 0.25%, 0.5% or 0.1% SLS 
1994 volunteers (PBS), 13.9% NA (prop-an-ol) 
Le et al, 1995 ACD or lCD 3% SLS (DW) 
uninvolved 
-····- -·-- --
Skin site Application Biopsy (B) 
Blister (SB) 
gluteal 24 hrs B- 48 hrs 
volar forearm 48 hrs B- 1 hr later 
back 30 mins or 3 hrs B - 24 or 48 
hrs 
upper back 24 hrs B- 72 hrs 
forearm 48 hrs (replaced B - 2, 5, 7 & 
every 24 hrs) 14 days 
forearm 48 hrs SB 
upper back 24 or 48 hrs B- 1 - 5days 
These similar inflammatory responses, result through different initiating pathways 
driven either by allergen or irritant. Investigation into early irritant reactions, taking 
place prior to 72 hours, may be helpful in understanding the pathogenesis ofiCD. 
Experimentally induced irritation may affect the epidermis in different ways. The 
type and severity of damage caused is dependent on the type of irritant, its 
concentration and the time of application used. A wide variety of histopathological 
changes; including spongiosis, vesiculation, intracellular oedema, necrosis and 
parakeratosis have been observed after irritant exposure (Table 1.6). For example, 
dithranol (DL) irritation results in mild spongiosis (Willis et al, 1989). DL has also 
been shown to damage KC, LC and melanocytes (Kanerva et al, 1984, Kanerva, 
1990). Induction of_ mitochondrial damage, often observed in the outer epidermal 
layers (Willis et al, 1989), is characteristic of DL irritation (Kanerva et a!, 1984, 
Kanerva, 1990). DL application may also result in KC swelling (Willis et al, 1989) 
and occasionally apoptosis (Kanerva, 1990). 
Epidermal oedema and spongiosis appear to be relatively non-specific occurring after 
application of many irritants, for example DL, benzalchonium chloride (BC), NA and 
SLS (Willis et al, 1986, Mikulowska and Falck, 1994). The degree of oedema 
produced probably reflects the intensity of inflammation. 
Experimentally induced SLS irritation results in acanthosis, parakeratosis, spongiosis 
and occasionally vesiculation (Willis et al, 1989, Mikulowska and Falck, 1994). In 
contrast, NA application has a profound affect upon the epidermal KC population. 
The nuclei are affected becoming shrunken, with condensed, darkly staining 
marginated heterochromatin (Willis et a!, 1989). 
Studies have also shown that some irritants may increase epidermal proliferation 
(Table 1.7, page 40), suggesting that alteration in KC kinetics may be partly 
responsible for the parakeratosis often seen in ICD reactions with common irritants 
such as SLS, DL and NA (Willis et al, 1992). Changes in epidermal proliferation 
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TABLE 1.6: 
Histopathalogical changes induced in experimental irritant reactions. Summary of 
experimental designs are outlined in Table 1.5 
REFERENCE Irritant SUMMARY OF FINDINGS 
Kanerva eta/, DL LC mitochondria damaged 
1984 
Willis et a/, 1986 BC Spongiosis and oedema observed at 12 hrs. 
Willis eta/, 1989 SLS Parakeratosis and patchy spongiosis observed. 
Keratohyalin granules were absent. 
NA No parakeratosis and minimal spongiosis. 
"Tongues of dense, irregularly shaped 
eosinophilic KC containing shrunken nuclei that 
extended downwards from the stratum 
granulosum" were also observed. 
PG Basketweave stratum corneum. Mild, patchy 
spongiosis . 
BC Mild, patchy spongiosis. Occasional areas of 
necrotic damage in the upper prickle layer. 
DL Some spongiosis, particularly in basal layers. 
Mitochondrial damage present m KC, 
particularly in the stratum granulosum and upper 
prickle layer. 
Kanerva, 1 990 DL LC damage- swollen mitochondria and broken 
cristae. KC were also affected. They became 
cytolytic with oedemic cytoplasm. A few 
scattered KC underwent dyskeratosis (apoptosis). 
KC and LC damage was evident for more than 
10 days. 
Mikulowska and SLS Acanthosis, focal spongiosis and intraepidermal 
Falck, 1994 vesiculation were common. 
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TABLE 1.7: 
Epidermal cellular infiltration and KC response to experimentally induced irritant 
reactions. Summary of experimental designs are outlined in Table 1.5. 
REFERENCE Irritant SUMMARY OF FINDINGS • 
Willis eta/, 1986 BC Epidermal lymphocyte influx begining at 6 hrs, 
increasing until maximal at 24 - 96 hrs. 
Lindberg eta/, SLS CD3 +ve cell infiltration into epidermis. KC 
1990 CD54 expression. 
NA CD3 +ve cell infiltration into epidermis. 
Infiltration was comparable to that seen with 
SLS irritation. No KC CD54 expression. 
Kanerva, 1 990 DL Epidermal T cell and macrophage infiltration. 
Brasch eta/, SLS Epidermal T cell infiltration. Cells were 
1992 helper/memory phenotype. Focal KC CD 54 
expression but no MHC II expression. 
Willis et al, 1993 co Epidermal vesicles containing large numbers of 
infiltrating cells of varying phenotypes 
(including CD4+ve and CD8+ve T cells, 
macrophages and neutrophils). Increased levels 
ofHLA-DR +ve cells. 
NA Very few inflammatory cells observed, decreased 
levels ofHLA-DR +ve epidermal cells. 
DL Single cells infiltrating epidermis, macrophages 
CD4+ve T cells, and neutrophils. Increased 
levels of HLA-DR +ve cells. 
SLS Macrophage and CD4+ve T cell epidermal 
infiltration. Epidermal neutrophils also 
observed. Increased levels of HLA-DR +ve cells. 
Gerberick et a!, SLS or Epidermal macrophage infiltration. 
1994 NA 
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are also common in other types of skin damage such as allergic dermatitis, UV and 
tape striping and are not specific. 
Exposure to irritants may result in the expression of immune associated antigens, 
such as CD54 and MHC II, on KCs (Table 1.7, page 40). These findings imply that 
KCs play an important regulatory role in the irritant response. KCs can also 
synthesise and secrete a wide spectrum of cytokines (see previous section) enabling 
them to play an active role in irritant responses 
One interesting feature of irritation is the migration of LCs from the epidermis 
(Mikulowska and Falck, 1994) to the regional draining lymph node (Brand et al, 
1993 ). Experimentally induced irritant reactions have provided contradictory results 
(Table 1.8, page 42), with groups showing increased (Scheynius et al, 1984), 
unchanged (Kanerva et al, 1984) and decreased (Ferguson et al, 1985, Scheynius at 
al, 1992) epidermal LC numbers. These findings may reflect differences in the 
concentration, application time and irritant used. For instance, 80% NA has been 
shown to result in a significant decrease in epidermal LC number (Lindberg et al, 
1990, Scheynius et al, 1992). In contrast, 5% SLS induced an increase in LC number 
(Lindberg and Emtestam, 1986, Willis et al, 1993). 
Epidermal and dermal infiltration occur in experimentally induced irritant reactions 
(Table 1. 7, page 40 and Table 1.9, page 43) This infiltrate is predominantly 
mononuclear, composed of T cells and macrophages (Ferguson eta/, 1985, Willis et 
al, 1993). The T cell population comprises both CD4+ve and CD8+ve cells, 
although the CD4+ve phenotype accounts for the majority of cells (A vnstorp et a/, 
1987). It is of interest that the pattern, and density of cellular infiltration may differ 
depending on the irritant used, for instance, neutrophils have been observed in SLS 
and croton oil (CO) reactions (Willis et al, 1993). 
For the study we chose three well characterised common irritants, nonanoic acid, 
sodium lauryl sulphate and dithranol, in order to explore the mechanisms of action of 
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TABLE 1.8: 
Epidermal LC response to experimentally induced irritant reactions. Summary of 
experimental designs are outlined in Table 1.5. 
REFERENCE Irritant SUMMARY OF FINDINGS 
Kanerva et a/, DL Normal epidermal CD1a+ve number, 
1984 mitochondrial damage. 
Ferguson et a/, SLS Decreased nwnber of epidermal CD 1 a+ve cells. 
1985 
Lindberg and SLS Increased nwnber of epidermal CD 1 a+ve cells at 
Emtestarn, 1986 48 and 96 hrs. Redistribution of LC with a 
polarisation towards the outer layers. 
Willis eta/, 1986 BC Increased nwnbers of basal and suprabasal 
CD1 a+ve cells by 6 hrs, occassional LC-
Lymphocyte aposition within the epidermis. At 
12 hrs, CDla+ve eQidermal numbers are normal. 
A vnstorp et a!, SLS or No effect on epidermal CD 1 a+ve nwnber. 
1987 co 
Lindberg et a!, SLS Minor diferences in epidermal CD la+ve cell 
1990 nwnber. 
NA Decreased nwnbers of epidermal CD 1 a+ve cells. 
Scheynius eta/, SLS Minor differences in epidermal CD 1 a+ve cell 
1992 nwnber. 
NA Decreased nwnber of ~idermal CD 1 a+ve cells. 
Brasch et al, SLS Decreased numbers of epidermal CD 1 a+ve cells. 
1992 
Mikulowska and SLS Decreased numbers of epidermal CD I a+ve cells 
Falck, 1994 at 48 hrs. They suggested that LC are migrating 
to the dermis. 
Willis et al, 1993 SLS Increased numbers of epidermal CD 1 a+ve cells. 




Dermal infiltration m response to experimentally induced irritant reactions. 
Summary of experimental designs are outlined in Table 1.5. 
REFERENCE Irritant SUMMARY OF FINDINGS 
Ferguson eta/, SLS Dermal infiltration was predominantly 
1985 mononuclear but neutrophils were also observed 
scattered throughout the dermis. CD4+ve and 
CD8+ve T cells were present, with CD4+ve 
_Qredominant. 
A vnstorp eta!, SLS or Macrophage and T cell infiltration was observed. 
1987 co CD4+ve and CD8+ve T cells were present, with 
CD4+ve predominant. 
Willis et a!, 1993 Table 1.5 Macrophage, neutrophil and T cell infiltration 
were observed. CD4+ve and CD8+ve T cells 
were J>fesent, with CD4+ve predominant. 
Mikulowska and SLS Mononuclear dermal infiltration. 
Falck, 1994 
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these different classes of irritants. The next section explores the current literature 
available on these three irritants. 
• DITHRANOL (DL) 
In 1878, Squires first used a crude extract of Goa powder to treat psoriasis. The anti-
psoriatic component of this powder was later shown to be an anthracene derivative, 
chrysarobine. By 1916 a synthetic analogue, I ,8-dihydroxy-9-anthrone (anthralin, 
dithranol , cignolin) had been produced which is still used for psoriasis treatment 
(reviewed by Ashton et a/, 1983). This synthetic product caused considerably less 
irritation than the original powder, but skin staining, as first described by Squires, 
still occurred. Even today skin irritation and discolouration remain the major 
therapeutic drawbacks to this psoriasis treatment (reviewed by Kanerva et a!, 1990, 
Ashton et a!, 1983). Psoriasis is characterised by hyperproliferation, parakeratosis, 
epidermal accumulation ofT cells and neutrophils and dermal inflammation. These 
features are resolved following topical therapy with DL. The exact mechanism of 
DL's action has still to be determined. 
DL inhibits of KC hyperproliferation (Willis et a!, 1992), granulocyte function and 
may also exert an immunosuppressive effect (reviewed by Kemeny et al, 1990, Van 
de Kerkhof, 1991 ). Decreased epidermal T cell numbers are also observed after DL 
application (Baker et al, 1985). Anti-chemotactic activity of DL has been described 
in psoriatic skin (Temowitz, 1987), which could account for the decreased T cell and 
neutrophil infiltration observed after DL treatment. DL is thought to influence KCs 
and lymphocytes by inhibition of DNA synthesis and repair, cellular respiration and 
key enzymes of the metabolic pathway. In vitro treatment of neutrophils with DL 
results in a dose dependent inhibition of migration, superoxide anion generation and 
leukotrine 84 production (reviewed by Kemeny et a! 1990)~ accounting for decreased 
neutrophil function. 
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Irritation, resulting in a dose and concentration dependent inflammatory response, 
has been observed in many studies (Mustakallio, 1979; Goransson, 1987). At a 
concentration of 0.02%, DL caused mild to moderate erythema, which induces non-
specific spongiosis and marked swelling of KCs in the upper epidermis (Wills et a!, 
1989). 
DL is strongly lipophilic, becoming associated with the cell membrane within 
minutes of epicutaneous application. Here DL is rapidly oxidised, causing 
production of superoxide which are thought to be responsible for the skin 
discolouration anions (reviewed by Kanerva et a!, 1990, Ashton et a!, 1983). These 
free radicals along with other mediators, such as histamine and platelet activating 
factor(P AF), induce .inflammation. DL may also affect lipid metabolism through 
interference with enzymic activity (reviewed by Kanerva et a!, 1990). DL 
penetration may be influenced by the vehicle in which it is applied, for instance, the 
hydrophilic vehicle propylene glycol enhances penetration into the dermis(reviewed 
by Ashton eta!, 1983). 
There is still some confusion as to whether DL affects epidermal LC density. Results 
have shown this to be unaffected (Kanerva et al, 1984) or decreased after irritation 
(Gawk.rodger et a!, 1986). Electron microscopy has shown that LC are sensitive to 
DL, with application resulting in swollen mitochondria with broken cristae, 
indicative of degeneration and therefore reduced function (Kanerva, 1990, Morliere 
et al, 1985). Mitochondrial inhibition is thought to arise through binding of free 
radicals to the cell membrane (reviewed by Ashton, 1983), resulting in decreased 
respiration and subsequently decreased energy production. KCs may also be affected 
by DL, becoming cytolytic with oedematous cytoplasm and sometimes undergoing 
apoptosis (reviewed by Kanerva, 1990). The diminished energy available for cell 
division and differentiation could, in part, explain some of the therapeutic effects, 
such as decreased proliferation, in DL treatment of psoriasis. This powerful anti-
mitotic effect may also be mediated through inhibition of DNA replication and/or 
cytosolic enzymes (reviewed by Kanerva, 1990). 
43 
• NONANOIC ACID (NA) 
Nonanoic or pelargonic acid is a C9 free fatty acid, found in lacquers, plastics, 
synthetic flavours and .odours, turbojet lubricants and gasoline. NA causes irritation 
after occluded and repeated exposure (Stillman et a/, 1975). Forty eight hour patch 
testing on normal skin caused KC damage in the upper layers of the epidermis. 
Examination of these KCs revealed the presence of dense aggregates of keratin 
filaments in the cytoplasm, indicative of disturbances in KC metabolism and 
differentiation (Willis et a/, 1989). Studies also showed an increase in basal KC 
proliferation which may explain the presence of parakeratosis (Willis et a/, 1989; 
Willis eta!, 1992). For these reasons NA is commonly used in studies investigating 
irritancy and also as an experimental model for parakeratosis (Wahlberg eta!, 1985). 
NA irritation fails to cause leucocyte exocytosis or epidermal ICAM-1 expression 
(Lindberg et a!, 1990). This lack of response may be the result of induction of 
localised immune-inhibitory factors. If present in large enough concentrations these 
factors could suppress the affects of pro-inflammatory mediators (Willis eta/, 1993). 
NA irritation has also been shown to affect LCs. Various groups have shown that 
NA application results in a dramatic decrease in epidermal LC density (Willis et a/, 
1990, Lindberg et al, 1990), coupled with a decrease in dendrite length. Electron 
microscopy revealed that the NA induced morphological signs of LC injury (Willis et 
a/, 1990). 
• SODIUM LAURYL SULFATE (SLS) 
Sodium lauryl sulfate is an anionic detergent commonly used in cleaning products 
and cosmetics and as an emulsifier in many pharmaceutical products. This detergent 
has been shown to induce considerable changes in skin, including increased TEWL, 
blood flow, SC turnover time and pH (reviewed in Wilhelm et a!, 1994; Lee and 
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Maibach, 1995). The intensity and duration of the resultant inflammatory response 
is related to the number of applications and concentration (Novak and Francom, 
1984). 
SLS irritation results i"n KC damage, including induction of parakeratosis (Willis et 
a!, 1991, 1992). Parakeratosis may have a number of causes, including increased KC 
proliferation, incomplete keratinization or direct cytotoxic injury. SLS induced 
irritation is accompanied by increased levels of IL-6 (Berardesca and Distante, 1994) 
and TNFa (Hunziker et a!, 1992). IL-6 and IL-8 are potent KC growth factors 
(Grossman et a/, 1989, Tuschil et al, 1992) and may be responsible for the 
hyperproliferation and parakeratosis often observed (Willis e/ al, 1989). SLS has 
also been shown to influence LC numbers. Groups have shown increased epidermal 
cell numbers (Lindberg et a!, 1990), decreased (reviewed by Falck, 1981) or minor 
differences (Scheynius et a!, 1992), or unaltered numbers but showing evidence of 
LC degeneration and decreased dendrite length (Willis et a!, 1990). Brand and 
colleagues have demonstrated in human volunteers that LC migration from the skin 
to the regional lymph nodes takes place during experimentally induced SLS irritation 
(Brand et al, 1992, 1993, 1995). They developed a method of microsurgical lymph 
cannulation in order to investigate the phenotype and numbers of cells present in the 
lymph before and after experimental irritation. 10% SLS in distilled water was 
applied to the foot 48 hours after cannulation. Application of SLS was repeated after 
24 hours and remained on the skin for a total of 36 hours (Brand et a!, 1993). 
Leucocyte numbers were investigated from 2 - 8 days after irritation. Results showed 
increased numbers of LCs, T and B cells even at 8 days when the clinical reaction 
had resolved (Brand et a/, 1992, 1993, 1995). LCs may migrate into the skin soon 
after irritation and then as the reaction progresses they leave via the afferent lymph. 
Several mechanisms have been put forward to explain the effect of SLS on the skin, 
including : 
I. removal of epidermal lipid through the solubilizing action of surfactants. 
2. denaturation of epidermal proteins. 
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Penetration of SLS through the outermost epidermal layers allows the irritant to reach 
areas where tissue function may be affected. SLS has been shown to solubilize 
cholesterol, free fatty acids and the esters of these compounds (Froebe et a/, 1990). 
Despite this, only very small amounts of lipid are actually removed from the SC. 
Froebe and co-workers have shown that application of 2% SLS removes only 4% of 
the total SC lipid. These findings are of interest and suggest that lipid removal alone 
cannot be responsible for irritation (Froebe et a!, 1990). The quantity of SC lipid is 
therefore not affected by irritation; however, significant changes in lipid classes, for 
instance ceramides, have been observed. Changes in the distribution of certain 
ceramide species have been observed in SLS irritation (Fulmer et a!, 1986). These 
changes are thought to reflect altered keratinization associated with abnormal 
ceramide biosynthesis. 
SLS may bind to and reversibly denature epidermal keratin (Harrold.S, 1959, Froebe 
et a!, 1990). Binding to SC proteins may alter barrier function (Fullerton, 1994 ), one 
mechanism through which SLS may exert its irritant effect. Binding of proteins may 
be defensive, preventing the irritant from penetrating further into the epidermis 
(Blank and Gould, 1959). 
Radioactively labelled SLS has been shown to penetrate the skin in a concentration 
and temperature dependent manner (Emilson et a/, 1993). Small amounts of SLS 
penetrate through the epidermis into the dermis, but the majority remains on the skin 
surface or in the SC (Fullerton eta!, 1994). 
1.4. AUTOIMMUNITY 
This thesis proposes that chronic lCD may in some patients have an autoimmune 
component. The inflammatory response to certain irritants results in epidermal 
damage and could result in the release of a normally sequestered self Ag. An 
immune response raised against this self Ag will result in autoimmunity. 
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The term autoimmune disease refers to a wide spectrum of systemic and organ 
specific diseases, characterised by damage to tissues caused by humoral and/or cell 
mediated immune responses. These are complex disease processes involving many 
components including, envirorunental, genetic and immunologic factors. 
Several mechanisms have been put forward to explain the induction of pathologic 
autoimmune responses (reviewed in Bona et al, 1993, Stites et al, 1994). 
For example: 
• release of sequestered Ag 
• molecular mimicry and cross-reactivity 
• polyclonal T cell activation- superantigens (sAg) 
• generation of neo-self determinants 
A s~questered or cryptic Ag is normally unavailable to the immune system and 
therefore avoids tolerance induction. Sequestered Ags can be found in privileged 
sites, such as the cornea of the eye (anatomical sequestration) (reviewed by Gery and 
Strelein, 1994), or may simply be unavailable to the immune system because they are 
inside cells (molecular sequestration). Release of such Ags may occur as a result of 
trauma or inflarrunation, providing an opportunity for development of autoimmunity. 
It has been suggested that if the availability of a sequestered Ag increases beyond a 
certain threshold a specific T cell response will occur resulting in autoimmunuity. 
Increased threshold may also arise as a result of molecular mimicry or interaction 
with sAg. (Lipham et al, 1991, Appelmelk eta/, 1996) 
Induction of autoimmunity can also occur through immunisation with an Ag that 
cross-reacts with or has identical antigenic sites (molecular mimicry) to a self-Ag 
(Appelmelk er al, 1996). The resultant immune response will therefore recognise 
both self and foreign Ag. Anti-idiotype auto-Abs may also be the consequence of a 
natural immune response. With these initiation methods persistence of the stimulus 
would ensure continued autoimmunity. 
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Polyclonal T cell activation has also been considered as a contributing mechanism, 
particularly in systemic diseases, such as Systemic lupus erythematosus. Polyclonal 
activation involves proliferation of many T cell clones of different specificity. For 
example, superantigens are capable of stimulating T cells through binding MHC II and 
the VJ3 domains of the T cell receptor irrespective ofT cell Ag specificity (Figure 
1.5). 
FIGURE 1.5: 
Polyclonal T cell activation through superantigen binding. Super Ag binds more 









Autoimmune responses may be directed against newly created self determinants, neo-
Ag. Neo-Ags may be generated through drug or other haptenic groups binding to self 
Ag or through recombination, conversion or mutation following viral infection. The 
resultant auto-Abs may recognise not only the neo-protein but also the native protein 
and may therefore persist after the stimulus has been withdrawn (Kubicka-Muranyi et 
al, 1995). 
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• EXAMPLES OF CUTANEOUS 
AUTOIMMUNITY 
PEtvfi>I-llGUS AND PEtvfi>I-llGOID 
Pemphigus refers to a large group of bullous diseases characterised by epidermal 
cell- cell detachment (acantholysis), leading to blister formation. These diseases are 
considered to have an autoimmune component due to the presence of circulating and 
skin auto-Abs directed against KCs (reviewed by Thivolet, 1994 ). 
Pemphigus vulgaris (PV) is a potentially lethal disease in which blister formation 
occurs just above the basal layer. The epidermal blisters occur as a result of the loss 
of cell-cell adhesion caused by the action of auto-Abs against a KC cell surface 
glycoprotein, the PV antigen (PV A) (Thivolet, 1994, Amagon, 1995). PV A is a 
130kDa molecule belonging to the desmoglein subfamily of cadherin adhesion 
molecules (Karpati eta/, 1994). 
Bullous pemphigoid is another blistering disease, characterised by auto-Abs directed 
against molecules in the lamina Iucida of the basement membrane which are thought 
to be involved in epidermal-dermal adhesion. The target Ags have been identified as 
two molecules of molecular weight 230kDa and 180kDa (reviewed by Giudice et 
all995 , Fairley et al, 1995). 
GUTTATE PSORJASIS 
Guttate psoriasis is a T-cell mediated disease known to be associated with 
streptococcal throat infections. The observations that T lymphocytes with certain Vp 
TCR families predominate in lesions of this type of psoriasis, suggests that 
streptococcal sAg and induction of autoimmunity may be involved in disease 
pathogenesis. Valdimarsson and colleagues have recently proposed an autoimmune 
model for the onset and maintenance of guttate psoriasis (reviewed by Vladimarsson 
eta!, 1995). 
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SCLERODERMA (SYSTEMIC SCLEROSIS) 
The term scleroderma includes a heterogeneous group of localised and systemic 
conditions causing thickening and hardening of the skin. Sera from patients with 
scleroderma contain a wide range of auto-Abs, including various anti-nuclear Abs 
(Parodi et a/, 1995), Abs to polynucleotides and Abs that react with collagen 
(reviewed by Maddison, 1988). Anti-nuclear Abs for example can be detected in 
95% of patients. Anti-nuclear Abs and Abs directed against nuclear antigens such as 
topisomerase 1 are capable of complement fixation. This suggests that these auto-
Abs may be directly involved in disease pathogenesis through initiation of 
complement-mediated tissue injury (reviewed by Maddison, 1988). 
1.5. AIMS OF THESIS 
This chapter has reviewed relevant information to date concerning the three irritants 
chosen for this study. DL, an alcohol, has been studied in respect to psoriasis 
treatment, the success of which appears to effect the anti-mitotic· potential of DL. 
NA represents the acid group of irritants and SLS is a member of the detergents class, 
one of the largest groups of chemicals with irritant capabilities. All three irritants can 
produce inflammatory skin responses, but the histological components of these 
reactions seem very different. The cellular and molecular mechanisms involved in 
these different patterns of skin damage have yet to be fully investigated. 
A unique approach was undertaken for this investigation of chronic lCD, involving 
comparison of patients with chronic ICD and normal healthy volunteers. The study 
aimed to determine whether the intrinsic nature of the skin from patients with chronic 
ICD contributes to disease pathogenesis and if this method of experimental irritation 
is a good model for chronic ICD. 
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The central purpose of this project was to define the role(s) of the inflammatory and 
immunological responses in the pathogenesis of chronic lCD, and to determine the 
nature of the early inflammatory/ immunological events in experimentally induced 
irritant reactions in healthy volunteers and patients with chronic lCD. 
The experimental aims of the study were:-
• to compare the light histological appearance of biopsies taken from skin treated 
with different irritants (NA, SLS and DL) to induce a similar degree of erythema. 
• to compare changes in the epidermal Langerhans cell population after irritation. 
To investigate any differences between normal volunteer skin and the uninvolved 
skin of patients with chronic lCD. 
• to compare sequential changes in the cellular infiltrate, accessory/adhesion 
molecule expression and cytokine profiles after irritation. 
• to compare 1 and 6 hour with 24 and 48 hour reactions. This investigation aimed 
to define initiating or early events taking place in an irritant reaction. The later 
time-points of 24 and 48 hours allowed this study to investigate the more 
established phase of the reaction. 
• to compare atopies with non-atopies, males with females and patients with and 
without irritant dermatitis lesions at the time of experimentation. This study 
aimed to determine if any particular group of individuals were more susceptible 
to experimental irritation. 
• to investigate whether the blood of patients with lCD contained antibodies 
against skin antigens which might indicate that some cases of chronic lCD 
represent a form of autoimmune disease. 
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2.0. MATERIALS AND METHODS 
All reagents were purchased from SIGMA unless otherwise stated. 
2.1. CLINICAL DETAILS 
Ethical approval for taking biopsies and suction blisters from human subjects was 
obtained from the Lothian Research Ethics Committee. All patients involved with the 
study gave informed, written consent. 
• PATIENT DETAILS 
Patients were recruited from the Dermatology out patient clinic at The Royal 
Infirmary, Edinburgh. All patients had a history of chronic irritant dermatitis for a 
period of at least six weeks, a minimum of one criteria outlined in Table 2.1 and had 
attended the patch test clinic showing no relevant positive allergic reactions. A 
summary of patient details, including atopic status, age and sex, are shown in Table 
2.2. Full patient details are outlined in appendix I. 
• IRRITANTS AND GRADING OF ERYTHEMA 
Optimal concentrations of the three irritants (NA, SLS & DL) were determined by 
titration on normal healthy volunteers to produce similar grades of moderate but 
distinct erythema, assessed visually (Table 2.3) and with a Minolta Chroma Meter 
CR-300, by 48 hrs. Subsequently the concentrations used for the final study were 
80% nonanoic acid in propan-1-ol (w/w) and (w/v) 5% aqueous sodium lauryl 
sulphate and 0.0 I% dithranol in yellow soft paraffin (w/w). The vehicle controls used 
were propan-1-ol, distilled water and yellow soft paraffin respectively. 
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TABLE 2.1: 
Criteria used for the diagnosis of chronic irritant dermatitis. 
HISTORY • occupational exposure 
• affected areas relatively static 
CLINICAL • erythema, hyperkeratosis or fissuring 
• glazed, scaled appearance of skin 
• if hand dermatitis * the above plus 
ring pattern 
pulpitis 
dorsa of the hands 
PATCH TESTS Negative (or non relevant positive reaction) 
* as the majority of patients in the studies had hand dermatitis, important clinical 
patterns (summarised below) which suggest an irritant aetiology were used for patient 
assessment. 
Ring pattern - i.e. underneath ring 
Pulpitis - the pulps of the fingers 
TABLE 2.2: 




ACTIVE lCD 28 
NO ACTIVE TCD 7 
AGE-RANGE 20- 58 
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Visual clinical grading scale. 
GRADE DEFINITION OF REACTION 
0 No reaction 
1 Barely perceptible erythema 
2 Moderate but distinct erythema with no induration 
3 Indurated erythema 
4 Bullae formation/ crusting 
• IRRITANT APPLICATION AND TISSUE BIOPSIES 
Tissue biopsies were taken, under 1% lignocaine local anesthesia, from clinically 
unaffected skin on the volar surface of the forearm. A normal control biopsy was 
taken at time zero. Three standard 8mm Finn chamberl were then applied, two 
containing 15~1 of the irritant and one containing the same volume of the vehicle for 
that irritant (vehicle control). Patches were removed after 1, 6, 24 or 48 hours; one 
hour later the degree of erythema was assessed visually and using the Chroma Meter. 
Three 6mm punch biopsies were then taken from each patient (1 vehicle control, 2 
experimental). Half of each biopsy was snap frozen in liquid nitrogen and the 
remainder formalin fixed and paraffin embedded. 
• SUCTION BLISTERS (Plate 2.1) 
A total of 120~1) was applied to the volar aspect of the forearm, for 1 , 6 or 24 hrs 
prior to raising blisters, using standard four 8mm Finn ChambersR (30J..tl of irritant in 
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each chamber). Irritant was Suction blisters were then raised under pressure at the site 
of the irritant reactions using plastic chambers based on the DerrnovacR (Kiistala, 
1968). Suction blister fluid was removed from each blister using a sterile needle, 
pooled and stored at -70°C ( 40 -200J.1l). The epidermal roofs were then carefully 
excised, snap frozen in liquid N2, and stored at -193°C. 
2.2. HAEMATOXYLIN AND EOSIN (H & E) SECTIONS 
• H & E staining 
Paraffin sections (3J.1m) were cut from ice-cooled paraffin blocks using a microtome 
and floated on warm water onto poly-L-lysine coated glass slides. The slides were 
dried overnight in a 37°C incubator. The paraffin sections were then dewaxed in 
xylene and passed down through an alcohol gradient (100% ethanol, 74% ethanol, 
64% ethanol) to water (rehydration). Sections were immersed in Harris' 
Haematoxylin (BDH chemicals Ltd.), 5 mins, in order to stain the nuclei . After 
washing in water, sections were differentiated using 1% acid alcohol (5-1 0 seconds) 
and washed again. Following differentiation sections were placed in Scotts Tap water 
(1-2 mins.), washed and stained with alcoholic/aqueous Eosin (1 min). The sections 
were washed and dehydrated by moving back up through the alcohol gradient to 
xylene. Finally the sections were mounted in Pertex (Cell path Ltd.) and examined 
under a light microscope. 
• Analysis of H & E sections 
Each of the sections stained using the above method was assessed microscopically by 
three independent observers (Dr. Shahidullah, C. Sands and myself) and the results 
recorded on the proforma shown in Table 2.4a,b,c. Sections were assessed for a 
variety of parameters, firstly the presence or absence of appendages was noted (e.g. 
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PLATE 2.1: 
Suction blisters raised on site of experimental irritation. 
hair follicles, sweat ducts), and then assessment was continued as outlined in Table 
2.4a, 2.4b and 2.4c. 
Table 2.4a: Analysis of stratum corneum. 
Stratum corneum - 0 - compact 
1 - basketweave 
parakeratosis (yes) - 1 
(none) - 0 
Starting with the Stratum corneum, this was categorised as either compact or 
basketweave in structure. The presence or absence of parakeratosis was also noted. 
Table 2.4b: Analysis of epidermis. 
KEY: 
I. C. -intracellular oedema Yes. -vesiculation Spon.- spongiosis 
N - neutrophil E - eosinophil 
Oedema 0 - nil 
I -mild (<25%) 
2- mod (25-75%) 
3- heavy (>75%) 




0 - nil 1 - present 
Granulocyte (G) 
Mononuclear (M) 
Apoptosis Oedema Infiltra t Cells in 
Granular Layer 
Prickle cell Layer 
Basal Layer 
I .C. Ves Spon 
e infiltrate 
G M 
Biopsies were scored for the presence or absence of apoptosis in the prickle and basal 
layer only. The granular layer was not analysed as the dark keratohyalin granules 
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present in this area present technical difficulties for scoring. The total number of 
apoptotic cells per mrnlbasement membrane was also recorded (see section 2.4.). 
The three epidermal layers (granular, prickle and basal) were assessed for oedema and 
cellular infiltration. Three types of oedema were analysed: intracellular, spongiosis 
(intercellular) and vesiculation. All three were scored on an arbitrary scale according 
to the severity of oedema, O(nil), ! (mild), 2(moderate) and 3(heavy). Cellular 
infiltration was scored according to severity, O(negligible), 1 (mild) and 2(heavy), and 
cell type, G(granulocytic) and M(mononuclear). The granulocytic group was then 
further divided into neutrophils and eosinophils using morphological criteria. 
Table 2.4c: Analysis of dermis. 
Oedema 0- nil Infiltrate(overall) 0- negligible 
1 -mild (<25%) 1 - mild 
2- mod (25-75%) 2- heavy 
3- heavy (>75%) 
Cellular Infiltrate 
0 - nil 1 - present 
Granulocyte (G) 
Mononuclear (M) 







The dermis was also assessed for the presence of oedema and cellular infiltration. The 
dermis was divided into separate compartments for the purpose of analysis. These 
sections included the papillary dermis, reticular dermis, perivascular areas, peri-
appendage areas (hair follicle and/or sweat duct). The arbitrary scoring scale was the 
same as that employed for the epidermis. 
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All the categorised data was entered onto a Microsoft Access(v2.0) database and 
analysed using the Minitab statistical analysis package. The methods of statistical 
analysis are described in section 2.5. 
2.3. IMMUNOCYTOCHEMICAL STAINING 
All immunocytochemical staining was carried out in a semi-automated, "Sequenza" 
(Shandon) wet chamber (Plate 2.2). This system allows many slides to be stained 
simultaneously, significant reduction in background staining and reproducible results 
over time. The Sequenza uses plastic clips to hold the slides in a rack. A fine space 
exists between the slide and the plastic clip allowing 1 OOJ.!l of liquid to be held in an 
even film against the slide by capillary action. Placing more fluid into the reservoir at 
the top of the plastic clip displaces the fluid held against the section allowing 
standardisation of volumes and incubation times. Sections were analysed using the 
HOME microscope as outlined in section 2.4. 
All antibodies were titrated on skin tissue to determine optimum dilution and 
incubation conditions (see Tables 2.5a and b). 
• PARAFFIN SECTIONS (Table 2.5a) 
Paraffin embedded sections (3Jlm) were deparaffinised and rehydrated by passing 
through an alcohol gradient (see H&E section). When using the chromagen 3,3-
diaminobenzidine for visualisation, endogenous peroxidase was blocked prior to 
staining (3% Hydrogen Peroxide (H202) , Fisons) in distilled water (DW) for 15 mins). 
Antigen retrieval was carried out for certain antigens on paraffin sections only. 
Crosslinks caused by the paraffin embedding process may be broken using trypsin 
(ICN Biomedicals Inc.) or microwaving to reveal the antigen under investigation. 
Trypsin treatment (0.1% trypsin, 0.1% CaCb pH7 .8) was carried out for 30 mins at 
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PLATE 2.2: 
The "Sequenza" (Shandon). 
37°C or sections were microwaved in citrate buffer (1.05g sodium citrate in 500ml DW, 
pH 6.0) for 2x 5mins then allowed to cool for at least 20 mins. 
Before staining sections were washed in running tap water, clipped into the Sequenza 
and washed with buffer (0.1% BSA!fris buffered saline (TBS), pH7.6). Sections were 
pre-incubated for 10 mins with I OOml of blocking buffer, either 20% normal rabbit 
serum (NRS (SAPU), diluted in TBS), 20% normal swine serum (NSS, Seralab) or 20% 
normal goat serum (NGS, SAPU) depending on the species in which the secondary 
antibody was raised. Pre-incubation in serum helps to prevent non-specific binding of 
antibodies to Fe receptors. After blocking, sections were incubated in 1 OOfll of primary 
antibody diluted optimally in blocking buffer ( l hour, room temp.). For some 
antibodies. optimal incubation times were found to be overnight at 4°C or for 2 hours at 
37°C (Table 2.4a) . Sections were then washed twice in TBS (reservoir filled twice. 2x 
5 mins) before incubation (30 mins, room temp) in biotinylated secondary antibody, 
again di luted in blocking serum. Washing was repeated as before and sections 
incubated (30 mins, room temp) in ABC- streptavidin HRP complex (for DAB 
chromagen) or ABC-AP complex (for Fast red visualisation) (ABC kits, DAKO). 
Sections were washed as before and the antibody staining visualised. 
DAB VISUALISATION 
Each section was incubated with I OOfll of DAB (3 ,3-diaminobenzidine)/hydrogen 
peroxide substrate solution. DAB was applied to each section at a concentration of 
0.5mg/ml of l% hydrogen peroxide for 5 minutes and sections washed in water. The 
slides were then removed from the Sequenza racks and counterstained in haematoxylin 
(1 min) before ' bluing up' in Scott' s Tap water. Finally the sections were dehydrated by 
moving up through an alcohol gradient before mounting in pertex. 
FAST RED VISUALISATION 
All sections were incubated with 500~-tl of alkaline phosphates substrate (Appendix II) ( 
30 mins, in the dark), then washed off with water. Sections were then counterstained 
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··Table 2.5a : 
Antibodies used on paraffin tissue sections 




I MIB-1/Ki-67 Proliferating cells, Ki-67 Ag 1/30 M 3 7°C, 2 hours IFR 
CD68 Macropbages 1,1200 T room temp. I FR 
CDla Langerhans cells Neat T room temp. I FR 
Bcl-2 AJI nucleated cells 1/10 M room temp I DAB 
Bax AJI nucleated cells 1150 T room temp I DAB 
Bcl-x AJI nucleated cells 1150 T room temp I DAB 
CD95/fas Leucocytes, epithelial cells 1/300 T room temp I DAB 
•. SEE APPENDIX 11 FOR DETAILS OF ANTIBODY SOURCE 
as with DAB visualisation but were mounted, without dehydration, using an aqueous 
mountant (BDH) as Fast red substrate is dissolved by xylene. 
• FROZEN SECTIONS (Table 2.Sb) 
Snap-frozen skin biopsies were partially thawed and then transferred onto a cool metal 
chuck. The biopsy was then frozen in OCT (Bayer Diagnostics) using liquid nitrogen 
and 6~-tm sections were cut at -20°C using a cryostat. The frozen sections were air dried 
for a minimum of 3 hours and then fixed in dry/distilled acetone (Fisons) for l 0 mins. 
As with paraffin staining, sections were washed in running tap water, clipped into the 
Sequenza and then washed with TBS buffer. Sections were blocked with serum and 
stained following the same procedure as for paraffin sections. Fast red visualisation was 
the only method employed for frozen sections. 
2.4. The H.O.M.E microscope 
(Highly Optimised Microscope Environment) 
The Zeiss HOME microscope allows quantitative image analysis by linking a mouse 
driven personal computer directly to the microscope field of view. This system allows 
the viewer to count cells and delineate areas using the mouse while looking down the 
microscope. This HOME was used to delineate both epidermis and dermjs, eliminating 
any appendageal areas (Pl.ate 2.3), and allowing the density of positive cells to be 
calculated for both dermal and epidermal areas. The length of basement membrane and 
average epidennal thickness were also measured. All data were saved onto the 
computer hard disc and could be checked by other members of the team at a later time. 
All numerical data obtained from the HOME microscope was entered onto Microsoft 
Access (v2.0) relational databases and analysed using the Minitab statistical package. 
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•• Table 2.5b : 
Antibodies used on frozen tissue sections 
Antibody Specificity Optimal Dilution 
CD3 T cells 1110 
CD4 T cells: CD4 1/10 
CD8 T cells: CD8 1/10 
CD15 Neutrophils 1/ 10 
CD 54 ICAM-1 1/50 
IFNy IFNy 1/300 
L243 MHC II 1/100 
CDla Langerhans cells 1/400 
CD62E E-selectin 1/ 100 
•• SEE APPENDIX ll FOR DETAILS OF ANTIBODY SOURCE 
Temperature Detection: 
(ON - overnight) Fast Red (FR) 
DAB 
4°C ON FR 
4°C ON FR 
4°C ON FR 
room temp FR 
room temp. FR 
room temp. FR 
room temp FR 
room temp. FR 
room temp. FR 
• DATABASE DESIGN DETAILS 
Relational databases were used, in which the data were represented as tables. Each row 
in a table has the same number of labelled columns (Field), describing the nature of the 
data in that column (e.g. patient code). The design of a table included the definition of 
field names, the order in which fields should appear in the table, the type of data that 
each field contained, and the size and format of the fie lds. A primary key denotes a 
unique index on the table which cannot be repeated. In the case of our data the primary 
key chosen was the patient code, which allowed all data associated with the patient code 
to be linked. 
2.5. STATISTICAL ANALYSIS 
Non-parametric statistics were chosen after taking advice from Professor Leonard in the 
ST A TLAB at The Kings buildings, Edinburgh University and Dr. Robin Prescott in The 
Department of Public Health, Edinburgh University. 
This group of tests were chosen for two main reasons : 
1. Inferences are not made about the population from which the sample was taken. 
2. These tests enable analysis of numerically graded data (ordinal), which make up a 
large proportion of the results obtained in this study. 
Overall changes within each group, i.e. 0, 1 and 6 hours or 0, 24 and 48 hours, were 
investigated using the Friedman test. Any significant differences were then further 
qualified by comparison of paired samples, using the McNemar/Sign test. Analysis of 
results (numerical) between groups were carried out using either a Wilcoxon signed 
ranks sum test (paired data) or a Mann Whitney-U test (non-paired data); exact versions 
of these tests were used because of the small sample sizes. 
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PLATE 2.3: 
Analysis of CDla+ve cells using the HOME microscope. The computer overlay is 
shown in green. Crosses mark positive cell. The basement membrane (BM) can be 
measured and epidermal area calculated (green shaded area, A) 
2.6. IN SITU CELL DEATH DETECTION 
The in situ cell death detection kit supplied by Boehringer and Manheim (Cat No. 
1684809) was used following the manufacturers instructions briefly outlined here. 
Paraffin sections (311m) were cut and rehydrated as for immunocytochemistry. Sections 
were then incubated in proteinase K (20mg/ml, 15mins room temperature), to remove 
crosslinking and to allow fluroscein labelled nucleotide binding of DNA strand breaks. 
Sections were then incubated with 50 j.tl negative control (FITC labelled nucleotide 
mixture) or with 50 j.tl enzyme reaction mixture (terminal deoxynucleotidyl transferase) 
for 60mins at 370C. Slides were then washed in PBS, incubated with an anti-fluroscein 
antibody (30 mins, J70C), washed in PBS and visualised using a standard Fast Red 
procedure. Slides were counterstained with haematoxylin and mounted in aquarnount. 
2.7. CYTOKINE ASSAYS 
• INTERLEUKIN-1 (IL-la ) & INTERLEUKIN-8 (IL-8) 
Commercial assay kits produced by R&D systems (IL-l, code: DLA50 and IL-8, code: 
08000) were used to determine the amount of cytokine present in the suction blister 
fluid. The assays employed the quantitative "sandwich" enzyme immunoassay 
technique (ELISA). A 96 well microtiter plate was provided in the kit, this was pre-
coated with monoclonal antibody specific for the cytokine under investigation. Serial 
dilutions of standards and samples were pi petted into the wells and allowed to incubate 
for 2 hours at room temperature. Any cytokine present in the samples bind to the 
antibody attached to the plate. After washing away any unbound proteins, an enzyme-
linked polyclonal antibody specific for the cytokine being measured was added to the 
wells to "sandwich" the cytokine immobilised during the first incubation. Following a 
wash to remove any unbound antibody-enzyme reagent, the substrate so lution was 
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added to each well. The intensity of the coloured product produced was proportional to 
the amount of cytokine present in the sample. The colour development was stopped 
after 3-5 mins. and the optical density of each well read on a Dynatech MR5000 plate 
reader. A standard curve was plotted, using optical density versus the concentration of 
the known standards. By comparing the optical densities of the unknown samples with 
the standard curve, the concentration of cytokine present was determined. The lowest 
limit of detection was 3.9pg/ml for the IL-l a ELISA and 93.8pg/ml for the IL-8 ELISA. 
• INTERFERON GAMMA (IFNy) 
A commercially available ELISA kit produced by Genzyme (code: 1556-00) was used to 
determine the amount of IFNy present in the suction blister fluid. A 96 well microtiter 
plate was coated overnight with monoclonal anti-human lFNy antibody (4°C) and then 
washed to remove any unbound antibody. Serial dilution 's of standards and samples 
were then pipetted into the wells and incubated at 37°C for 2 hours. After washing, the 
plate was incubated with a polyclonal goat anti-human IFNy antibody, washed and 
incubated with a donkey anti-goat biotinylated antibody. The streptav idin-peroxidase 
solution was then added to the plate before the final incubation with the substrate 
reagent, resulting in a colour change. The colour development was stopped after 4-6 
mins. and the plate read at 492 nm on the MR5000 plate reader. A standard curve was 
plotted as for the other assays and the concentration of IFNy present in the samples 
calculated from the standard curve. The lowest limit of detection with thi s kit was 3.0 
pg/ml. 
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2.8. WESTERN BLOTTING 
• SKIN L YSA TES 
Skin biopsies (6mm) from lesional sites of patients with ICD or normal skin biopsies 
from breast reductions were used for Western Blotting. The epidermis was separated 
fi·om the dermis by incubation (37°C for 4 hours) with Dispase (Gibco BRL) and then 
washed in Phosphate Buffered Saline (PBS) (UNIPATH Ltd.). The epidermis and 
dermis were then lysed separately in 0.5ml of lysis buffer. The lysis buffer used was 
based on a method by Peterson and Wuepper (1984) (Appendix II). The lysis process 
involved freeze thawing the samples three times using liquid nitrogen, followed by 
ultrasonication for 3 mins. The lysates were spun in a microcentrifuge (l ,OOOrpm, 2 
mins) and the supernatant collected. The amount of protein in each sample was 
determined using the Biorad DC assay following the manufacturers instructions. 
Known protein standards (Bio-Rad, serial dilution's of y-globulin, 1.37 mg/ml-
0.17mg/ml) were run along with the test samples, all samples were run in triplicate. The 
concentration of protein present in each sample was then calculated from the standard 
curve. 
• CASTING GELS 
The Biorad minigel system (Plate 2.4) was used for Western Blotting analysis of the 
protein lysates. The glass plate sandwiches were assembled into the clamp assembly, as 
per the manufacturer's instructions. A single toothed comb was placed in the assembled 
glass sandwich and a mark made on the glass plate to indicate the pouring level of the 
separating gel. The combs were then set aside for use later. 
I 0 ml of 10% acrylamide separating gel (Appendix U) was prepared, and after swirling 
gently, was pipetted between the glass plates up to the previously marked 
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level. The gel was then overlaid with water to ensure even setting. After allowing the 
gel to polymerise for 40 mins, the water was drained off and the stacking gel prepared 
(Appendix II). The single toothed comb was inserted into the glass sandwich and the 
stacking gel pipetted over it. The stacking gel was then left to set for 30 mins. 
• RUNNING THE GEL 
The clamp assemblies holding the glass plates were removed from the casting stand 
and transferred to the inner core. Running buffer (Appendix II) was poured into the 
upper buffer chamber up ·to the level of the larger glass plate and the lower buffer 
chamber was filled to a level at least 1 em above the bottom of the glass plates, so as 
to maintain the electric circuit. 
Lysates ( l :2 dilution) and pre-stained molecular weight markers (Bio-Rad) were 
boiled for 5 mins. in reducing sample buffer (Appendix II) and then loaded onto the 
gel. The gel was then run at 200V until the leading edge of the Bromophenol blue 
reached the edge of the gel. 
• ELECTROPHORETIC TRANSFER 
The power supply was disconnected, the inner core removed and the running buffer 
poured off. The gels were placed in transfer buffer (Appendix II) to equilibrate before 
transfer. Nitrocellulose (Amersham Life Science) and filter paper (x2) pieces were cut 
to the size of each gel and were also soaked in transfer buffer. The gels were then 
sandwiched between nitrocellulose and filter paper, as shown in Fig 2.1 and any 
trapped air was removed by rolling a pipette gently across the sandwich before it was 
clipped into the transfer apparatus. Transfer was carried out for 1 hour at 1 OOV. After 
transfer the strip of nitrocellulose with the molecular weight markers was removed 
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and dried and the rest of the nitrocellulose blocked overnight ( 4 °C in 5% Marvel/PBS) 
to prevent non-specific binding in the detection stage. 
Figure 2.1 












The method used was adapted from work by Wallace and colleagues (Wallace eta!, 
1994). Test serum taken from the patient at the same time as the biopsy was optimally 
diluted (1150) in MarvelffBS/tween and incubated with the nitrocellulose ( lhr, room 
temperature). The nitrocellulose was then washed thoroughly in TBS/tween and then 
incubated with mouse anti-human lgG (DAKO)(l: 1000, 60 mins.). After washing the 
nitrocellulose was then incubated with a biotinylated rabbit anti-mouse antibody 
(Dakopatts) (1: 1000, 30 mins), washed and incubated with ABC-AP (1:30) for30 
mins. Detection of bands was carried out using nitro blue tetrazolium/ 5-bromo-4-
chloro-3 indolyl phosphate (NBT/BCIP) (Appendix II). 
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3.0. RESULTS 
(Appendix IV for raw data) 
A pilot study, based on previous work from C.Willis and colleagues (Willis et al, 
1988 and 1989), was carried out by Dr. Shahidullah (HS) to determine the optimal 
concentrations of irritant to be used in the study. Irritants were titrated on normal 
healthy volunteers to produce similar grades of erythema by 48 hours (Plate 3.1, data 
shown in appendix III). Subsequently the concentrations used were 80% NA in 
propan-1-ol (w/w), 5% aqueous SLS (w/v) and 0.01% DL in yellow soft paraffin 
(w/v). 
Colorimeteric analysis showed that NA produced a time dependent increase in 
erythema, whereas significant erythema was not observed until 6 hours after SLS 
application (appendix Ill). Despite these differences both SLS and NA resulted in 
comparable erythema by 48 hours. Erythema was measured using a Minolta Chroma 
Meter CR-300 which graded the redness of the skin. DL irritation resulted in 
yellow/brown staining of the skin. This staining interfered with the Minolta readings 
making it impossible to quantitatively assess erythema. For this reason DL was 
dropped from the study, hence the limited data relating to DL irritation. 
No differences were observed, in any of the parameters tested, between atopies and 
non-atopies, males and females or patients with or without active disease. Data 




DL irritation resulted in minimal epidermal damage; with no parakeratosis, mild 
spongiosis in less than 15% of biopsies (Table 3.1 , Plate 3.2) and no vesicultaion. 
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PLATE 3.1: 
a) Irritant contact dermatitis. 
b) Experimentally induced erythema 24 hours after irritant application. 
Intracellular oedema was observed in both control and irritant biopsies. Significant 
basal layer oedema occurred at 1 and 6 hours after DL application (p<0.05, Friedman 
test). 
EPIDERMAL INFILTRATION AND ACCESSORY MOLECULE EXPRESSION 
Epidermal leucocyte infiltration was absent, with all biopsies showing normal 
epidermal leucocyte numbers, i.e. less than 4 leucocytes/mm basement membrane 
(BM). Epidermal granulocytes were absent. Focal KC CD54 expression was 
observed in irritant treated biopsies. 
DERMAL INFILTRATION 
DL application had no effect on dermal leucocyte infiltration with mild papillary 
dermal and perivascular infiltration, comprised predominantly of mononuclear cells 
observed in approximately 75% of both control and irritant treated biopsies. 
Significant reticular dermis leucocyte infiltration was not ob~erved. A few scattered 
granulocytes were observed. 
TABLE 3.1: 
H & E analysis of data relating to epidermal damage 1 and 6 hours after DL 
application. The results shown indicate the percentage of positive biopsies for each of 
the parameters investigated. 
% of POSIDVE BIOPSIES 
PARAMETER Control DL (n = 16) 
(n = 16) 
0 hours 1 hour 6 hours 
Parakeratosis 0 0 0 
Intracellular Oedema (basal) - mild 63 44 44 
Intracellular Oedema (basal) - moderate 0 19 13 
Intracellular Oedema (basal) - severe 0 0 13 
Spongiosis (prickle)- mild 6.3 12.5 12.5 
Spongiosis (prickle)- moderate 0 0 6 
Spongiosis (prickle)- severe 0 0 0 
Vesiculation 0 0 0 
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PLATE 3.2: 
H & E section 6 hours after DL application (mag. x20). 
Minimal epidermal changes compared with control (0 hour). 
• SUMMARY 
DL irritation evoked only mild erythema even 48 hours after application, a result 
reflected by the minimal changes reported in the histological studies. A small 
amount of focal KC CD54 expression was observed in the two 24 and 48 hour 
biopsies examined but conclusions can not be drawn from such a small sample of 
patients. In summary, intracellular oedema was the extent of the epidermal damage 
resulting from DL application, with no apparent affect on the dermis. 
Since the erythema produced by DL irritation was not comparable to that resulting 
from NA and SLS it seems likely that the poor inflammatory response to DL simply 
reflects an inadequate irritant concentration. 
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3.2. SODIUM LAURYL SULFATE & NONANOIC ACID 
3.3. EPIDERMAL CHANGES 
• H&E ANALYSIS (Tables 3.2a and b) 
1). SLS 
Parakeratosis was observed at 24 and 48 hours after irritation (Plate 3.3), but, 
because of small sample size, this was not significantly different from control groups. 
In comparison with control biopsies significant spongiosis was observed at I , 6, 24 
and 48 hours (p<O.Ol, Friedman Test), and severe spongiosis by 48 hours (p<0.02, 
McNemar Test). By the later timepoints of 24 and 48 hours spongiosis became 
extensive enough to cause vesiculation (2/8 and 3/8 biopsies respectively, Plate 3.4). 
Mild basal layer intracellular oedema was observed in both control and irritant 
treated biopsies. 
2). NA 
Parakeratosis was observed in 43% (3/7) of biopsies at 48 hours, but this was not 
significant. Although spongiosis and vesiculation were evident at both early and late 
timepoints, this was not significantly greater than in untreated samples. Mild to 
moderate intracellular oedema was observed at 24 hours. At 48 hours basal layer 
oedema had increased with 57% of biopsies showing moderate and 14% severe 
intracellular oedema. 
• SUMMARY 
Investigation of H & E stained sections revealed that NA and SLS application 
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The data indicate that NA irritation leads to mild spongiosis, whereas SLS results in 
severe spongiosis, often progressing to vesiculation by 24 and 48 hours. 
Parakeratosis was observed with both irritants by 24 and 48 hours, although this was 




a) H & E section showing epidermal changes 48 hours after a) SLS application and 
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H & E analysis of data relating to epidermal damage 1 and 6 hours after N A and SLS 
application. The results shown indicate the percentage of positive biopsies for each of 
the parameters investigated 
% of POSITIVE BIOPSJES 
PARAMETER Control NA (n = 17) SLS (n = 16) 
(n =33) 
0 hrs 1 hr 6hrs 1 hr 6 hrs 
Parakeratosis 0 6 12 0 6 
Intracellular Oedema (basal) - mild 49 59 47 57 63 
Intracellular Oedema (basal) - moderate 12 18 12 19 12.5 
Intracellular Oedema (basal) - severe 0 0 14 0 0 
Spongiosis (prickle)- mild 21 24 29 19 31 
Spongiosis (prickle)- moderate 0 6 12 0 6 
Spongiosis (prickle)- severe 0 6 6 0 0 
Vesiculation 6 6 24 6 12.5 
TABLE 3.2b: 
H & E analysis of data relating to epidermal damage 24 and 48 hours after NA and 
SLS application. The results shown indicate the percentage of positive biopsies for 
each of the parameters investigated. 
% of POSITIVE BIOPSJES 
PARAMETER - Control NA SLS 
{n = 15} (n = 7) (n ;, 8) 
0 hrs 24 hs 48 hrs 24 brs 48 
hrs 
Parakeratosis 0 14 43 38 50 
Intracellular Oedema (basal) - mild 67 57 14 50 50 
Intracellular Oedema (basal) - moderate 0 29 57 0 0 
Intracellular Oedema (basal) - severe 0 0 14 0 0 
Spongiosis (prickle)- mild 13 14 14 0 0 
Spongiosis (prickle)- moderate 0 14 43 25 13 
Spongiosis (prickle)- severe 0 14 14 13 75 
Vesiculation 0 14 0 25 38 
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• CELLULAR INFILTRATION AND CD54/ICAM-1 
MOLECULE EXPRESSION (Table 3.3) 
1). SLS 
Control and irritant biopsies taken up to 6 hours showed normal numbers of 
epidermal C03+ve lymphocytes , i.e. <4 cells/mm basement membrane. However by 
24 (p<0.04) and 48 (p<0.02) hours epidermal CD3+ve lymphocyte infiltration had 
occurred (Plate 3.6). Further investigation of the CD3+ve subset of lymphocyte 
revealed that after 24 hours the ratio of CD4+ve/CD8+ve lymphocytes was 3:1 
(ratios were calculated using mean values). By 48 hours the numbers of CD8+ve 
lymphocytes had increased and the number of C04+ve lymphocytes decreased 
reducing the ratio to 2: 1 (Table 3.4). Significant neutrophil, eosinophil and mast cell 
exocytosis were not observed. However, epidermal macrophage (CD68) infiltration 
was observed at 48 hours (p<0.04). 
Epidermal CD54 expression was not observed in control biopsies, although 13/39 
(33%) of SLS treated biopsies showed focal CD54 expression. Intense focal CD54 
expression correlated (1 00%) with sites of epidermal CD3+ve lymphocyte infiltration 
(plate 3.6). However CD3+ve cells were observed in epidermal areas without CD54 
expression; 15% (5/34) of biopsies with epidermal CD3+ve infiltration lacked 
epidermal CD54 expression. 
2). NA 
Epidermal lymphocyte infiltration was absent, with all biopsies showing normal 
CD3+ve cell numbers within the epidermis, i.e. all groups showing less than 4 
lymphocytes/mm BM. Neutrophil, eosinophil and mast cell infiltration were also 
absent in the epidermis. Statistically significant but mild epidermal macrophage 
(CD68) infiltration however, was observed at 24 (p<0.04) and 48 (p<0.04) hours 
(Table 3.3). KC C0 54 expression was not observed. 
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PLATE 3.6: 
a) uninvolved skin, < 4 CD3+ve cells/mm basement membrane 
b) SLS irritation, 48 hours, CD3+ve epidermal infiltration 
c) uninvolved skin, ICAM-1 expressed on endothelium 
d) SLS irritation, 48 hours, focal epidermal ICAM-1 expression 
(frozen sections , mag. x20). 

• SUMMARY 
SLS and NA irritation result in very different panems of epidermal cellular 
infiltration. SLS induced epidermal lymphocyte infiltration, with a CD3+ve 
lymphocyte influx evident by 24 hours. Investigation of the epidermal T lymphocyte 
subset present after SLS irritation showed infiltration of both CD4+ve and CD8+ve 
cells. The CD4/CD8 ratio changed with time of irritant exposure, decreasing from 
3: I at 24 hours to 2: I by 48 hours. NA did not induce epidermal lymphocyte 
infiltration. Epidermal macrophages were observed after both NA and SLS irritation. 
Following SLS irritation, the resultant focal KC CD54 expression correlated with the 
extensive lymphocyte exocytosis. Infiltration was however also observed in areas 
lacking CD54 expression. 
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TABLE 3.3: 
Median number (and range) of CD3+ve and CD68+ve cell per mrn basement 
membrane at 0, 24 and 48 hours after SLS and NA application. *denotes results that 
are significantly different from control data (Wilcoxon-signed ranks sum test). 
TIME (hrs) CD3+ve (T lymphocytes) CD68+ve (macropha2es) 
MEDIAN RANGE MEDIAN RANGE 
SLS n = 7 n = 8 
0 0 0-9 0 0-0.4 
24 14.4 * (p<0.04) 0-50.5 1.8 0-16.7 
48 12.9*(p<0.02) 3.2- 37.2 10.3*(p<0.04) 0-26.4 
NA n =6 n = 7 
0 0 0 -0 0 0-0 
24 0 0-0 t.9*(p<0.04) 0 -18.8 
48 0 0-5.3 2.3*(p<0.04) 1.1 -10.6 
TABLE 3.4: 
Median number (and range) ofCD4+ve and CD8+ve cell per mm basement membrane 
at 0, 24 and 48 hours after SLS application. 
TIME (hrs) CD4+ve (T lymphocytes) CD8+ve Ovmohocvtes) 
(n) MEDIAN RANGE MEDIAN RANGE 
0 (n= l3) 0 0-0 0 0-0 
24 (n=7) 13.6 0- 37.5 0.2 0 - 12.4 
48 (n=6) 10.5 0- 54.1 8.6 0- 13.5 
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• MHC II EXPRESSION & EPIDERMAL CDl a+ve LC 
(Plates 3.7 and 3.8 and Tables 3.5, 3.6 and 3.7) 
Epidermal LC nwnber was investigated in normal skin from volunteers. Comparison 
of LC nwnber between volunteer biopsies and those taken from clinically normal 
sites in patients with chronic ICD revealed that patients have intrinsically higher 
levels of epidermal LC (p<0.03. Mann Whitney-U test, Table 3.5, Pla te 3.8a). 
TABLE 3.5: 
Median nwnber (and range) of epidermal CD la+ve cells per mm basement 
I membrane in cl inically normal skin from patients with chronic ICD and normal 
healthy volunteers. The two groups are significantly different (p <0.03. Mann-
Whitney U test). 
I N MEDIAN RANGE 
VOLUNTEERS 18 9.1 -t 8- 15.5 
lCD PATIENTS j -ts 12.2 1.3- 30 
1). SLS 
A normal epidermal distribution of dendritic MHC II+ve cells (i.e. LC) was observed 
in control and irritant treated biopsies. However, by 6 hours after SLS application 
3/9 biopsies showed evidence of focal KC MHC II expression (Pla te 3. 7a). At 24 
and 48 hours KC MHC II expression was more prominent. with 8110 biopsies 
showing at least one area of focal KC expression (Plate 3. 7b ). 
A significant (Friedman Test. p<0.05) change in LC density was observed between 
control. I and 6 hour biopsies and also between control. 24 and 48 hour biopsies 
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(p<0.05). The decrease was significant at 48 hours (p<0.04) when assessed using the 
Wilcoxon-signed ranks sum test (Table 3.6). 
2). NA 
A normal epidermal distribution of dendritic MHC II+ve (i.e. LC) cells was observed 
in control and irritant treated biopsies. At 6 hours the distribution of MHC II 
expression was again normal , with 2/5 biopsies showing focal KC expression. The 
majority of biopsies (9/11) at 24 and 48 hours showed basal expression of MHC II, 
MHC II+ve infiltrating cells were observed in one biopsy. 
Control biopsies showed a normal epidermal suprabasal distribution of LC (Plate 
3.8b) however by 6 hours after NA application the cells had moved into a 
predominantly basal position in 12116 biopsies (Plate 3.8c). Basal layer distribution 
remained prominent at 24 (4/5 biopsies) and 48 (4/5 biopsies) hours (Plate 3.8d). 
Comparison of control, 24 and 48 hour biopsies revealed a significant (p<O.O 1, 
Friedman test) change in LC density, represented by a decrease in epidermal LC 
numbers at 24 hours (p<0.04) and 48 hours (p<0.002). 
Comparison of SLS with NA revealed that even though SLS resulted in decreased 
epidermal LC numbers the results after NA application were considerably more 
dramatic. Significantly larger decreases in LC number were shown by 24 (p<O.Ol) 
and 48 (p<0.008) hours after NA application. 
CONFOCAL LASER SCANNING MICROSCOPY (CSLM) - NA IRRlT ATION 
CSLM data confirmed the immunohistochemical results discussed in the previous 
paragraph, showing a reduction in LC number (Table 3.7) after NA application with 
cells becoming rounded by 24 hours. 
Normal healthy volunteers had a median of 5.6 dendrites/LC with a median length of 
14.5jlm prior to NA application. Patients with chronic ICD had a median of 4.5 
dendrites/LC with a median length of 11.5jlm. Neither of these parameters was 
significant ly different between the two groups (Mann Whitney U-Test). 
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PLATE 3.8: 
a) normal, unirritated skin (normal volunteer), CD 1 a+ve cells 
b) normal, unirritated skin (ICD patient), CD I a+ve cells 
c) NA irritation, 6 hours, CD la+ve cells 
d) NA irritation, 48 hours, CD I a+ve cells 
(frozen sections, mag. X20). 

PLATE 3.7: 
a) MHC II expression 6 hours after SLS irritation. (mag. x20). 
b) MHC ll expression 48 hours after SLS application. (mag. x20) 
Irritant application resulted in a change in both dendrite number and length. By 24 
hours volunteers showed significantly 'decreased numbers of dendrites compared to 
time 0 controls (median 3.5 dendrites!LC, p<0.03). Volunteers also showed 
significantly decreased dendrite length at 6 (median 4.5J.lm. p<O.OO I) and 24 hours 
(median 5.0J.lm, p<O.OO I) after NA application. Patients did not sho,,· a significant 
decrease in the number of dendrites when compared to time 0 controls. However. 
dendrite length was significantly decreased at 24 hours (median 5.0J.lm, p<O.OOl). 
Comparison between patients and volunteers revealed that at 6 hours the decrease in 
dendrite length was significantly greater in volunteers than patients (p<O.OO I). At I 
and 24 hours no differences were observed between the two groups. 
• SUMMARY 
Clinically normal skin from patients with chronic ICD have a higher number of 
epidem1al LC than normal skin from healthy volunteers. 
Epidermal LC responded to cutaneous irritant application, v·:ith a more prominent 
response occurring after NA irritation. In contrast, KC response to irritation was only 
obserYed with SLS application. 
SLS caused focal KC activation, manife~ted by MHC II expression. from 6 hours, 
and a decrease in epidermal LC density at 48 hours. 
NA application failed to induce KC activation; the LC population however was 
dramatically affected. Irritation led to a redistribution of the epidermal LC, resulting 
in a predominantly basal distribution by 6 hours. A dramatic reduction in epidermal 
LC number occurred by 24 hours, combined with qualitative cellular changes 
resulting in more rounded cell bodies with fewer, shoner dendrites. 
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TABLE 3.6: 
Median number (and range) of epidermal CD 1 a+ve cells per mm basement membrane 
at 0, 1, 6 ,24 and 48 hours after a). SLS and b). NA application. *denotes results that 
are significantly different from control data (Wilcoxon-signed ranks sum test). 
a) median number and range of CD 1 a+ve LC after SLS application. 
TIME (hours) N MEDIAN RANGE 
0 12 12.2 5.6- 16.3 
1 12 9.2 5-25.6 
6 12 8.0 2.5- 18.8 
0 6 19.0 8.6-30 
24 6 11.3 9.6- 31 
48 6 9.8*(p<0.04) 5.5- 11.2 
b) median number and range of CD ! a+ve LC after NA application. 
TIME (hours) N MEDIAN RANGE 
0 15 12.7 6.2- 17.8 
l 15 12.1 4.2- 21.3 
6 15 10.8 2.6- 27.5 
0 6 12.5 9.2- 21.3 
24 6 7.4*(p<0.04) 2.9- 10.2 
48 5 3.0*(p<0.002) 0.5-5.0 
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TABLE 3.7: 
Median (and range) number of LC per square mm at 0, 1, 6 and 24 hours after NA 
application (CSLM data) . 
TIME (hrs) N MEDIAN RANGE 
VOLUNTEERS 
0 10 383.5 162- 652 
1 9 450.0 247-597 
6 6 342.5 285- 371 
24 5 144.0 94-241 
PATIENTS 
0 3 418 418 -427 
1 9 326 224-407 
6 6 218 153-318 
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3.2.7. CELL PROLIFERATION AND DEATH 
PROLIFERATION (Table 3.8) 
I). SLS 
Cells undergoing DNA synthesis were detected using an anti -Ki-67 Ab. Ki-67 reacts 
with a nuclear Ag expressed on all human proliferating cells. Expression of this Ag 
occurs preferentially during late G~, S, M and G2 phases of the cell cycle. Basal layer 
Ki-67+ve cells were not significantly different from control levels at I and 6 hours 
after irritation. Comparison (Friedman Test) of control and irritant treated biopsies at 
24 and 48 hours, revealed a significant difference in the number of Ki-67+ve 
cells/mm basement membrane (p<O.OS). When assessed using a Wilcoxon-signed 
ranks sum test a significant increase in the numbers of proliferating cells occurred at 
48 hours (p<0.04. Plate 3.9). This increase in cellular proliferation corresponded 
with increased epidermal thickness (48 hours, p<0.02, Table 3.9). 
2). NA 
The number of Ki-67+ve basal cells was not significantly different from control 
levels at I and 6 hours after irritation. Comparison (Friedman Test) of control and 
irritant treated biopsies at 24 and 48 hours, revealed a significant difference in the 
number of Ki-67+vc cells/mm BM (p<O.OS). Using the Wilcoxon-signed ranks sum 
test thi s difference was shown to be the result of a decrease in proliferation by 24 
hours (p<0.04), increasing again by 48 hours. The difference between 24 and 48 
hours was significant (p<0.03). Increased epidermal thickness was observed at 6 
hours (p<0.04), the trend continued at 24 and 48 hours but was not significant. This 
may be due to small sample size (n = 5). 
APOPTOSIS 
Only the prickle and basal layers were assessed for the presence of apoptosis. The 
granular layer was not analysed as the dark keratohyalin granules present in this area 
present technical difficulties for scoring. 
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TABLE 3.8: 
Median number (and range) of Ki-67+ve cells per mm basement membrane at 0, 24 
and 48 hours after SLS and NA application. *denotes results that are significantly 
different from control data (Wilcoxon-signed ranks sum test). 
TIME (hrs) N Ki-67+ve cells/rum BM 
MEDIAN RANGE 
SLS 
0 6 28.2 12.8- 45 
24 6 28.6 8.7-46.7 
48 6 56.2*(p<0.05) 30.2 - 212.1 
NA 
0 6 30.5 13.3- 128.8 
24 6 13.4 * (p<0.04) 6.9- 25.1 
48 6 45.9 38.6- 78 
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PLATE 3.9: 
a) Ki-67+ve cells in unirritated skin (mag. x20) 
b) Ki-67+ve cells 48 hours after SLS irritation. (mag. x20). 
TABLE 3.9: 
Median epidermal thickness in J.!m (and range) at 0, 1, 6 ,24 and 48 hours after a) . 
SLS and b). NA application. *denotes results that are significantly different from 
control data (Wilcoxon-signed ranks sum test). 
a) epidermal thickness after SLS application. 
TIME (hours) N MEDIAN RANGE 
0 12 73.5 54.5- 121 
1 12 77 55.3- 100 
6 12 73.7 60 - 98.5 
0 7 57 42 - 67.7 
24 7 62.3 52- 196 
48 7 89.5*(p<0.02) 73.7- 108 
b) epidermal thickness after NA application. 
TIME (hours) N MEDIAN RANGE 
0 16 69.7 50-102 
1 16 72.5 50- 128.3 
6 16 78.2 * (p<0.04) 60- 111.3 
0 5 73.3 55.2- 110.5 
24 5 108 105- 119 
48 5 123.3 108- 167 
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1). SLS 
Prickle and basal layer apoptosis was observed after SLS application. yet the 
numbers of apoptotic cells did not rise significantly above control levels. At 24 and 
48 ·hours 3/8 and 5/8 biopsies showed prickle layer apoptosis. Incidence of basal 
layer apoptosis was similar, with 5/8 and 4/8 positive biopsies at 24 and 48 hours 
respectively. However, the actual number of apoptotic cells/mm BM in each biopsy 
was low (24 hours, median 0.2, range 0 -1.4; 48 hours, median 0.2. range 0 -0.9) not 
rising above control levels. 
Paraffin sections stained with monoclonal CD 1 a Ab were assessed morphologically 
for the presence of basal and prickle layer LC apoptosis. Apoptotic cells present after 
SLS application were almost exclusively of KC origin. The exception being one 
biopsy at 48 hours showing evidence of LC apoptosis. 
2). NA (Table 3.10) 
Prickle layer apoptosis was not evident in control or irritant treated biopsies taken at 
1 and 6 hours after irritation. However, by 24 and 48 hours, 4/7 and 4/7 biopsies 
respectively showed prickle layer apoptosis. Findings similar to those after SLS 
application.. Basal layer apoptosis was present in more biopsies than prickle layer 
apoptosis. Basal layer apoptotic cells were observed at 1, 6, 24 and 48 hours (311 5, 
10/ 16. 717 and 7/8 biopsies respectively, Plate 3.10). At 24 hours. the numbers of 
apoptotic cells were significantly larger than in control groups (p<0.02). 
Furthermore, comparison of NA with SLS treatment revealed a significantly higher 
incidence of basal layer apoptosis at 6 (p<0.002) and 24 (p<0.04) hours after NA 
application. TUNEL (terminal deoxynucleotide transferase-mediated dUTP-biotin 
nick-end labelling assay) was used to confirm the morphological assessment of 
apoptotic cells in biopsies previously shown to be positive (Plate 3.11). 
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PLATE 3.10: 
Basal layer apoptotic cell 48 hours after NA application, a) mag. x20 and 
b) mag. xlOO 
TABLE 3.10: 
Number of basal layer apoptotic cells per mm basement membrane at 0, 24 and 48 
hours after NA application. *denotes results that are significantly different from 
control data (Wilcoxon-signed ranks sum test). 
STATISTICS CONTROL 24 Hours 48 Hours 
0 0.2 1.4 
0 1.9 5.2 
0.3 0.5 0.2 
0 0.2 0.4 
0 6.4 0 
0 1.0 0.4 
0 2.8 1.6 
n 7 7 7 
MEDIAN 0 1.0* 0.4 
Paraffin sections stained with monoclonal CDla Ab were assessed morphologically 
for the presence of basal and prickle layer LC apoptosis. Basal layer CD l a+ve 
apoptotic cells were observed in biopsies taken at 1, 6 ,24 and 48 hours after NA 
application (2/15, 1/15, 3/7 and 1/7 biopsies respectively). Prickle layer CD l a+ve 
apoptosis was also observed in biopsies taken 1, 6, 24 and 48 hours after N A 
application (1/15, 2115, 4/7 and l/7 biopsies respectively). LC apoptosis was most 
prevalent in the prickle layer accounting for 85 - l 00% of the total number of 
apoptotic cells, with 60% of the total LC population undergoing apoptosis by 24 and 
48 hours (Plate 3.12). 
• SUMMARY 
Irritation had a marked affect on basal KC proliferation and epidermal thickness. 
SLS application resulted in increased proliferation at 24 and 48 hours, with a 
corresponding increase in epidermal thickness at 48 hours. Results from NA 
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application were different, showing an initial decrease in proliferation at 24 hours. 
Basal layer KC proliferation had returned to normal control levels by 48 hours. 
Increased epidermal thickness was observed by 6 hours after irritation and did not 
appear to correlate with increased proliferation. 
SLS irritation did not result in significant apoptosis when compared with control 
biopsies. In contrast, NA irritation induced significant levels of basal layer KC 
apoptosis at 6 and 24 hours. NA also induced LC apoptosis, accounting for 85 -
I 00% of the prickle layer apoptosis observed. Approximately 60% of the LC 
population were seen to be undergoing apoptosis by 24 and 48 hours, suggesting that 




a) In situ cell death detection, unirritated skin. (mag. x20) 
b). In situ cell death detection 48 hours after NA application. (mag. x20 and x40). 
PLATE 3.12: 
CD I a+ve apoptotic cells (A) 48 hours after NA application. (mag. x20). 
Normal LC (LC). 
• CD95, AND THE BCL-2-LIKE GENE FAMILY 
This section investigates genes that might be important in induction of apoptosis in 
the skin. 
1). CONTROL BIOPSIES (Table 3.11) 
Mild CD95/fas expression was seen in the basal, prickle and granular layers of all 
control biopsies. 
Mild bcl-2 expression was observed in the basal layer of all biopsies and the prickle 
layer of 60% of biopsies. In contrast, bcl-2 expression was not observed in the 
granular layer. The pattern of bcl-x expression was similar in the basal, prickle and 
granular layers of all biopsies. Moderate bax expression was observed in the basal, 
prickle and granular layers in the majority of biopsies. The stratum corneum was 
negative for all bcl-2-like genes investigated. 
Comparison of bcl-2. bcl-x and bax expression revealed significant differences in the 
basal, prickle and granular layers. In all three layers bcl-x and bax expression was 
significantly stronger than bcl-2 expression (Table 3.12), with no difference found 
between bcl-x and bax. 
2). SLS 
CD95/fas expression was not significantly different from control levels. Bcl-2, bcl-x 
and bax levels were not significantly different from control levels. 
Comparison of bcl-2, bcl-x and bax levels at 24 and 48 hours after SLS irritation 
revealed significant differences in the basal, prickle and granular layers. Bax and 
bcl-x expression were found to be significantly greater than bcl-2 expression in the 
basal layer at 48 hours after SLS application (Friedman test). Due to small sample 
size this test was not significant using the McNemar test. Results from the McNemar 
test are shown in Table 3.13. Prickle and granular layer differences were noted only 
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at 24 hours, showing significantly stronger bcl-x and bax expression when compared 
with bcl-2. 
3). NA 
CD95 expression observed was similar to control levels. Bcl-2, bcl-x and bax levels 
were not significantly different from control levels. 
Comparison of bcl-2, bcl-x and bax levels at 24 and 48 hours after NA irritation 
revealed significant differences in the prickle layer. By 48 hours after NA 
application bcl-x and bax expression were significantly stronger than bcl-2 
expression (McNemar test, p<0.03 and p<0.004 respectively). 
• SUMMARY 
In control skin bcl-2 expression was present in the basal and prickle layers and absent 
in the granular layer. Bcl-2 expression was not observed in the granular layer. The 
results show that bcl-2 expression decreases as the KC move towards the outer 
epidermal layers. Bcl-2 expression was not observed in the granular layer and 
stratum corneum where the cells eventually die as a result of terminal differentiation. 
Similar levels ofbcl-x and bax expression were observed in all three layers of normal 
skin. Expression of which was significantly stronger than bcl-2. 
In irritant treated biopsies differences in the intensity of staining occurred between 
bcl-2, bcl-x and bax. As with control skin, bcl-x and bax staining intensity was 
stronger than bcl-2. After SLS irritation bcl-x and bax staining was significantly 
greater at 24 hours and basal layer staining at 48 hours. NA application induced 
differences in the prickle layer only, showing significantly stronger bcl-x and bax 
staining by 48 hours. 
TABLE 3.11: 
The patterns of bcl-2, bcl-x and bax expression in the a). basal layer, b) prickle layer 
and c). granular layer ofunirritated control skin from patients with chronic lCD. 
a). Basal layer expression 
% OF BIOPSIES (n = 13) 
MOLECULE NEGATIVE MILD MODERATE SEVERE 
bcl-2 0 100 0 0 
bcl-x 0 31 62 7 
bax 0 23 54 23 
b). Prickle layer expression 
% OF BIOPSIES (n = 13) 
MOLECULE NEGATIVE MILD MODERATE SEVERE 
bcl-2 39 61 0 0 
bcl-x 0 8 77 15 
bax 0 23 54 23 
c).Granular layer expression 
% OF BIOPSIES (n = 11) 
MOLECULE NEGATIVE MILD MODERATE SEVERE 
bcl-2 100 0 0 0 
bcl-x 0 0 64 36 
bax 0 27 36 37 
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Table 3.12: 
McNemar Test. comparison of the intensity of bcl-2. bcl-x and bax expression in 
control biopsies. 
PVALUE 
GROUPS COMPARED BASAL PRICKLE GRANULAR 
bcl-2 vs bcl-x p<0.04 p<0.0004 p<O.OOl 
bcl-2 vs bax p<0.02 p<0.002 p<O.OOI 
bcl-x vs bax NS NS NS 
Table 3.13: 
McNemar Test, comparison of the intensity of bcl-2, bcl-x and bax expression after 
SLS irritation. Time-point stated in brackets is the time after SLS application to 
which the results refer. 
PVALUE 
GROUPS COMPARED BASAL PRICKLE GRANULAR 
(48 hrs) (24 hrs) (24 hours) 
bcl-2 vs bcl-x NS p<0.02 p<0.03 
bcl-2 vs bax NS p<0.02 P<0.03 
bcl-x vs bax NS NS NS 
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3.4. DERMAL CHANGES- SLS and NA 
• MONONUCLEAR CELL RECRUITMENT 
I). SLS (Table 3.14a) 
Moderate mononuclear papillary perivascular infiltration was observed m 
approximately 75% of control and SLS treated biopsies taken at I and 6 hours. 
Infiltration increased significantly by 24 and 48 hours (p<0.05, Friedman test) with 
88% of biopsies showing heavy perivascular infiltration by 48 hours after SLS 
application (p<0.02, McNemar test). 
Reticular dermis mononuclear cell infiltration was also found to be moderate in 
control and irritant treated biopsies taken up to 24 hours. However, by 48 hours heavy 
reticular infiltration was evident (p<0.02, McNemar test) reflecting the increased 
perivascular infiltration also seen at this time. 
2). NA (Table 3.14b) 
Moderate mononuclear cell perivascular infiltration was observed in approximately 
half of control and NA treated biopsies taken at 1 hour. By 6 hours, infi ltration had 
significantly increased (p<0.03, McNemar test), with moderate infiltration in 70% of 
biopsies and heavy in 18%. Although not significantly greater than in control 
biopsies, increased infiltration continued to be evident at 24 and 48 hours after 
irritation. 
In the reticular dermis infiltration was significantly greater (p<0.02) at 6 hours after 
NA application. As in perivascular areas the trend of increased infiltration continued 







Analysis performed on H&E stained sections. Mononuclear cell infiltration after SLS application,+ (mild),++ (moderate) and+++ (heavy). 
Data presented as% of positive biopsies. 
Control n=24 1 HR n= 16 6HRS n=16 24HRS n=8 48HRS n=8 
+ ++ +++ + ++ +++ + ++ +++ + ++ +++ + ++ 
Pe.-ivascular I 32 62 4 25 75 0 13 81 6 37 25 38 0 12 
Reticular 75 25 0 69 31 0 38 56 6 62 0 38 11 25 
Table 3.14b: 
Analysis performed on H&E stained sections. Mononuclear cell infiltration after NA application, + (mild), ++ (moderate) and +++ (heavy). 
Data presented as % of positive biopsies. 
Control n=24 1 HR n=16 6HRS n=16 24HRS n=8 48HRS n=8 
+ ++ +++ + ++ +++ + ++ +++ + ++ +++ + ++ 
Perivascular I 42 58 0 53 47 0 11 71 18 0 71 29 0 57 







• CD3+ve LYMPHOCYTE INFILTRATION 
1). SLS 
As with mononuclear cell infiltration normal levels of CD3+ve lymphocytes were 
observed in control biopsies. However, by 1 and 6 hours after SLS application 
lymphocyte movement from perivascular areas into the surrounding papillary dermis 
had occurred. By 24 and 48 hours this had progressed to heavy CD3+ve leucocyte 
infiltration throughout the dermis (3/5 and 4/5 biopsies respectively, Plate 3.13). 
2). NA 
Control biopsies showed a few scattered perivascular CD3+ve lymphocytes. NA 
application resulted in lymphocyte movement from the perivascular areas into the 
papillary dermis by 6, 24 and 48 hours (6/13, 2/3 and 2/3 biopsies respectively). 
• NEUTROPHIL RECRUITMENT 
Neutrophils were assessed morphologically (H&E sections) and using a monoclonal 
CD 15 A b. Neutrophil infiltration was not observed in control biopsies. Dermal 
neutrophils were observed after both NA and SLS irritation (Table 3.15). NA 
induced significant levels of infiltration earlier than SLS (p<0.04 at 6 hours) but was 
ot seen at 24 hours. Higher neutrophil numbers were observed at 24 hours in SLS 
treated biopsies (p<0.05). 
• EOSINOPHIL AND MAST CELL RECRUITMENT 
Eosinophils were assessed morphologically using H&E stained sections. Eosinophils 
were absent in control biopsies. Dermal eosinophils were noted in irritant treated 
biopsies (Table 3.16), with the numbers of positive biopsies significantly greater than 
controls at 6 hours after SLS application (perivascular eosinophils). 
109 
Mast cells (assessed using an Ab directed against mast cell tryptase) were observed in 
all control and irritant treated biopsies (range 7.0 - 82.9), with no significant 
difference between groups. 
• ADHESION MOLECULE EXPRESSION 
1). SLS 
Intensity of expression was difficult to assess due to the poor dermal architecture in 
frozen sections; therefore conclusions were only made about presence or absence of 
expression. CD54 and CD62E expression was observed on the endothelium of all 
biopsies. CD54 expression was also observed on cells in the dermal infiltrate. 
Dermal infiltrate expression was present in 4/ 10, 4114, 4/6 and 4/5 biopsies at 1, 6, 24 
and 48 hours respectively. 
2). NA 
As with SLS application, CD54 and CD62E expressiOn was observed on the 
endothelium of all biopsies. CD54+ve infiltrating cells were also observed, with 3/15, 
5/12, 2/4 and 1/3 biopsies at 1, 6, 24 and 48 hours respectively. 
• SUMMARY 
Dermal cellular infiltration occurred following application of both irritants. However 
this was more pronounced after SLS application, resulting in heavy perivascular and 
reticular dermis infiltration by 48 hours. The CD3+ve lymphocytes present in SLS 
induced dermal infiltrate moved from the perivascular areas into the surrounding 
papillary dermis producing a heavy CD3+ve infiltration throughout the dermis by 48 
hours. 
C054+ve infiltrating cells were observed after irritation, agam these were more 
pronounced after SLS application. These results suggest that a large proportion of the 
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dermal infiltrate observed 48 hours after SLS application comprises activated T 
lymphocytes. 
Differential recruitment of neutrophils was observed. In the case of NA irritation, 
neutrophils were observed in the papillary dermis by 6 hours, but, this influx was not 
sustained at 24 and 48 hours. In contrast, SLS application resulted in the dermal 
accumulation of neutrophils by 24 and 48 hours. 
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PLATE 3.13: 
Dermal CD3+ve lymphocyte infiltration 48 hours after SLS application (mag. xi 0) 
(P- perivascular, D- diffuse) 
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TABLE 3.15a: 
Median number (and range) of dermal CD IS+ve cells per mm2 dermis at 0, 1. 6 ,24 
and -+8 hours after SLS application. *denotes results that are significantly different 
...... 
from control data (Wilcoxon-signed ranks sum test). ~ denotes statistical differences 
between NA and SLS (Mann-Whitney U test). 
a) median number and range of CD 15+ve (neutrophils) after SLS application. 
TIME (hours) N MEDIAN RANGE 
0 16 0 0-0 
1 16 0 0-0.4 
6 16 0 0-7.9 
0 8 0 0-0 
24 8 5.9~ 0-88.9 
-+8 8 1.6 0-88.6 
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TABLE 3.15b: 
Median number (and range) of dermal CD 15,-ve cells per mm2 dermis at 0. I. 6 .24 
and 48 hours after NA application. *denotes results that are significantly different 
.... 
from control data (Wilcoxon-signed ranks sum test). ~ denotes statistical differences 
between NA and SLS (Mann-Whitney U test). 
b) median number and range of CD15+ve (neutrophils) after NA application. 
TIME (hours) N MEDIAN RANGE 
0 17 0 0 - 0 
1 17 0 0- 5.1 
6 17 10.3** 0- -'8.8 
0 7 0 j 0-0 
24 7 0 0 - 12.1 
-'8 7 0 0 - 9.8 
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TABLE 3.16: 
Dermal eosinophil recruitment after a). SLS and b). NA application. * denotes data 
that is significantly different from contol. data (McNemar test). 
a). percentage of biopsies with dermal eosinophils after SLS application. 
TIME (ms) N PERlV ASCULAR RETICULAR 
(PAPILLARY) 
0 16 6 0 
1 16 0 0 
6 16 38* 19 
0 8 0 0 
24 8 38 25 
~8 8 38 38 
b). percentage of biopsies with dermal eosinophils after NA application. 
TIME (hrs) N PERIVASCULAR RETICULAR 
(PAPILLARY) 
0 17 0 0 
1 17 18 0 
6 17 24 0 
0 7 0 0 
24 7 0 0 
48 7 14 0 
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3.5. CYTOKINE PRODUCTION 
• PILOT STUDY 
The small amounts of blister fluid obtained from each subject (50 - 200j.ll) limited the 
number of cytok.ines that could be quantified using ELISA. For this reason a pilot 
study was carried out (using normal volunteers) to determine the cytokines of major 
importance in our model system. 
We measured IL-8, MIP-I a, TNFa, IL~2, IFNy and IL-Ia, all suggested to play 
important roles in cutaneous inflammation. Table 3.17 summarises the results from 
this pilot study. On the basis of these results we chose to include IL-l a, IL-8 and 
IFNy in the main study. 
TABLE 3.17: 
Cytokine assay results from pilot study. Table shows the mean concentration of 
cytokine at I, 6 or 24 hours after NA irritation. 
CYTOK.INE I HOUR n 6 HOURS n 24 Hours n . 
IL-8 negative 3 1.6 ng/ml 3 not tested -
MIP-la not tested - negative 3 negative I 
TNFa not tested - negative I negative I 
IL-2 not tested - not tested - negative 2 
IFNy not tested - 3.2 ng/ml 1 0.6 ng/ml 3 
IL-Ia not tested - 97.8 pg/ml I not tested -
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• IFNy 
IFNy was not detected in patient samples at I or 6 hours after NA irritation. 
Unfortunately the data from all 24 hour samples was not valid due to a faulty assay 
kit. 
• IL-l a (Graph 3.1) 
Untreated control samples from normal volunteers showed detectable levels of IL-l a 
(5/5 samples). IL-l a .was detected in blister fluid from both patients and volunteers 
after NA application. In patients IL-l a was found at 1, 6 and 24 hours ( 4/ 19, 4/6 and 
4111 samples respectively) with no significant difference found between groups. In 
contrast detectable levels of IL-l a were seen at only 1 and 24 hours in volunteers 
( 4110 and 6110 samples), with significantly higher cytokine levels at 24 in 
comparison with 6 hours (p<0.03, Mann Whitney-U test). 
• IL-8 
IL-8 assays were carried out after both NA and SLS irritation. 
1). SLS 
Assays confirmed IL-8 to be present in blister fluid from both patients and volunteers 
at all timepoints. Samples were only taken from patients at 24 hours and all 3 
showed detectable IL-8. In the volunteer group IL-8 was detected in untreated 
control samples as well as in SLS treated samples taken at 1, 6 and 24 hours ( 4/ 16, 
2/3, 7/8 and 6/8 respectively). Concentrations of IL-8 detected are outlined in the 
Table 3.18. 
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GRAPH 3.1: IL-1 alpha ELISA results.
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1 hr (n = 19)
□ 6 hrs (n = 6)
□ 24 hrs (n= 11)
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Volunteer samples taken 1 hour after irritation were not ~ignificantly different ~rom 
unirritated controls. However, by 6 and 24 hours after irritation significantly 
increased levels ofiL-8 were detected (p<0.006 and p<0.003, Mann-Whitney U test). 
Comparison of 24 hour patient samples with unirritated volunteer controls revealed 
that SLS irritation induced a significant increase in IL-8 production (p<0.004, Mann-
Whitney U test). IL-8 levels in irritant treated patient and volunteer groups were not 
significantly different, possibly due to small sample size in the patient group. 
TABLE 3.18: 
Shows the median (and range) concentrations (pg/ml) ofiL-8 detected at 0, 1, 6 and 
24 hours after SLS application. *determines data which is significantly different 
from control data (Mann-whitney U test). 
VOLUNTEERS 
Time (hrs) n Median (pg/ml) Range (pg/ml) 
0 16 0 0-849 
I 3 492 0 - 1153 
6 8 340* 0- 1398 
24 8 237* 0- 1079 
PATIENTS 
Time (hrs) n Median (pg/ml) Range (pg/ml) 
24 3 1109* 607- 18515 
2). NA 
Assays detected small amounts of IL-8 in blister fluid from both patients and 
volunteers although not at all timepoints investigated (Table 3.19). In the patient 
group IL-8 was detected at I and 6 hours after SLS application (2119 and I /6 samples 
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respectively); whereas in the volunteer group IL-8 was detected at 6 and 24 hours 
(311 0 and 2110 samples respectively). Concentrations of cytokine found are outlined 
in table 3.19. 
No significant differences were found between the different timepoints, including 
time 0 controls, in either patient or volunteer groups, suggesting that NA application 
has no affect on IL-8 production. There were also no differences found between 
patient and volunteer samples. 
TABLE 3.19: 
Shows the median (and range) concentrations (pg/ml) ofiL-8 detected at 0, 1, 6 and 
24 hours after NA application. 
VOLUNTEERS 
Time (hrs) n Median (pg/ml) Range (pg/ml) 
0 16 0 0-849 
1 10 0 0-0 
6 10 0 0-672 
24 10 0 0-910 
PATIENTS 
Time (hrs) n Median (pg/ml) Range (pg/ml) 
1 19 0 0-565 
6 6 0 0- 1200 
24 11 0 0 - 0 
3). COMPARJSON OFNA AND SLS 
Comparison of NA and SLS irritation revealed significantly higher concentrations of 
IL-8 in blister fluid from SLS treated patients (p<0.004, Mann-Whitney U test). This 
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comparison could only be made at 24 hours due to the small number of patients in the 
SLS treatment group. 
In the previous section we observed that IL-8 production after NA application was no 
different in patient and volunteer groups, for this reason the data was pooled allowing 
further analysis. The pooled group was compared with data from SLS irritated 
volunteers. This data revealed that SLS irritation results in significantly higher 
concentrations of IL-8 at all three timepoints investigated (Table 3.20). 
TABLE 3.20: 
Comparison of IL-8 levels in blister fluid from SLS treated (volunteers) and NA 
treated (pooled data) skin. 





IL- l ex production was induced by NA irritation. In patients IL-l ex was detected at I, 
6 and 24 hours, whereas in volunteers detection was confined to I and 24 hours. 
IL-8 was found in both uninvolved and irritant treated groups. NA irritation did not 
induce a significant IL-8 response. In contrast, SLS irritation led to significant IL-8 
production at I, 6 and 24 hours, in both patient and volunteers groups. 
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3.6. AUTO-ANTIBODY DETECTION IN PATIENTS 
WITH CHRONIC lCD. 
Sera from 8 patients with chronic lCD were tested against lysates from normal skin, 
lesional lCD skin, normal tonsil and normal liver. Endogenous biotin and other 
background bands were detected in normal skin but no specific staining with sera 
was found. In contrast, 4/8, 3/8, 5/8 and 5/8 lCD sera tested against dermal lysates 
from 4 different lCD patients produced a specific band at about 75 k.DA (Table 
3.22). In the two epidermal lysates investigated a band of about 75kDa was detected 
in 3/8 and 4/8 sera tested (Table 3.23). Sera from 4 normal individuals were also 
tested showing no specific bands. 
Graph 3.2 outlines the method used to calculate the molecular weight of the auto-
antigen detected in these 4 patients. 
3.6.1. SUMMARY 
An antigen of approximately 75k.DA was detected, using sera from patients with 
chronic ICD, in lesional dermal and epidermal extracts. 
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GRAPH 3.2: 
Shows the log of molecular weights plotted against relative front. Method used to 
calculate the molecular weight of bands seen on the gel. 







- I ::s 5 ~ ... . ... .. . 
(.) 
G) -0 s 
00 
0 -
···• ······ ... .··. ... 
·· ..... 
······• ······ ... 
•··· 
4 ' t-




Relative mobility of molecular weights and specific bands, detected with sera from 
ICD patients, in normal dermal extracts. 
148 k.Da 0.15 0.09 0.04 0.06 
60k.DA 0.41 0.33 0.30 0.31 
42k.DA 0.57 0.49 0.45 0.47 
30k.DA 0.76 0.69 0.65 0.64 
22k.DA 0.84 0.78 0.77 0.75 
17 k.DA 0.96 0.91 0.90 0.89 
Band 0.38 0.33 0.31 0.33 
M. Wt (band) 77kDa 77kDa 78 k.Da 71 kDA 
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TABLE 3.23: 
Relative mobility of molecular weights and specific bands, detected with sera from 
ICD patients, in normal epidermal extracts. 
148 kDa 0.07 0.06 
60kDA 0.3 0.3 
42kDA 0.48 0.43 
30kDA 0.61 0.61 
22kDA 0.7 0.72 
17 kDA 0.86 0.87 
Band 0.26 0.28 
M. Wt (band) 73 kDA 75kDA 
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4.0. DISCUSSION 
Cells of the epidermis, including KC and LC have long been recognised as being 
dynamically involved in the development of contact dermatitis (Gawkrodger et al, 
1986, Gawkrodger et al, 1987). The overall aim of this thesis was to investigate the 
epidermal and dermal changes in response to irritant application in order to clarify 
the role(s) of the inflammatory and immunological responses in the pathogenesis of 
lCD. 
Previous investigations on irritant reactions have focused on events at time-points 
greater than 20 hours after irritant application on skin of patients allergic contact 
dermatitis or normal human skin. The approach adopted in this study was to 
investigate early events (1 and 6 hours) in comparison with events at 24 and 48 hours 
after experimental irritation on the skin of patients with chronic lCD. These findings 
were then compared with data concerning normal skin, thus providing information on 
differences between the two groups. 
To achieve this, a detailed histopathological study was undertaken which compared 
clinically similar irritant reactions elicited on the clinically normal-looking skin of 
patients with chronic ICD. Comparisons were made between 80% NA, 5% SLS and 
0.01% DL irritancy at 5 time-points ranging from 0 - 48 hours. These three 
chemically different irritants were chosen because they represent different modes of 
action on the skin. 
• Anionic detergents, such as SLS, have been used widely in research and have 
demonstrated the greatest irritant potential of all substances tested (reviewed by 
Wilhelm eta/, 1994). SLS has multiple modes of action including removal of 
surface lipids, denaturation of keratins and surface glycoproteins and impairment 
of barrier function through increased permeability to water (Kligman and 
Wooding, 1967). 
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• NA is a C9 free fatty acid which alters the skin lipid profile. It appears to have a 
consistent irritant effect (Stillman et a/, 1975), hence its use as a test substance 
for histochemical and E.M. studies of irritancy (Wahlberg et a/, 1985). Patch 
testing with 80% NA for 48 hours induced dyskeratosis suggesting a disturbance 
in KC metabolism and differentiation (Willis et a/, 1989). Experimental NA 
irritancy has been shown to result in an increase in the density of proliferating KC 
(Willis eta!, 1992, 1993). 
• DL, an anthralin derivative, is commonly used in the treatment of psoriasis. It 
causes the release of prostaglandins which are considered to be the major factor 
involved in the decreased KC proliferation observed upon treatment. When 
applied to the skin, DL is oxidised which results in the generation of free radicals, 
thought to be responsible for irritation. 
Gawkrodger and colleagues have shown epidermal T cell and macrophage exocytosis 
in response to 48 hour application of 0.1% DL (Gawkrodger et a/, 1986). The data 
presented in this thesis relates to 1 and 6 hour applications of 0.01% DL, and the lack 
of cellular infiltration is probably due to insufficient exposure time and/or irritant 
concentration. Two biopsies taken at 48 hours after 0.01% DL application showed 
evidence of ICAM-1 expression. This would suggest that KC activation and T cell 
infiltration might be evident if a larger patient group was investigated. 
DL has been shown to affect LC, resulting in disrupted mitochondrial function and 
decreased (Gawkrodger et a/, 1986) or unchanged (Kanerva, 1984) LC density. 
There is some uncertainty in the literature concerning epidermal LC density, but this 
again may simply reflect differences in experimental design. 
KC mitochondrial damage has also been observed (reviewed by Kanerva et a/, 1990, 
Gawkrodger et a!, 1986) although this was less severe than that demonstrated in LC. 
Mitochondrial damage has been postulated to contribute to the decreased epidermal 
proliferation for which DL is therapeutically utilised. 
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The data presented in this study clearly show that 80% NA , 5% SLS and 0.01 % DL 
induce different patterns of epidermal damage, cellular activation and infiltration. 
Despite early experiments to titrate suitable concentrations of the irritants 0.01% DL 
irritation evoked only mild erythema, even after 48 hours. These findings were 
reflected in the minimal histopathological changes observed which amounted to mild 
spongiosis in less than 15% of patients and basal layer intracellular oedema in the 
epidermis. Irritation had no apparent effect on the dermis. Evaluation of the 
erythema was carried out using a Minolta chroma meter which measured the degree 
of skin redness. The brown staining due to DL affected measurements making it 
difficult to grade the induced erythema. Further investigation, by eye, of the 
erythema produced by DL suggested that this was not comparable to that provoked 
by NA and SLS. For this reason dithranol was then omitted from the study. In 
summary it seems likely that the poor inflammatory response to DL reflects an 
inadequate concentration of this irritant but it is also possible that DL may be slower 
acting than the other irritants, requiring 48 hours or more to induce erythema 
equivalent to that seen with NA and SLS at 24 hours. 
As I aimed to compare irritant reactions of similar intensity, further discussion will 
focus on the irritant reactions following application of 80% NA and 5% SLS. 
4.1. VEHICLE CONTROLS, GENDER, ACTIVE 
DISEASE AND ATOPY. 
NA was applied to the skin in the vehicle propan-1-ol whereas SLS was made up in 
an aqueous solution. Both vehicles induced a minimal epidermal response, but this 
was not significantly different from control (unirritated, normal-looking) skin taken 
from the same group of lCD patients. Four biopsies were taken from each subject, 
one from clinically normal skin at 0 hours, one vehicle control and two irritant 
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treated samples. This design meant that there were only half the nwnber of vehicle 
control biopsies in comparison with irritant treated biopsies. Therefore, when 
carrying out analysis on paired data the sample groups were greatly diminished. For 
this reason vehicle control and time 0 control biopsies were analysed initially. No 
significant differences were found between these groups suggesting that the vehicle 
plays no significant role in these forms of experimentally induced irritation. 
Therefore, further analysis included irritant treated samples paired with the 
corresponding time 0 controls. 
Comparisons were made between male and female patients and groups with and 
without active disease. No differences were found between these groups for any of 
the parameters investigated. 
Previous studies have suggested that atopic skin, compared with normal skin, is more 
susceptible to irritation (Rystedt, 1990).. Impaired barrier function in atopic subjects 
is believed to contribute to this irritant susceptibility (Tupker et al, 1990). This does 
not appear to be the case in patients with chronic lCD as there was no difference in 
irritant susceptibility between atopic and non-atopic patients. It is possible that 
patients with chronic lCD have impaired cutaneous barrier function and that this 
factor, coupled with my observations of higher basal levels of partially activated LC 
and increased IL-Ia, may explain the increased irritant susceptibility, regardless of 
atopic status. This hypothesis would explain why, in the context of this study, atopic 
status did not influence experimental irritation. 
4.2. EPIDERMAL DAMAGE 
In 1989 Willis and co-workers showed that 48 hour NA (80%) application, on 
normal volunteers, induced KC changes which were indicative of disordered 
keratinisation accompanied by mild spongiosis. In contrast, 48 hour irritation with 
5% SLS was shown to result in moderate reactions, characterised by alterations in 
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KC morphology and parakeratosis (Willis et al, 1989). The results presented in this 
study have also shown different patterns of epidermal damage. 80% NA produced 
mild spongiosis, while 5% SLS caused severe spongiosis which often progressed to 
vesiculation at 24 and 48 hours. My results confirm Willis' findings that SLS induces 
parakeratosis in the later phase of irritation (24 and 48 hours) but I have shown that 
NA irritation may also induce parakeratosis. Parakeratosis may result from increased 
epidermal mitosis (Fisher and Maibach, 1975) or accelerated keratinisation (Wolff et 
al, 1987). Both of these processes may be induced through production of KC growth 
factors such as IL-6 and IL-8 (Grossman eta/, 1989, Tuschil eta!, 1992). My data 
show significant IL-8 production after SLS application, confirming previous reports 
(Wilmer eta!, 1994, Wilmer and Luster,. 1995). 
4.3. EPIDERMAL PROLIFERATION 
SLS application caused increased KC proliferation by 24 and 48 hours and epidermal 
thickening at 48 hours. These findings corroborate previous studies carried out in 
vitro and on normal volunteers (Varani eta!, 1991 , Willis eta/, 1993, Berardesca and 
Distante, 1994). IL-8 may contribute to the increased proliferation observed. In 
contrast, NA decreased KC proliferation, at 24 hours which returned to normal by 48 
hours. This may reflect the lack of IL-8 production observed after NA irritation but 
also suggests that other anti-proliferative factors are involved. Two such factors 
could be TGF-0 (Choi and Fuchs, 1990) and IFNy (Symington, 1989) which have 
been shown in vivo and in vitro respectively to result in decreased basal KC 
proliferation. 
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4.4. CELLULAR INFILTRATION 
ICAM-1 (CD54) mediates adhesion of KCs through binding to its ligand on T cells, 
LF A-1 (CD 11 a/CD 18). It has been demonstrated that a progressive loss in KC 
ability to upregulate ICAM-1 expression occurs with differentiation (Little et a/, 
1996). This might suggest that KCs of the basal and suprabasal layer preferentially 
initiate and amplify inflammatory reactions. This study has shown that, following 
SLS application, the resultant focal basal KC ICAM-1 expression correlates with 
extensive epidermal lymphocyte infiltration. These findings suggest that basal layer 
KC may indeed be pivotal in the initiation of inflammation. In addition, epidermal 
lymphocyte infiltration was observed in areas lacking ICAM-1 expression. These 
findings indicate that I CAM -1/LF A -1 interactions are more important in the trapping 
of infiltrating cells within the epidermis rather than their recruitment from the blood 
stream. KC activation as defined by MHC II expression, and IL-8 production was 
also evident by 24 hours after SLS application. IL-8 is an important T cell 
chemoattractant and may contribute to T cell recruitment into the epidermis. 
Investigation of epidermal T-cell subsets showed recruitment of both CD4+ve and 
CD8+ve T cells after SLS application. Epidermal CD4+ve T cell infiltration occurs 
more rapidly than CD8+ve T cell recruitment. Although the phenotype of the 
infiltrating T cells has yet to be characterised it is possible that the initial influx of 
CD4+ve T cells consists of recirculating CD4+ve, CLA +ve memory T cells that 
migrate rapidly into the skin upon irritation. These T cells could become activated by 
Ag presentation in the presence of co-stimulatory molecules even though the nature 
of the Ag providing the activating stimulus has yet to be determined. Antigenic 
stimuli could be produced as a direct result of epidermal damage, for example 
through degradation of epidermal proteins. It is also possible that induction of an 
autoimmune response could be responsible for the T cell influx observed. 
Memory T cells do not require EC activation to the same degree as na"ive T cells and 
are therefore recruited at an early stage of the response. Once in the epidermis these 
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cells bind to activated epidermal KC via ICAM-1/LF A-1 resulting in further T cell 
and KC activation and consequent cytokine production. The endothelium then 
becomes highly activated, expressing adhesion molecules which bind to and activate 
nai've CD4+ve and CD8+ve T cells. These cells then migrate into the damaged area. 
It is possible that CD8+ve cytotoxic T cells require prior KC activation via CD4+ve 
T cells before they are able to exert their effects. It is possible that CD8+ve cytotoxic 
T cells may also contribute to the epidermal damage which leads to autoimmunity 
and disease chronicity (see section 4.9.). Such a response could become self-
perpetuating, with or without an autoimmune component. CD8+ve cytotoxic T cells 
would cause further epidermal damage leading to release of primary cytokines and 
recruitment of more memory CD4+ve T cells and so the cycle would continue. This 
model relies on the absence or inadequate production of inhibitory factors such as IL-
l 0 and IL-l ra, a feature speculated to lead to exaggerated inflammation. 
The prominent T cell response seen following SLS irritation (Figure 4.1) contrasts 
sharply with the lack ofT lymphocyte infiltration and KC activation detected after 
NA application. Lymphocyte exocytosis and migration may be absent as a direct 
result of the lack of KC activation and ICAM-1 expression and/or chemotactic 
factors such as IL-8 and IL-l. ELISA studies have shown that NA irritation causes 
minimal IL-8 production and thereby a lack ofT cell chemoattraction. It is of interest 
that a similar level of macrophage exocytosis was observed by 48 hours after both 
NA and SLS irritation. This suggests that macrophage recruitment occurs 
independently of T cell recruitment possibly through the production of different 
chemotactic agents, such as monocyte activating chemotactic factor. It is possible 
that macrophage exocytosis occurs as a non-specific response to tissue injury. This 
influx would provide protection through phagocytosis of microbes and production of 
a wide variety of pro-inflammatory cytokines, for example IL-l and TNFa.. IL-l a. 
has been shown to contribute to oedema and mononuclear cell chemotaxis (Miossec 
et a/, 1984, Dowd et a/, 1988), and may explain why irritation by both NA and SLS 
results in mild spongiosis and macrophage infiltration. IL-l also recruits T cells to 
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FIGURE 4.1: 
Diagramatic representation of SLS induced T lymphocyte recruitment from the blood 




SLS application results in release of epidermal stores of 
IL-l aand induces further KC cytokine production e.g. IL-
8, TNFa. (see Figure 4.2) 
EC EXPRESSION. OF CD62E 
~~~ MONOOTE 
~.\JvF I \ Fl l 
MEMORY T CELL - CD4+ve, CLA +ve 
(It\ ta...--.. T cells moves to epidermis and bind to KC 
Q Q through CD 54/CD 11 a interactions. 
1 
Release ofT cell and KC cytokines, for example IL- l , IL-8, IFNy and TNFa 
ENDOTHELIAL ACTIVATION 1 
EC activation causes adhesion molecule expression. Naive T cells bind to EC adhesion 
molecules and move through the endothelium. CD4+ve and CD8+ve naive T cells are 
present with CD8+ve numbers increasing over time. These CD8+ve cells could be 
involved in epidermal tissue destruction, leading to further cytokine release and T cell 
infiltration. 
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the site of tissue injury suggesting that the lack of epidermal T cell trapping after NA 
application may be due to the absence ofKC activation and ICAM-1 expression. 
4.5. CYTOKINE PROFILES 
Relatively low levels of cytokine is released from normal skin. In contrast, injury or 
disease results in KC production of several pro-inflammatory cytokines including IL-
Ia, TNFa and IL-6 (reviewed by Barker and MacDonald, 1992, Nickoloff and 
Turka, 1993). A trend towards different levels of 11-1 a expression between patient 
and volunteer groups after NA irritation was noted. Larger nwnbers would be 
required to determine if this was a real finding. Preswnably similar results would be 
seen after SLS irritation as IL-l a release represents a non-specific, protective 
response. Patients continually produced IL-l a whereas in the volunteer group IL-l a 
was detected at only 1 and 24 hours, with a dip at 6 hours. One explanation is that in 
patients with chronic lCD, the KC may be in a perpetual state of activation or partial 
activation and therefore continuously synthesise and release IL-l a. A generally 
increased state of activation is also implied by the increased levels of LC in the 
normal skin of patients with chronic lCD. LC can also produce IL-Ia (reviewed by 
Sauder, 1984) which may contribute to the increased levels of this cytokine detected. 
In situ hybridisation and in vitro studies should be utilised to determine the 
contribution of these two cell types, thus giving a more complete picture of the 
response occurring here. 
It is possible that KC in normal skin release pre-formed stores ofiL-1 a immediately 
upon NA irritation ( 1 hour). These stores are depleted by 6 hours, hence the dip in 
IL-Ia detection. By 24 hours new IL-Ia synthesis has increased to detectable levels. 
It would be of interest to investigate the IL-l a production after SLS and DL 
irritation. Unfortunately we could not obtain sufficient material to do this in our 
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investigation. Results from a similar investigation using SLS and DL would clarify 
the role of KC IL-l a release in this model system. 
The IL-8 induction observed after SLS irritation may be important for T cell and 
Neutrophil recruitment as well as the increased KC proliferation and parakeratosis 
observed. IL-8 production was not significant after NA application and have been 
responsible for the lack of cellular infiltration, KC proliferation and parakeratosis 
observed. 
Data presented in this thesis have shown that the patterns of cytokine induction upon 
irritation appear to be different depending upon on the irritant used. It is therefore 
possible that the cytokine profile induced by experimental irritation may be closely 
related to the ensuing cutaneous response. 
4.6. LANGERHANS CELL RESPONSE TO 
IRRITATION 
The function of LC as APC has been studied extensively in allergic contact 
dermatitis (Si lberberg, 1973, Sting! et al 1977, 1978, Braathen and Thorsby, 1980, 
Cumberbatch et al 1992) but their role in ICD is as yet poorly understood. 
Experimentally induced lCD reactions have provided contradictory results, with 
groups showing increased (Scheynius et a!, 1984 ), unchanged (Kanerva et a!, 1984) 
and decreased (Ferguson et al, 1985) epidermal LC numbers. These findings may 
reflect differences in the concentration, application time or irritant used. This study, 
comparing clinically similar reactions to NA and SLS, strengthens previous 
suggestions in the literature (Willis eta/, 1990) that the chemical nature of the irritant 
is one of the most important factors influencing the epidermal LC population. 
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The effect of experimental irritation on the LC population may be crucial for the 
outcome of an inflammatory response. NA irritation had a dramatic, damaging effect 
on epidermal LCs and caused minimal inflammation, whereas SLS had a minimal 
effect and induced a more intense inflammatory response. SLS application caused a 
decrease in epidermal LC numbers by 48 hours. This reduction was not due to LC 
apoptosis and may simply represent a migration of LCs to the draining lymph nodes 
as has been previously described in the literature (Brand et al, 1992). In contrast, NA 
irritation led to a redistribution of LCs, resulting in a predominantly basal position by 
6 hours, with a dramatic reduction in number occurring by 24 hours as a result of LC 
migration or apoptosis. Eighty five to one hundred percent of the total number of 
apoptotic cells in the prickle layer were CD 1 a+ve, which may explain the epidermal 
redistribution pattern. LC migration may also play a role in this redistribution. By 
24 and 48 hours sixty percent of LCs were undergoing apoptosis, accounting for the 
dramatic decrease in LC number. CSLM analysis suggests that LC redistribution is 
coupled with a reduction in dendrite length and possibly APC function. 
I propose, that NA irritation results in a dramatic decrease in the potential for Ag-
specific responses. LCs are the APC of the skin and process and present Ags present 
in the skin. Antigen is taken up in the epidermis and transported by the LCs to the 
regional lymph node where it is presented to T cells. Nai"ve T cells will recognise 
foreign peptide in association with MHC molecules on LCs and become activated. 
These sensitised T cells then travel to the skin and participate in the resultant antigen-
specific inflammatory response. In this manner epidermal LCS enable a rapid and 
specific response to any epidermal damage. In the case ofNA irritation LC function 
is decreased and cutaneous foreign or self antigen remains undetected by the immune 
system. In my view this implies that NA irritation induces a form of cutaneous 
'immunological anergy', suggesting that irritant reactions resulting from NA 
application are not likely to result in chronic lCD. The lack of APC capability may 
however cause other problems such as increased infections. NA induced LC damage 
could be put to therapeutic benefit in Ag driven diseases, such as allergic contact 
dermatitis. This study does not indicate how long NA induced cutaneous 
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'immunosupression' may last. It may be that DC are. rapidly recruited from the 
peripheral blood to replace the damaged epidermal population. Results from this 
study show that dermal LC numbers have not increased by 48 hours, but it seems 
likely that this cell population will replenish. Repopulation of epidermal LC is a 
factor to be taken into consideration ifNA treatment is to be utilised therapeutically. 
It would be of interest to carry out further experiments to try and answer the question 
of LC replenishment. Application of NA for 48 hours should be carried out as 
before. The patch should then be removed but biopsies would not be taken until at 
least 72 hours had elapsed. Analysis of these samples would provide valuable 
information concerning regeneration of the LC population. 
Comparison of samples from untreated normal volunteers, and clinically normal lCD 
patients, revealed a small difference in LC number, dendrite number and length. 
Clinically normal skin from lCD patients had more epidermal LC; with fewer, shorter 
dendrites, than those in he skin of normal volunteers. These findings suggest that LC 
in these patients may be in a partially activated state, with shorter dendrites, already 
partially rounded up and ready to migrate upon irritation. 
Following NA application MHC II expression was confined to the epidermal LC. 
KC activation, defined by MHC II expression, was not evident. This lack of KC 
activation may reflect the general 'immuological anergy' as well as the increase in 
epidermal APC apoptosis. Antigen specific T cell activation and migration into the 
epidermis would not occur because of the decreased LC population and therefore 
lack of APC function. Cutaneous 'immunological anergy' in this context may 
involve a dampening down of any non-specific inflammatory response. Mechanism 
by which this could be achieved include induction of increased IL-l 0 and/or 
decreased IL-l production. 
NA application resulted in basal and prickle layer apoptosis at 24 and 48 hours, a 
pathological effect not induced by SLS. It is well known that KC produce a wide 
variety of cytokines, many of which may be involved in of the apoptotic process. LC 
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viability has been shown to be dramatically decreased by IL-l 0, resulting in apoptosis 
(Ludewig et a/, 1995). Therefore, induction of IL-l 0 may be one mechanism by 
which NA irritation can induce LC apoptosis. Removal of growth factors or 
cytokines may also result in induction of apoptosis and deserves investigation. GM-
CSF (Heufler et al, 1988, Kolenik et al, 1990), TNFa (Kimber and Cumberbatch, 
1992) and IL-l (Heufler et a/, 1988) are important in LC maturation and migration. 
Removal of these cytokines may result in the LC remaining in the epidermis and 
undergoing apoptosis. TNFR ligation (reviewed by Cohen, 1992) and CD95/fas 
binding have also been implicated (Sayama et al, 1994) in induction of apoptosis. 
TNFa induced apoptosis has yet to be investigated in the context of irritant reactions. 
Previous investigations, carried out on normal healthy volunteers show some similar 
findings to the results presented here in patients with chronic lCD but this was not 
found to be the case in the comparison of epidermal LC numbers and IL-l a 
production. Continuous IL-l a production was observed in patients with chronic 
lCD, which suggests that the KC in these individuals may also be in a partially 
activated state. This study has described increased numbers of LCs in normal skin 
from patients with chronic lCD compared with normal volunteers. This difference 
between the LC populations suggests that these cells may play a pivotal role in either 
induction or maintenance of chronic lCD. 
4.7. TERMINAL DIFFERENTIATION AND CELL 
DEATH 
UVB irradiation has been shown to induce KC apoptosis (Schwarz et a!, 1993) in 
conjunction with increased TNFa production (Trefzer et a!, 1993). In this situation 
TNFR ligation has been suggested as a possible apoptotic initiation signal, though 
other factors would also be required (Schwarz et al, 1993). These apoptotic or 
'sunburn' cells are assumed to be KC. Recent data, presented at the 1996 September 
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meeting of the European Society of Dermatological Research has shown that UVB 
irradiation can induce apoptosis in LC (Rattis et al, 1996). This finding in 
conjunction with my investigations suggests that LC may be more sensitive to 
'environmentally' induced apoptosis than KC. It would therefore be of interest to 
further investigate the cellular nature of ' sunburn' cells as they may be LC as well as 
KC in origin. 
For lymphocytes the time span from initial cell shrinkage through to removal of 
apoptotic bodies is relatively short, in the region of 1 to 3 hours, whereas in 
epidermal KC, TD requires 48 to 72 hours (reviewed by Haake and Polakowska, 
1993). In ICD, signs of the classical form of apoptosis as well as TD have been 
observed, suggesting that different initiating/control mechanisms are involved. 
CD95/fas is a member of the TNF receptor family, which can initiate the apoptotic 
process upon ligation by Fas-ligand (Sauda et a/, 1993). CD95 is expressed 
constitutively on normal KC but is not functionally active, i.e. it does not induce 
apoptosis upon ligation (Matsue et a/, 1994). KC activation via IFNy results in 
funct ional activation (Matsue et a!, 1995) and up-regulation of CD95 expression 
(Sayama et al, 1994). Antibody binding studies have shown that CD95 ligation on T 
cells can result in activation and proliferation rather than apoptosis (Alderson et a!, 
1993). It is therefore possible that the levels of CD95 expressed, the activation state 
of the cell (T cell and KC), may determine the outcome of the response upon ligation. 
In the context of this study I propose that, following experimentally induced SLS 
irritation, in contrast with normal KC, KC CD95/fas ligation would be functiona. 
SLS irritation causes KC to become activated, expressing both MHC II and ICAM-1 , 
therefore CD95 ligation could induce both T cell and KC proliferation and/or 
apoptosis. SLS application results in increased dermal and epidermal cellular 
infiltration. Many of the T lymphocytes present in this influx will be fas-L positive 
and could bind to functional CD95 expressed on the epidermal KC inducing KC 
activation and proliferation or apoptosis. In contrast, NA irritation does not result in 
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KC activation, which suggests that CD95 is not functional in this situation. The fact 
that significant levels of apoptosis were not observed after SLS application indicates 
that CD95 ligation does not play an important role in this form of irritant induced 
apoptosis. In the context of SLS irritation CD95/fas ligation may be important in KC 
activation and proliferation. It would be of interest to carry out in vitro 
experimentation to determine the functional significance of CD95 expression in 
irritant treated KC. 
As cells arise in the basal layer they express bcl-2 (Hockenbury et a/, 1991) and are 
therefore protected from PCD. Cells that are about to undergo TD, move outwards 
and down-regulate bcl-2 expression. It has been suggested that this loss of bcl-2 
expression may in fact be one of the triggers for KC movement. TGF-P has also 
been suggested to play a role as an apoptotic trigger. This cytokine inhibits KC 
proliferation and is synthesised within the prickle layer just prior to the onset of TD 
(Choi and Fuchs, 1990). Investigation into the levels of TGF-P produced after NA 
irritation, may provide some explanation for the increased prickle layer LC apoptosis 
and decreased KC proliferation observed. The production ofTGF-P at 24 hours after 
NA application could induce the decreased proliferation observed at this timepoint, 
proliferation would then return to normal by 48 hours as the TGF-P activity 
decreases. In this model TGF-P could also provide a trigger for the induction of 
apoptosis which occurs by 48 hours. An apoptotic trigger is just one signal in a 
complex pathway. The resultant cell death may therefore not occur immediately 
upon TGF-P binding as further stimuli are required. Not only are there different 
initiating and control mechanisms in the apoptotic process but I have also 
demonstrated apoptosis in different cell populations upon irritation. 
Understanding the complex mechanisms responsible for epidermal apoptosis will 
undoubtedly have an impact on our understanding of skin disease and aid 
development of future strategies for therapeutic intervention in cutaneous disease. 
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4.8. DERMAL RESPONSES 
Previous studies on irritant reactions m normal volunteers have shown a 
predominantly mononuclear cell dermal infiltrate, of mainly T cells and 
macrophages, occurring by 24 hours. This study confirms that dermal infiltration, the 
majority of which is mononuclear, occurs after irritation, although the density and 
pattern of the response differed considerably between NA and SLS. SLS induced a 
larger infiltration, resulting in heavy perivascular and reticular dermis infiltration by 
48 hours after application. The infiltrate was composed mainly of CD3+ve 
lymphocytes, which moved from the perivascular areas into the surrounding papillary 
dermis to produce the heavy infiltration observed throughout the dermis at 48 hours. 
The large dermal influx observed after SLS application reflects the epidermal T cell 
infiltration and may represent an increase in targeted cellular trafficking. Increased 
cellular migration occurs via IL-8 and IL-l chemotaxisis and endothelial activation, 
all of which have been observed after SLS irritation. 
EC expression of E-Selectin (CD62E), which binds to the CLA expressed on skin 
homing T lymphocytes and sialyl Lewis X on neutrophils accounts for residual T cell 
and neutrophil exocytosis important in immune surveillance. Irritation results in the 
release of stored IL-l from the SC (Nickoloff and Naidu, 1994). This IL-l acts 
together with TNFcx and IL-l ex secreted by subsequently activated KC, leading to 
endothelial cell activation and expression of E-Selectin, VCAM-1 (CD 1 06) and 
ICAM-1 (Dustin, 1986, reviewed by McKenzie and Sauder, 1990). These adhesion 
molecules, through interaction with leucocyte ligands, play a key role in leucocyte 
migration (reviewed by Barker and MacDonald, 1992). The intensity of endothelial 
cell ICAM-1 expression has been shown to correlate with the degree of dermal 
infiltration and is therefore a molecule of central importance in inflammation 
(Griffiths et a!, 1989). 
Although, in the case of NA irritation, neutrophils were seen in the papillary dermis 
by 6 hours this influx was not sustained. In contrast, SLS irritation caused the dermal 
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accumulation of higher numbers of neutrophils at 24 and 48 hours. High numbers of 
neutrophils have been noted previously in SLS reactions (Willis e( a/, 1989), as this 
data has confirmed. It is possible that the intrinsic chemical nature of SLS itself may 
in part be responsible for neutrophil infiltration. Ingression may also be brought 
about by the release of KC cytokines, including IL-8, which is a potent neutrophil 
chemoattractant (Barker et a/, 1992, Leonard and Yoshimura, 1990), the production 
of which occurs after SLS application. 
4.9. AUTOIMMUNITY 
In this thesis I have speculated that chronic ICD may be exacerbated by, or even 
represent an immune response to damaged epidermal components. If the early 
inflammatory response to epidermal irritation does not succeed in clearing the 
damage caused to the skin, 'damaged self -Ags may be processed and presented by 
epidermal LC. This may have no consequence unless the damage is widespread 
and/or prolonged, in which case self-tolerance may be broken down giving rise to 
autoimmunity. In some individuals response against damaged self tissue may 
become self maintaining, resulting in chronic dermatitis even after exposure to the 
original irritant has ceased. This phenomenon could explain the chronicity of lCD 
seen in a proportion of patients, despite all attempts to avoid irritants. 
In more than half of the chronic lCD lesions investigated in this study patients 
showed evidence of circulating auto-Abs directed against cutaneous components. 
Auto-Abs from the sera of one patient could detect an Ag of similar molecular weight 
in biopsies taken from chronic lesions in the majority of patients tested. This 
suggests this is not an isolated finding and that irritation results in specific self tissue 
damage or alteration resulting in auto-Ag formation. The antibodies present in the 
patient sera recognise an Ag of about 75kDa which is present in both epidermal and 
dermal lysates. Such an Ag could be LC derived as these cells migrate from the 
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epidermis into the dermis. However there are numerous other possibilities including 
example the Ag may represent an altered basement membrane component. 
Immunological cytotoxicity is an endpoint of the immune response, which in the 
skin, may involve destruction of tumours and exogenous micro-organisms. It is also 
a mechanism of disease induction, especially in autoimmunity. Adhesion molecules, 
such as ICAM-1, are essential for CD8+ve T lyrnphocyte/KC binding, activation and 
finally target lysis. Macrophages are also a effector of cytotoxicity producing a less 
specific response which is not dependant on KC activation and ICAM-1 expression. 
Norris has proposed that disease specific ICAM-1 induction is a determinant in 
disease initiation and for the pattern of the resultant damage (Norris, 1990). The 
state of KC differentiation influences ICAM-1 expression (Little et a/, 1996); 
therefore MHC II restricted cytotoxicity and the consequent epidermal damage is 
likely to occur in the basal or suprabasal layers where ICAM-1 expression is 
prominent. I have shown that experimentally induced SLS irritation results in T 
lymphocyte exocytosis from the blood stream and migration into the epidermis. This 
epidermal influx correlates with KC ICAM-1 expression. A proportion of these 
infiltrating cells are CD8+ve, the contribution of which increases with time of irritant 
exposure. I therefore propose a model of SLS irritation in which CD8+ve T 
lymphocyte mediated cytotoxity may play a central role in the epidermal damage 
seen after SLS application and could lead to induction of autoimmunity. 
This thesis has shown that, due to lack of detection of auto-Ag in normal skin, the 
release of an epidermally or dermally sequestered Ag is unlikely to contribute to 
autoimmunity. It is however possible that production of a neo-Ag may result in the 
induction of an autoimmune response. Irritant mediated alteration of self KCs, LCs, 
a constituent of the basement membrane or other cutaneous molecules could result in 
an Ab or cell mediated autoimmune response to this neo-Ag and may contribute to 
the chronicity of the disease. 
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4.10. GENERAL DISCUSSION 
The two irritants chosen for this study appear to interact with the skin in 
fundamentally different ways. The type of tissue damage and resultant cellular 
activation and infiltration induced is central to the outcome of the resultant irritant 
response. 
SLS 
SLS irritation induced a classical inflammatory response. Epidermal damage was 
evident and could be severe, with spongiosis, vesiculation and parakeratosis. I 
propose that this initial epidermal damage results in the release of primary cytokines 
such as IL-l and TNFa. These cytokines induce EC activation which leads to 
leucocyte extravasation and migration into the dermis and eventually the epidermis 
where they are involved in KC activation. KC activation, defined by MHC II and 
I CAM-I expression, may ·lead to further cytokine production, for example of the 
potent T cell and neutrophil chemoattractant IL-8. Increased IL-8 production could 
be one mechanism by which increased KC proliferation and parakeratosis occur in 
this irritant reaction. 
In this model I have suggested that CD4+ve CLA+ve memory T cells are recruited 
initially, resulting in increased KC activation, cytokine production and eventually 
naYve T cell (CD4+ve and CD8+ve) epidermal infiltration. I have speculated that the 
CD8+ve T cells may be cytotoxic in nature and result in further tissue damage. This 
would initiate a second release of primary cytokines and resultant memory T cell 
influx into the dermis, and finally, the epidermis. If the balance of inhibitory 
cytokines is insufficient then this irritant response may become self-perpetuating and 
result in chronic inflammation. It will be important to study the changing cytokine 
profiles of the irritant response to SLS to determine if this switch to CD8+ve T cell 
infiltration alters the cytokine environment. For instance, if an increase in pro-
inflammatory cytokines or down-regulation of inhibitory cytokines were described 
this would shed some light on the reasons for continued inflammation. The results 
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outlined in this study also suggest that an autoimmune response directed against 
CD8+ve T cell tissue damage or SLS altered self-Ag could contribute to chronicity. 
Previous reports in the literature suggest that LC migration is crucial only in response 
to allergen, however recent reports corroborated in this thesis strongly indicate that 
LC migration out of the epidermis may also occur during ICD reactions, particularly 
in the case of SLS (Mitulowska, 1994, Brand et a/, 1993, Brasch et a/, 1992,). The 
purpose of this LC migration is unclear, since lCD is reputed to be a T-cell 
independent reaction. I propose that the T cell response does have a role to play in 
lCD, and that LC migration may reflect a role in autoimmunity. The initial LC 
migration is probably a non-specific response to KC cytokine release but may 
eventually be part of an auto-Ag specific response. 
In conclusion, these studies indicate that chronic inflammation is complex involving 
the interactions of multiple factors, many of which are not accounted for in this 
model It seems likely that in the case of SLS irritation, unchecked inflammation 
resulting from aberrant cytokine profiles and extensive T cell infiltration contribute 
to the severity of the response. 
NA 
The epidermal response to NA irritation was much less dramatic resulting in minimal 
epidermal damage and inflammation. As with SLS irritation the initial skin insult 
would result in the release of primary cytokines such as IL-l and TNFa. These 
primary cytokines are responsible for the oedema observed. In the model I have 
proposed for NA irritation this initial insult has very different consequences from 
SLS. KC activation and the resultant T cell infiltration were not observed. One 
explanation would be the overall 'immunosuppressive' affect that NA exerts on the 
skin. NA results in LC apoptosis either directly or through induction of IL-l 0 and/or 
TGF-P. IL-l 0 induction would also account for the lack of KC activation as it down-
regulates IFNy induced MHC II expression. Other inhibitory cytokines, such as 
TGF-p, contribute to the dampening down of epidermal response through decreased 
KC proliferation and a consequently reduce the induction of chronic inflammation. 
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Production of pro-inflammatory cytokines such as IL-8 are decreased in this 
environment and may also contribute to the lack of KC proliferation and activation. 
NA irritation resulted in increased IL- l a. production, which is a potent inducer of IL-
8 (Matsushima and Oppenheim, 1989), but IL-8 production was not detected. The 
action of any one cytokine is therefore clearly dependent upon interactions with other 
factors. The whole epicutaneous environment should be taken into consideration 
before conclusions can be made concerning the influence of any particular factor. I 
feel that my findings agree with the theory put forward by Willis and colleagues 
(Willis et al, 1989) that a given pattern of cytokine production is specific for certain 
chemicals and/or irritants and may affect the way in which KC and LC contribute to 
inflammation. I would also suggest that NA and SLS appear to differentially affect 
cytokine production and induction of apoptosis. Further in situ hybridisation studies 
continuing on from the work presented in this thesis aim to define more clearly the 
distinct cytokine profiles induced by NA and SLS irritation. I propose that in depth 
investigation of the cytokine profiles initiated upon irritation and the changes 
undergone as the response progresses is the key to understanding chronic ICD. 
NA irritation dramatically influenced the more delicate LC population. The numbers 
of epidermal LC decreased substantially upon irritation. This reduction was due to 
extensive LC apoptosis and not as a result of migration. Thus in comparison with 
SLS, NA has a profoundly different effect on the LC population. NA destroys the 
epidermal LC population, and therefore decreases the capability for Ag specific 
immune responses to occur. Thus in the case of NA irritation autoimmunity is 
unlikely to play a major role. 
The data obtained from the LC study have revealed important differences in the LC 
population between normal volunteers and patients with chronic ICD. Patients have 
increased basal levels of LC, with fewer, shorter dendrites. These cells appear to be 
partially rounded up as if they are in a perpetually activated state ready to migrate 
from the epidermis immediately upon irritation. The KC in normal skin of these 
patients appear to be constitutively producing higher levels of IL-l a.. I conclude that 
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patients with chronic lCD have irritant 'sensitive' skin. This may result from the 
increased IL-l a production observed coupled with the fact that the LC population is 
activated and can therefore respond more rapidly and possibly to lower irritant 
concentrations than normal volunteers. In vitro functional studies require to be 
carried out on these two populations. Results from thls type of investigation may 
give some insight into why one person should be more susceptible to irritation than 
another. 
4.11. IS THIS A GOOD MODEL FOR CHRONIC lCD? 
The observations made in this study indicate that irritants are likely to produce a 
spectrum of reactions and therefore what is true for one may not be the case for 
another. This makes understanding of chronic lCD and potential therapeutic 
interventions complicated. 
The model of experimental irritation used here provides useful information 
concerning the irritant response at certain time-points. For instance, investigation of 
early time-points can provide details of the induction process. With this model it is 
also possible to study resolving irritant responses as the experimentally induced 
erythema disappears with time. This is as yet an unexplored area which may reveal 
anomalies, with chronic lCD reflecting poor resolution of the response. I speculate 
that altered cytokine profiles are pivotal with a lack of inhibitory factors such as IL-
l 0 and increased pro-inflammatory cytokines leading to the chronicity of 
inflanunation observed in some patients. 
Of course this model only investigates a single exposure to one irritant and a repeat 
exposure model may be closer to the situation in the real disease. Other factors must 
also be taken into consideration such as environmental factors and the influence of 
other irritants. It has also been suggested that the size of Finn chamber used can 
dramatically influence any resultant irritation (Mikulowska and Andersson, 1996). It 
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was shown that 48 hour application of 1% SLS in 8mm and 12 mm Finn chambers 
differentially affected the LC population. Application using the 8mm chambers 
could result in increased, unchanged or decreased LC numbers; whereas with the 12 
mm chambers a decrease in the LC population occurred. These data indicate that 
this model of experimental irritation must be used with caution. Comparisons are 
only of value if made between groups who have used the same irritant concentration 
and equivalent Finn chamber size. They also suggest that larger areas of skin may be 
required for adequate penetration of an irritant substance. Pilot tests should be 
carried out to determine if a particular experimental condition gives consistent results 
over time. In conclusion, I feel that the complex, multifactorial nature of chronic 
lCD requires creation of an animal model, using defmed conditions, allowing for a 
more detailed study. 
4.12. CONCLUSIONS 
The data presented here indicate that the pathological processes induced by NA and 
SLS are distinct despite equivalent clinical responses. 
SLS (Figure 4.2) 
SLS damaged the epidermis causing epidermal thickening, parakeratosis and severe 
spongiosis which often led to vesiculation. Increased basal layer proliferation was 
also induced, a factor contributing to the hyperplasia and parakeratosis observed. 
SLS irritation resulted in epidermal KC activation, probably through induction of IL-
l , IL-8 and probably TNFa. KC expression of MHC II and CD 54 was evident, 
enabling infiltrating T lymphocytes to interact with KC, thus leading to further 
cellular activation and cytokine production. ICAM-1 expression correlated with the 
epidermal T cell influx, which comprised CD4+ve and CD8+ve T cells. The 
presence of CD8+ve cytotoxic T lymphocytes may account for some of the epidermal 
damage observed. ICAM-1/LFA-1 binding is probably most important for trapping 
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FIGURE 4.2: 
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ofT cells in the epidermis, while chemotactic factors such as IL-l and IL-8 promote 
T cell recruitment. Heavy dermal infiltration was also observed, reflecting epidermal 
events. 
IL-8 production was detected, accounting in part for the increased epidermal and 
dermal cellular infiltration and increased KC proliferation. I propose that IL-l a (not 
measured) will also be induced, acting in synergy with IL-8 to produce endothelial 
activation and increased T cell recruitment. 
The LC population was slightly reduced by 48 hours after irritation. The reduction in 
number is thought to be due to migration to the draining lymph nodes under the 
control of cytokines produced by activated KC, such as GM-CSF and IL-l. The 
potential for Ag specific mediated responses remains intact after SLS irritation, 
unlike NA. This may affect chronicity by continued T cell activation and LC-
mediated autoimmunity towards a neo-Ag. 
NA (Figure 4.3) 
NA irritation had a minimal effect on epidermal architecture, resulting in mild 
spongiosis and a degree of parakeratosis. The oedema observed was probably 
induced as a result of IL-l a release from the granular layer. However, the epidermal 
cellular population was affected by irritation, with basal KC proliferation decreasing 
at 24 hours. This was a transient phase with proliferation levels returning to normal 
by 48 hours. Decreased proliferation may be mediated by increased levels of TGF-~ 
and IFNy (neither measured) and/or decreased levels of KC growth factors such as 
IL-8 and IL-6. IL-8 induction was not observed after NA application, therefore 
decreased levels of this cytokine may be an important factor. 
NA failed to induce KC activation or T cell infiltration, although epidermal 
macrophage infiltration was evident. Nevertheless, IL-l a was detectable, and should 
therefore have induced KC activation and T cell exocytosis from the blood into the 
dermis and epidermis. Lack of activation may result from increased levels of 
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FIGURE4.3: 
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regulatory molecules such as IL-l RA or IL-l R2 and/or decreased IL-l R I expression. 
Lack of KC activation, and therefore MHC II and I CAM-I expression, mean that any 
T cells recruited through IL- l chemotaxis had no method of binding to KC in order 
to remain in the epidermis to become activated. The existence of epidermal 
macrophages suggests that T cell recruitment did occur and that it was failure of 
epidermal trapping that resulted in the lack of epidermal T cell infiltration observed. 
NA had a dramatic influence on the epidermal LC population by causmg a 
redistribution and eventual decrease in LC by apoptosis. Although apoptosis 
induction may be a direct effect of irritation its more likely to be cytokine mediated. 
The lack of epidermal LCs means that the ability to initiate Ag-specific T cell 
mediated responses is greatly diminished. In lCD this could be beneficial as it would 
reduce the possibility of autoimmunity a feature which could be utilised 
therapeutically. But in normal individuals it may be detrimental by dampening down 
an important aspect ofthe skin's protective function. 
4.13. FUTURE STUDIES 
I would extend the projects investigation of the presence of auto-Abs in patients with 
chronic lCD. An increase in the numbers of patients in study would be required to 
confirm the presence of an auto-Ag. Purification of the auto-Ag from the gel would 
allow characterisation of the physical and chemical properties of this molecule. 
An animal model is required for in depth studies into the cellular and molecular 
mechanisms involved in the onset and maintenance of chronic lCD. It is possible 
that this purified auto-Ag could be used in the creation of an animal model for 
chronic ICD. Creation of an animal model, through repeat irritant exposure, would 
be of great value in this field. 
152 
The purified Ag could be injected into a rabbit in order to produce specific polyclonal 
Abs. These specific Abs could then be used in immunohistochemical and Western 
blotting studies to determine the nature of the Ag. For instance does it bind LC or 
KC on tissue sections or LC lysates on Western blots ? 
In vitro studies in conjunction with in vivo investigations in an animal model could 
provide valuable information not easily obtainable from human volunteers and 
patients with chronic lCD. Functional studies should be carried out on LCs isolated 
from clinically normal skin of patients with chronic lCD. These LC populations 
could then be compared with normal human LCs in order to ascertain any 
fundamental differences in these populations. Investigation into the functional 
significance of CD95/fas expression on KC and LC could also be important. Is there 
any difference in CD95 function between cells derived from patients with chronic 
ICD and normal healthy volunteers? How do these different cell types respond to 
irritant exposure? What is the influence of cytokines, e.g. IL-10, TGFp, on the 
function of CD95/fas and other adhesion/accessory molecules ? 
It is of course important to carry out basic functional studies using both the in vitro 
and animal model systems. Studies could include investigation of KC and LC 
responses to various irritant stimuli, cytokine production and expression of activation 
markers. Examination of the influence of various cytokines, growth factors and anti-
cytokine Abs could provide information about the control of irritant reactions. 
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APPENDIX I 
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TABLE I : Patient details contd. 
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APPENDIX II 
1). Solutions required for immunohistochemistry. 
All chemicals purchased from Sigma unless otherwise stated. 
Fast Red 
Napthol AS-MX Phosphate 2mg 
N,N-dimethylformamide 0.2ml 
O.lM Tris Buffer pH8.2 9.8ml 
l.OM levamisole 1 OJ-11 
Fast red TR 1 Omg 
Filtered before use 
D 'I f fb d' eta1 s o an 1 o 1es use d on para ffi f f m 1ssue sec 1ons 
ANTIBODY SOURCE CODE 
Mast cell tryptase DAKO Ltd M7052 
MIB-1 Immunotech 0505 
CD68 DAKO Ltd. M0876 
CD15 DAKP Ltd. M0733 
CDla Immunotech 1590 
Bcl-2 DAKO Ltd. M0887 
Bax Satacruz Biotechnology, Inc SC-930 
Bcl-x Satacruz Biotechnology, Inc SC-1690 
CD95 Satacruz Biotechnology, Inc SC-715 
Details of antibodies used on frozen tissue sections 
ANTIBODY SOURCE CODE 
CD3 DAKOLtd. M0835 
CD4 DAKO Ltd. M0716 
CD& DAKO Ltd. M0707 
CD 54 Genzyme 2136-01 
IFNy Chern icon 22-19 
L243 Keith Guy -
CD1a DAKOLtd. M0721 





















2). Solutions required for gel electrophoresis and Western Blotting. 
All chemicals purchased from Sigma unless otherwise stated. 
10% Separating Gel (lOml) 
Distilled Water 
1.5M Tris-HCL pH8.8 
10% WN SDS 
Acrylamide/Bis 30% (Flowgen) 
1 0% ammonium persulphate 
TEMED 
4% Stacking Gel (lOml) 
Distilled Water 
0.5M Tris-HCL pH66.8 
10% WN SDS 
Acrylamide/Bis 30% (Flowgen) 
10% ammonium persulphate 
TEMED 




Distilled Water 300m! 
Sample Buffer 
SOmM Tris-HCL (pH 6.8) 
1 OOmM dithiothreitol 
2% Sodium Laury! sulfate 














Alkaline phosphatase buffer (pH9.0) 
I ris 6.05g 
NaCl 2.92g 
4M MgCl 1.25ml 









Alkaline phosphatase buffer (pH9.0) 
Tris 6.05g 
NaCl 2.92g 
4M MgCl 1.25ml 
Distilled Water 500ml 
NBT/BCIP Substrate solution 
NBT 66~1 
BCIP 33 ~I 
Alkaline phosphate 1 0 ml 
buffer 
NBT - stock 75mg/ml in 70% dimethyl formamide 
BCIP - stock 50mg/ml in dimethyl formamide 
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Graph shows mean erythema readings at 0, 1, 6, 24 and 48 hours 
after DL application. (n=9) 
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Graph shows mean erythema readings at 0, 1, 6, 24 and 48 hours 
after NA application (n=14) 
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1. Friedman Test 
DL (basal layer IO) comparison of control, l and 6hr biopsies p<0.05 
Spongiosis 
1. Friedman Test 
SLS (prickle layer SP) comparison of control, l and 6hr biopsies 
(prickle layer SP) comparison of controL 24 and 48hr biopsies 
2. McNemar Test 
SLS con vs 48 hrs p<0.02 
Vesiculation 
SLS 24hrs 2/8 (basal) and 2/8 (prickle) 
48hrs 3/8 (basal and prickle) 
NOT SIGNIFICANT probably due to small sample size 
Para keratosis 
SLS 24hrs 3/7 positive biopsies 
48hrs 4/7 positive biopsies 




2. Eosinophil Recruitment 
1) SLS 
EPIDERMAL 
24 hrs 2/8 biopsies 
48 hrs 118 biopsies 
PAPILLARY DERMIS 
24 hrs 2/8 biopsies 
RETICULAR DERMIS 
6 hrs 3116 biopsies 
24 hrs 2/8 biopsies 
48 hrs 3/8 biopsies 
2). NA 
EPIDERMAL 
24 hrs 1/7 biopsies 
PAPILLARY DERMIS 
1 hr 2117 biopsies 
6 hrs 311 7 biopsies 
RETICULAR 
6 hrs 4/17 biopsies 
PERIVASCULAR 
6 hrs 6/16 biopsies 
24 hrs 3/8 biopsies 
48 hrs 3/8 biopsies 
PERIVASCULAR 
1 hr 3/ 17 biopsies 
6 hrs 411 7 biopsies 
48 hrs 1/7 biopsies 
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3. Average Epidermal Thickness (J.lm) 
a) NA 
STATISTICS CONTROL 1 Hour 6 Hours 
65.5 128.3 77.7 
84 109 91 
69 75 89.5 
87 63 70 
50 50 87.3 
70.3 71.6 78.7 
80.3 94.5 96 
60.6 62.8 64.5 
67.3 64.3 66.5 
50 62 60 
83.5 82.3 85.3 
74.3 73.4 60 
43.8 62.3 71.3 
102 81 95 
92.7 83 .8 11 1.3 
54.7 70 60.8 
N 16 16 16 
MEAN 70.9 77.1 79.1 
MEDIAN 69.7 72.5 78.2 
SE 4.2 5.0 3.8 
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b) SLS 
STATISTICS CONTROL 24 Hours 48 Hours 
57 78.5 171 
65.7 52 76.7 
57 58.7 106.5 
54 56.7 73.7 
42 196 82 
67.7 84.3 108 
52 62.3 89.5 
N 7 7 7 
MEAN 56.5 84.1 101.1 
MEDIAN 57.0 62.3 89.5 
SE .., " .) . .) 19.2 12.7 
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Average Epidermal Thickness contd. 
1. Friedman Test 
NA comparison of control, 1 and 6 hour biopsies 
SLS comparison of control, 24 and 48 hour biopsies 
2. McNemar Test 
SLS control vs 48 hours p<0.02 
3. Wilcoxon-Signed Rank Sum Test 
NA control vs 6 hours p<0.04 
SLS control vs 48 hours p<0.02 
4. Mann Whitney-U Test 





Basal Layer Apoptosis 
NA 
No. apoptotic cells/mm basement membrane. 
STATISTICS CONTROL 24 Hours 48 Hours 
0 0.2 1.4 
0 1.9 5.2 
0.3 0.5 0.2 
0 0.2 0.4 
0 6.4 0 
0 1.0 0.4 
0 2 .8 1.6 
N 7 7 7 
MEAN 0.04 1.9 1.3 
MEDIAN 0 1.0 0.4 
SE 0.04 0.8 0.7 
1. Friedman Test 
Na comparison of control, 24 and 48hr biopsies p<O.l (not significant) 
2. McNemar Test 
A control vs 24hrs p<0.03 
3. Wilcoxon-signed ranks sum test 
NA control vs 24 hrs p<0.02 
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4. Mann Whitney-U Test 
NA vs SLS 
6hrs p<O. 002 
24hrs p<0.04 
Priclde Layer Apoptosis 
NA 
No. apoptotic cells/mm basement membrane 
















N 15 15 
MEAN 0.02 0.08 
MEDIAN 0 0 






















1. Friedman Test 
NA comparison of control, 1 and 6hr biopsies not significant 
5. Epidermal proliferation 
No. proliferating cells/mm basement membrane, after application with a) NA or 
b)SLS. 
a) Results after NA application, No. Ki-67+ve cells/mm basement membrane 
STATISTICS CONTROL 24 Hours 48 Hours 
17.8 17.1 44.5 
128.8 10.7 78 
38.6 13.5 38.6 
31.9 6.9 82.7 
29 25. 1 39.8 
13.3 13.3 47.3 
N 6 6 6 
MEAN 43.2 14.4 55.2 
MEDIAN 30.5 13.4 45.9 
SE 17.5 2.5 8.1 
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b) Results after SLS application, No. Ki-67+ve cells/mm basement membrane 
STATISTICS CONTROL 24 Hours 48 Hours 
24.9 8.7 49.3 
29 32.1 30.2 
45 46.7 2 12.1 
12.8 16.4 117.1 
27.4 37.6 39.3 
38.2 25.2 63 
N 6 6 6 
MEAN 29.6 27.8 85.2 
MEDIAN 28.2 28.6 56.2 
SE 4.5 5.7 28.3 
1. Friedman Test 
NA -Comparison of control. 24 and 48 hours showed significant change p<0.05. 
SLS- Comparison of control, 24 and 48 hours showed significant change p<0.05. 
2. McNemar Test 
SLS- Control vs 48 hours p<0.03 
NA- control vs 24 hrs p<0.04 
24 hrs vs 48 hrs p<0.03 
3. Wicoxon-Signed Rank Sum Test 
SLS control vs 48 hours p<0.04 
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6. CD3/CD4/CD8 - Epidermal Results 
No CD3+ve cells/mm basement membrane after SLS application. 
STATISTICS CONTROL 24 Hours 48 Hours 
9 50.5 37.2 
0 5.7 12.9 
0 17.5 11.7 
0 0 8.1 
0 14.4 13.9 
0 14.1 17.3 
0 15 3.2 
N 7 7 7 
MEAN 1.3 16.7 14.9 
MEDfAN 0 14.4 12.9 
SE 1.3 6.1 4.1 
1. Friedman Test 
SLS - Comparison of control, 24 and 48 hr biopsies p<O.O 1 
2. MeN emar Test 
SLS control vs 24 hrs 
control vs 48 hrs 
CD4/CD8 Ratio 
24hrs 3: I 




3. Wilcoxon-Signed Rank Sum Test 
SLS CD3 control vs 24 hours p<0.04 
control vs 48 hours p<0.02 
7. CD68 - Epidermal Results 
a) Results after NA application, No. CD68+ve cells/mm basement membrane 
STATISTICS CONTROL 24 Hours 48 Hours 
0 0 1.1 
0 13 6.3 
0 1.7 1.5 
0 1.9 1.2 
0 0.1 7.1 
0 18.8 10.6 
0 3.7 2.3 
N 7 7 7 
MEAN 0 5.6 4.3 
MEDIAN 0 1.9 2.3 
SE 0 2.7 1.4 
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b) Results after SLS application, No.CD68 +ve cells/mm basement membrane 









N 8 8 
MEAN 0.1 3.7 
MEDIAN 0 1.8 
SE O.l 2.0 
1. Friedman Test 
NA comparison of control, 24 and 48 hr biopsies 
SLS comparision of control , 24 and 48 hr biopsies 
2. McNemar Test 
NA control vs 24 hrs 
control vs 48 hrs 




3. Wilcoxon-Signed Ranks Test 
NA control vs 24 hrs 
control vs 48 hrs 




















8. CD54 - Epidermal Results 
SLS controls - no focal expression 
1 hr - no focal expression 
6 hrs - 5114 biopsies showed focal expression 
24 hrs - 4/6 biopsies showed focal expression 
48 hrs -4/5 biopsies showed focal expression 
(not significant by McNemar test, due to small numbers) 
Intense focal CD 54 expression in the epidermis correlated ( 100%) with sites of 
CD3+ve lymphocyte exocytosis, although CD3+ve cells were found in areas lacking 
CD54 expression. Only 15% (5/34) biopsies without CD54 expression showed 
CD3+ve lymphocyte excocytosis. 
9. Langerhans Cells - Epidermal Results 
a) Results after NA application, No.CD1a +ve ce!ls/mm basement membrane 
STATISTICS CONTROL 24 Hours 48 Hours 
21.3 9 ND 
10.6 2.9 0.8 
9.2 5.8 0.5 
19 5.6 5.4 
13.5 9 3.5 
11.7 10.2 5 
N 6 6 5 
MEAN 14.2 7.1 3.0 
MEDIAN 12.5 7.4 3.5 
SE 2.0 1. 1 1.0 
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b) Results after SLS application, No.CDla +ve cells/mm basement membrane 
STATISTICS CONTROL 1 Hour 6 Hours 
6.6 9.4 5.3 
5.6 11 9. 1 
15.7 8.9 7.6 
7.8 8.6 4.11 
8.6 8.1 8 
7.6 8.6 7.2 
16.3 25.6 18.2 
13 14.9 18.8 
12.8 14.3 16.7 
12.9 12.9 7.9 
11.6 8 9.1 
15.4 5 2.5 
N 12 12 12 
MEAN 11.2 11.3 9.5 
MEDIAN 12.2 9.2 8.0 
SE 1.1 1.5 1.6 
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b) Results after SLS application, No.CD1a +ve cells/nun basement membrane 
STATISTICS CONTROL 24 Hours 48 Hours 
8.6 10 5.5 
24.6 18.6 19.2 
17.6 11.5 10.7 
20.2 11.1 5.7 
10.5 9.6 8.9 
30 31 11.2 
N 6 6 6 
MEAN 18.6 15.3 10.22 
MEDIAN 19.0 11.3 9.8 
SE 3.3 3.4 2.1 
1. Friedman Test 
NA comparison of control, 24 and 48hr biopsies p<0.01 
SLS comparison of control, 1 nad 6hr biopsies p<0.05 
comparision of contro, 24 and 48hr biopsies p<0.05 
2. MeN emar Test 
NA control vs 24hrs 
SLS control vs 48hrs 
p<0.03 
p<0.03 
3. Mann Whitney-U Test 
Comparision ofNA and SLS 
24hrs p<O.O 1 
48hrs p<0.008 
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4. Wilcoxon-Signed Ranks Test 
NA control vs 24 hrs 
SLS control vs 48 hrs 
p<0.04 
p<0.04 
Basal Layer CDla Apoptosis 
A I hr 2/ 15 biopsies 
6 hrs 1115 biopsies 
24 hrs 3/7 biopsies 
48 hrs 1/7 biopsies 
SLS 48 nrs 1/7 biopsies 
Prickle Layer CDla Apoptosis 
NA 1 hr 1/ 15 biopsies 
6 nrs 1/15 biopsies 
24 hrs 4/7 biopsies 
48 hrs I 17 biopsies 
Table I: Shows the percentage (and number of positive biopsies) of mean 
number of CD 1 a+ve apoptotic cells in the total apoptotic cell 
population after application of NA for 1, 6, 24 and 48 hours. 
TIMEPOfNT BASAL LAYER PRICKLE LAYER 
o/o(N) % (N) 
I Hour 31 (2) l 00 ( 1) 
6 Hours 14 (3) l 00 (3) 
24 Hours 50 (4) 86 (4) 
48 Hours 50 (2) 85 (2) 
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Table 2: Shows the percentage (and number ofbiopsies) of mean number and 
apoptotic CD 1 a+ve cells in the total CD 1 a population. 
TIMEPOfNT BASAL LAYER PRICKLE LAYER 
% (N) % (N) 
1 Hour 5 (2) 2 (2) 
6 Hours 2 (1) 0 (1) 
24 Hours 7 (4) 60 (4) 
48 Hours 14 (1) 57 (1) 
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10. CD15 - Dermal Results 
a) NA -number of CD 15+ve cells/mm2 dermis 
STATISTICS CONTROL 1 Hour 6 Hours 
0 0 17.3 
0 5.1 48.8 
0 1.4 14.1 
0 2.1 22.8 
0 0 10.3 
0 0 33.4 
0 0 10.7 
0 0 12.5 
0 0 36.3 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
N 17 17 17 
MEAN 0 0.5 12.1 
MEDIAN 0 0 10.3 
SE 0 0.3 3.7 
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1. Friedman Test 
NA comparison of control, 1 and 6 hour biopsies p<O.OS 
2. McNemar Test 
NA control vs 6hrs p<0.04 
3. Wilcoxon-Signed Ranks Test 
NA control vs 6 hrs p<0.009 
4. Mann-Whitney U Test 
NA vs SLS 6 hrs p<0.04 
11. MAST CELLS 
No epidermal mast cell infiltrate was observed afte NA or SLS irritation. 
Dermal mast cells were observed in all biopsies but no significant difference was 
foun between the different timepoints or irritants . 
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12. Western blottting raw data 
1 ). Dermal Extracts 
DISTANCE IRA VELLED 
PATIENT 1 PATIENT2 PATIENT3 PATIENT 4 
Dye fi·ont 56mm 54mm 50mm 53 nun 
M. Wt. Marker 
148 kDa 8.5 5 2 
..., 
.) 
60kDA 23 18 15 16.5 
42 kDA 32 26.5 22.5 25 
30kDA 42.5 37 32.5 34 
22 kDA 47 42 38.5 40 
17 kDA 54 49 45 47 
BAND 21 18 15.5 17.5 
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Relative mobility of molecular weights and specific bands. 
RELATIVE MOBIL1TY 
PATIENT! BATIENT2 PATJENT3 PATIENT4 
148 kDa 0.15 0.09 0.04 0.06 
60kDA 0.41 0.33 0.30 0.31 
42 kDA 0.57 0.49 0.45 0.47 
30 kDA 0.76 0.69 0.65 0.64 
22 kDA 0.84 0.78 0.77 0.75 
17kDA 0.96 0.91 0.90 0.89 
Band 0.38 0.33 0.31 0.33 
M. Wt (band) 77 kDa 77kDa 78 kDa 71 kDA 
2) Epidermal Extracts 
DISTANCE TRAVELLED 
PATIENT 1 PATIENT4 
Dye front 57 54 
M. Wt. Marker 
148 kDa 4 3 
60 kDA 17 16 
42 kDA 25 23 
30 kDA 35 33 
22kDA 40 39 
17kDA 49 4715 
BAND 15 15 
21 1 
Relative mobility of molecular weights and specific bands. 
RELATIVE MOBILITY 
PATIENT 1 PATIENT 4 
148 kDa 0.07 0.06 
60kDA 0.3 0.3 
42 kDA 0.48 0.43 
30 kDA 0.61 0.61 
22 kDA 0.7 0.72 
17 kDA 0.86 0.87 
Band 0.26 0.28 
M. Wt (band) 73 kDA 75 kDA 
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